data_2djj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2djj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 50.8 Cg_endo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.765 0.235 . . . . 72.519999999999996 112.326 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 65' ' ' ILE . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.010000000000005 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.120000000000005 111.651 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.409999999999997 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 16' ' ' ASN . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.120000000000005 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.268 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.329999999999998 110.857 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.230000000000004 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.129999999999995 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 33.7 m120 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.340000000000003 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.430000000000007 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 20' ' ' ILE . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 72.420000000000002 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.310000000000002 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.329999999999998 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.319999999999993 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 54.039999999999999 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 72.430000000000007 109.855 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.340000000000003 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.439999999999998 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.200000000000003 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.239999999999995 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.209999999999994 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.120000000000005 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.209999999999994 109.434 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.399999999999999 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.209999999999994 111.51 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.400000000000006 111.075 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.010000000000005 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 55.030000000000001 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.230000000000004 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.230000000000004 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.527 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.319999999999993 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.140000000000001 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.439999999999998 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.310000000000002 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 73.340000000000003 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.509999999999998 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 38.030000000000001 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.319999999999993 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 57' ' ' SER . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.329999999999998 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.340000000000003 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.310000000000002 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.319999999999993 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 64.140000000000001 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 75.109999999999999 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.450000000000003 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 75.439999999999998 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.520000000000003 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HD3' ' CD1' ' A' ' 118' ' ' TYR . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.150000000000006 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 73.200000000000003 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 111.774 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.409999999999997 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.120000000000005 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 111.422 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.310000000000002 110.169 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.119999999999997 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 HG22 ' HD3' ' A' ' 35' ' ' PRO . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.430000000000007 111.521 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.209999999999994 110.824 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.239999999999995 110.932 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 54.549999999999997 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.099999999999994 111.152 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.420000000000002 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.219999999999999 111.118 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 120.899 0.291 . . . . 54.439999999999998 112.262 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 63.100000000000001 111.232 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.340000000000003 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.404 ' HD2' ' CE2' ' A' ' 32' ' ' PHE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.150000000000006 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.428 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 71.150000000000006 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.632 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.150000000000006 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.409999999999997 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.239999999999995 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.439999999999998 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.420000000000002 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.329999999999998 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.489 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.409999999999997 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.46 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.030000000000001 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.430000000000007 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 53.310000000000002 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.100000000000001 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.130000000000003 112.842 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.230000000000004 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.420000000000002 110.778 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.407 HG21 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.229999999999997 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.150000000000006 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 74.209999999999994 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.140000000000001 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.409999999999997 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 74.439999999999998 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.340000000000003 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.520000000000003 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.230000000000004 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.130000000000003 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 75.450000000000003 108.375 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 75.420000000000002 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 75.209999999999994 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.457 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 74.329999999999998 111.11 179.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 CA-C-O 121.027 0.345 . . . . 72.519999999999996 112.42 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 65' ' ' ILE . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.010000000000005 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.120000000000005 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.13 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.120000000000005 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.010000000000005 110.38 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.329999999999998 111.228 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.129999999999995 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.340000000000003 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.430000000000007 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 20' ' ' ILE . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 72.420000000000002 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.310000000000002 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.239999999999995 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.329999999999998 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.319999999999993 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 54.039999999999999 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.120000000000005 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 72.430000000000007 109.557 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.340000000000003 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.439999999999998 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.200000000000003 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.239999999999995 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.209999999999994 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.120000000000005 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.209999999999994 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.399999999999999 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.417 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.209999999999994 111.511 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.257 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.010000000000005 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 55.030000000000001 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.519999999999996 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.319999999999993 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.450000000000003 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.140000000000001 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.439999999999998 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.557 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.310000000000002 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 73.340000000000003 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.509999999999998 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 74.230000000000004 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 38.030000000000001 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.319999999999993 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.329999999999998 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.340000000000003 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.310000000000002 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.319999999999993 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 64.140000000000001 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 75.109999999999999 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.450000000000003 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 75.439999999999998 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.520000000000003 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.150000000000006 110.047 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 73.200000000000003 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.129999999999995 111.903 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.484 HG23 ' CE2' ' A' ' 47' ' ' TYR . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.409999999999997 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.120000000000005 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.701 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.310000000000002 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.119999999999997 112.176 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.430000000000007 111.824 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.209999999999994 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.239999999999995 111.316 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 54.549999999999997 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.21 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.420000000000002 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.219999999999999 111.093 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 CA-C-O 120.972 0.322 . . . . 54.439999999999998 112.401 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 63.100000000000001 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.340000000000003 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.150000000000006 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.511 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 71.150000000000006 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.487 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.150000000000006 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.409999999999997 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.239999999999995 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.439999999999998 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.420000000000002 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 74.430000000000007 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.409999999999997 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.030000000000001 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.430000000000007 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 53.310000000000002 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.100000000000001 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.130000000000003 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.230000000000004 111.08 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 102' ' ' SER . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.420000000000002 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.049 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' CD1' ' HD3' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 74.209999999999994 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.140000000000001 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.409999999999997 109.949 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 74.439999999999998 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.541 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 75.329999999999998 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.520000000000003 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.230000000000004 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.130000000000003 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 75.450000000000003 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 75.420000000000002 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 75.209999999999994 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.43 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.400000000000006 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 74.329999999999998 111.049 179.892 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.006 0.336 . . . . 72.519999999999996 112.041 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.010000000000005 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.120000000000005 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.409999999999997 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 16' ' ' ASN . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.98 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.230000000000004 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CD1' ' CD1' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 p-10 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.340000000000003 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.6 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.430000000000007 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.6 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 72.420000000000002 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.310000000000002 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.239999999999995 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.319999999999993 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 54.039999999999999 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.120000000000005 110.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 110.158 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.439999999999998 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CD1' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.200000000000003 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.239999999999995 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.209999999999994 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.120000000000005 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.209999999999994 109.634 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.399999999999999 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.209999999999994 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.400000000000006 111.186 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.010000000000005 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 55.030000000000001 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.519999999999996 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.450000000000003 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.140000000000001 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.439999999999998 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.310000000000002 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.509999999999998 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 74.230000000000004 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 38.030000000000001 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.319999999999993 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.329999999999998 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.340000000000003 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.310000000000002 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.319999999999993 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 64.140000000000001 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 75.109999999999999 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.450000000000003 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 75.439999999999998 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.520000000000003 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.150000000000006 110.056 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 73.200000000000003 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.129999999999995 112.122 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.409999999999997 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.120000000000005 112.349 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 30' ' ' ILE . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.450000000000003 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.310000000000002 110.358 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.119999999999997 111.776 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.430000000000007 111.633 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.209999999999994 111.169 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 111.101 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 54.549999999999997 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.099999999999994 111.249 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.420000000000002 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.219999999999999 110.936 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 N-CA-C 113.286 0.456 . . . . 54.439999999999998 113.286 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 85' ' ' ILE . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 63.100000000000001 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.340000000000003 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.150000000000006 110.871 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 71.150000000000006 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.150000000000006 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.409999999999997 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.239999999999995 108.238 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.439999999999998 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.420000000000002 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.329999999999998 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 74.430000000000007 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.409999999999997 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.421 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.030000000000001 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.430000000000007 109.354 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 53.310000000000002 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.130000000000003 113.003 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.230000000000004 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.420000000000002 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.436 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.229999999999997 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 74.209999999999994 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.140000000000001 109.232 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.409999999999997 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 74.439999999999998 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.49 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 75.329999999999998 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.340000000000003 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.520000000000003 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.130000000000003 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 75.450000000000003 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 75.420000000000002 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 75.209999999999994 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 74.329999999999998 111.091 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.038 0.349 . . . . 72.519999999999996 112.703 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.010000000000005 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 111.89 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.409999999999997 109.723 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 109.978 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.329999999999998 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.230000000000004 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.129999999999995 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.340000000000003 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.430000000000007 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 20' ' ' ILE . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 72.420000000000002 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.310000000000002 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.239999999999995 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.329999999999998 110.505 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 54.039999999999999 111.042 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.569 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 72.430000000000007 109.697 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.340000000000003 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 66' ' ' ALA . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.439999999999998 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.200000000000003 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.239999999999995 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.547 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.209999999999994 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.120000000000005 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.209999999999994 109.57 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.399999999999999 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.209999999999994 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.400000000000006 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.010000000000005 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 55.030000000000001 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.230000000000004 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.230000000000004 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.319999999999993 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.450000000000003 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.140000000000001 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.439999999999998 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.310000000000002 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 73.340000000000003 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.509999999999998 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 74.230000000000004 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 38.030000000000001 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.319999999999993 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.329999999999998 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.340000000000003 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.310000000000002 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.319999999999993 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 64.140000000000001 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.450000000000003 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 75.439999999999998 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.520000000000003 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.150000000000006 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 73.200000000000003 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.129999999999995 111.566 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.120000000000005 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' CB ' ' ND2' ' A' ' 73' ' ' ASN . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.310000000000002 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.119999999999997 111.596 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.430000000000007 111.707 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 110.884 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 54.549999999999997 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.099999999999994 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.420000000000002 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.819 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.618 0.174 . . . . 54.439999999999998 112.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 85' ' ' ILE . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 63.100000000000001 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.624 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.340000000000003 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.150000000000006 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.489 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 71.150000000000006 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.150000000000006 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.409999999999997 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.239999999999995 108.837 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.439999999999998 112.302 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.441 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.420000000000002 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.146 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 74.430000000000007 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.409999999999997 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.030000000000001 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.430000000000007 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 53.310000000000002 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.130000000000003 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.230000000000004 109.13 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.420000000000002 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.229999999999997 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.150000000000006 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 74.209999999999994 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.140000000000001 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.409999999999997 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 74.439999999999998 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.517 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 75.329999999999998 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.340000000000003 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.520000000000003 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.230000000000004 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.130000000000003 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 75.450000000000003 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 75.420000000000002 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 75.209999999999994 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.432 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 74.329999999999998 111.138 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.932 0.305 . . . . 72.519999999999996 112.576 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.010000000000005 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.120000000000005 111.484 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.409999999999997 109.633 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.329999999999998 110.889 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.230000000000004 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.129999999999995 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.340000000000003 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.622 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.430000000000007 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.622 HG12 ' CG ' ' A' ' 19' ' ' GLU . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 72.420000000000002 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.310000000000002 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.239999999999995 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.329999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.319999999999993 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 54.039999999999999 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.120000000000005 110.513 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 72.430000000000007 109.624 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.340000000000003 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.439999999999998 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.200000000000003 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.209999999999994 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.120000000000005 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.209999999999994 109.596 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.399999999999999 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.568 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.209999999999994 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 111.624 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.010000000000005 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 55.030000000000001 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.230000000000004 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.519999999999996 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.230000000000004 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' C ' ' HD2' ' A' ' 45' ' ' PRO . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.319999999999993 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.450000000000003 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.140000000000001 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.439999999999998 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.310000000000002 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.509999999999998 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 74.230000000000004 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 38.030000000000001 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.319999999999993 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.329999999999998 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.310000000000002 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.319999999999993 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 64.140000000000001 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 75.109999999999999 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.450000000000003 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 75.439999999999998 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.520000000000003 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.150000000000006 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 54' ' ' TYR . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 73.200000000000003 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.120000000000005 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.450000000000003 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.310000000000002 110.587 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 111.78 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.430000000000007 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.209999999999994 111.217 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.239999999999995 111.069 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 54.549999999999997 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.4 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.420000000000002 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.918 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.757 0.232 . . . . 54.439999999999998 112.152 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 63.100000000000001 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.340000000000003 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.150000000000006 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 71.150000000000006 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.150000000000006 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.409999999999997 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.239999999999995 108.895 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.439999999999998 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.420000000000002 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 74.430000000000007 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.409999999999997 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 87' ' ' LEU . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.030000000000001 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.430000000000007 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 53.310000000000002 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.100000000000001 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.130000000000003 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.230000000000004 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.420000000000002 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 46' ' ' LYS . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.229999999999997 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.150000000000006 110.099 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 46' ' ' LYS . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.409999999999997 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 74.439999999999998 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.340000000000003 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.520000000000003 108.653 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.230000000000004 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.130000000000003 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 75.450000000000003 108.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 75.420000000000002 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 75.209999999999994 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.43 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.400000000000006 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 74.329999999999998 111.13 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo . . . . . 0 N--CA 1.46 -0.473 0 CA-C-O 120.835 0.264 . . . . 72.519999999999996 112.511 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 10' ' ' THR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.010000000000005 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 9' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.120000000000005 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.409999999999997 109.463 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 16' ' ' ASN . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.120000000000005 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.010000000000005 110.067 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.329999999999998 111.126 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.230000000000004 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.129999999999995 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.340000000000003 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.430000000000007 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 72.420000000000002 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.239999999999995 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' CG2' ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.329999999999998 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.319999999999993 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 54.039999999999999 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.120000000000005 110.897 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 72.430000000000007 109.816 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.439999999999998 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.200000000000003 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.239999999999995 111.603 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.120000000000005 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.209999999999994 109.761 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.399999999999999 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.209999999999994 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.400000000000006 111.172 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.010000000000005 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 55.030000000000001 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.230000000000004 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.519999999999996 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.230000000000004 110.097 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.319999999999993 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.450000000000003 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.140000000000001 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.439999999999998 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.428 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.310000000000002 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 73.340000000000003 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.509999999999998 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 74.230000000000004 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 38.030000000000001 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.319999999999993 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.329999999999998 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.310000000000002 112.124 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.319999999999993 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.450000000000003 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 75.439999999999998 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.150000000000006 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 54' ' ' TYR . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 73.200000000000003 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.129999999999995 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 54' ' ' TYR . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.409999999999997 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.120000000000005 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' CG1' ' CD1' ' A' ' 32' ' ' PHE . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.406 ' CB ' ' ND2' ' A' ' 73' ' ' ASN . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.310000000000002 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.119999999999997 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.430000000000007 111.567 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.209999999999994 110.858 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.406 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 22.0 m-80 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.239999999999995 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 54.549999999999997 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.099999999999994 111.114 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.219999999999999 110.991 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.785 0.244 . . . . 54.439999999999998 112.293 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 63.100000000000001 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.340000000000003 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.150000000000006 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 71.150000000000006 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.150000000000006 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.461 ' O ' ' CE ' ' A' ' 93' ' ' LYS . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.409999999999997 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.239999999999995 108.72 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.439999999999998 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.420000000000002 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 95' ' ' GLN . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.409999999999997 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.030000000000001 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.41 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.430000000000007 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 53.310000000000002 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.100000000000001 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.130000000000003 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.230000000000004 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.420000000000002 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.229999999999997 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 74.209999999999994 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.140000000000001 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.409999999999997 109.817 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 74.439999999999998 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.546 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 75.329999999999998 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.340000000000003 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.520000000000003 108.238 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.230000000000004 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.130000000000003 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.419 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 75.450000000000003 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 75.420000000000002 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 75.209999999999994 111.334 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.400000000000006 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.4 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 74.329999999999998 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.78 0.242 . . . . 72.519999999999996 112.131 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.010000000000005 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 111.511 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.409999999999997 109.596 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.120000000000005 112.04 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 15' ' ' LYS . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.010000000000005 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.329999999999998 109.856 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HB3' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.230000000000004 111.635 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.129999999999995 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.340000000000003 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.430000000000007 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 112.243 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.310000000000002 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.239999999999995 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.329999999999998 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 54.039999999999999 110.905 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.120000000000005 110.335 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 72.430000000000007 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.340000000000003 111.831 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' HA ' HD21 ' A' ' 87' ' ' LEU . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.439999999999998 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.200000000000003 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.239999999999995 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.209999999999994 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.120000000000005 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.209999999999994 109.63 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 71' ' ' THR . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.399999999999999 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.209999999999994 111.429 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.400000000000006 111.13 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.010000000000005 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 55.030000000000001 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.230000000000004 110.72 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.519999999999996 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.230000000000004 110.933 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.669 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.319999999999993 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.450000000000003 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.140000000000001 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.439999999999998 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.310000000000002 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 73.340000000000003 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 74.230000000000004 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 38.030000000000001 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.319999999999993 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.329999999999998 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.340000000000003 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.310000000000002 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.319999999999993 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 64.140000000000001 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 75.109999999999999 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.520000000000003 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 54' ' ' TYR . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.409999999999997 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.120000000000005 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.450000000000003 110.885 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.119999999999997 112.311 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.448 HG22 ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.430000000000007 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.209999999999994 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.406 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 9.9 m-80 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 54.549999999999997 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 111.103 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.420000000000002 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 111.079 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 121.003 0.334 . . . . 54.439999999999998 112.505 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 63.100000000000001 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.605 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.150000000000006 110.629 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.531 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 71.150000000000006 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.524 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.239999999999995 108.849 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.439999999999998 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.329999999999998 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 74.430000000000007 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.409999999999997 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.434 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.030000000000001 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.430000000000007 109.624 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 53.310000000000002 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.100000000000001 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.130000000000003 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.230000000000004 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.420000000000002 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.229999999999997 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.150000000000006 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 74.209999999999994 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.140000000000001 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.409999999999997 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.656 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 74.439999999999998 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.508 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 75.329999999999998 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.340000000000003 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.520000000000003 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.130000000000003 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 75.450000000000003 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 75.420000000000002 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 74.329999999999998 111.054 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 CA-C-O 120.669 0.195 . . . . 72.519999999999996 112.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 65' ' ' ILE . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.010000000000005 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.674 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.409999999999997 110.122 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.120000000000005 111.077 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' HA ' HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.010000000000005 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.329999999999998 110.261 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.230000000000004 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.527 ' CE2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.129999999999995 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.527 ' ND2' ' CE2' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.340000000000003 109.043 178.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.430000000000007 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 72.420000000000002 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.310000000000002 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.239999999999995 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.319999999999993 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 54.039999999999999 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.120000000000005 110.975 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 109.913 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.340000000000003 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.439999999999998 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.200000000000003 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.239999999999995 111.504 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.209999999999994 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.120000000000005 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.209999999999994 109.623 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.399999999999999 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.209999999999994 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.400000000000006 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.010000000000005 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 55.030000000000001 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.230000000000004 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.519999999999996 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.230000000000004 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.319999999999993 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.450000000000003 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.140000000000001 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' CD ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.439999999999998 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.310000000000002 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 73.340000000000003 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.509999999999998 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 74.230000000000004 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 38.030000000000001 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.319999999999993 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 57' ' ' SER . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.329999999999998 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 110.903 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.310000000000002 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.319999999999993 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 64.140000000000001 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 75.109999999999999 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.450000000000003 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 75.439999999999998 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.520000000000003 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.150000000000006 109.945 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 73.200000000000003 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.918 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.476 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.409999999999997 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.120000000000005 112.168 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.450000000000003 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.310000000000002 110.396 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.119999999999997 111.903 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.430000000000007 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.209999999999994 111.978 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.239999999999995 111.418 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 54.549999999999997 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.099999999999994 111.25 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.582 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.617 0.174 . . . . 54.439999999999998 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 85' ' ' ILE . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 63.100000000000001 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.340000000000003 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.150000000000006 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.537 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 71.150000000000006 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.150000000000006 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.409999999999997 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.239999999999995 108.917 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.439999999999998 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.329999999999998 111.312 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.552 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.409999999999997 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.504 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.030000000000001 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.430000000000007 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 53.310000000000002 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.100000000000001 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.130000000000003 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.229999999999997 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.150000000000006 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 74.209999999999994 110.379 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.140000000000001 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.409999999999997 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.641 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 74.439999999999998 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.51 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 75.329999999999998 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 110' ' ' LYS . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.520000000000003 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.230000000000004 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.130000000000003 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 75.450000000000003 108.542 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 75.420000000000002 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 74.329999999999998 111.024 179.784 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 40.9 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.084 0.368 . . . . 72.519999999999996 112.39 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 111.365 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 109.855 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 16' ' ' ASN . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.120000000000005 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 73' ' ' ASN . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.010000000000005 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 13' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.329999999999998 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.230000000000004 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.129999999999995 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.430000000000007 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 20' ' ' ILE . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 72.420000000000002 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 30' ' ' ILE . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.310000000000002 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.329999999999998 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.319999999999993 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 54.039999999999999 110.589 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.120000000000005 110.339 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 72.430000000000007 109.913 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' HA ' HD21 ' A' ' 87' ' ' LEU . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.439999999999998 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.200000000000003 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.239999999999995 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.563 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.209999999999994 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.120000000000005 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 109.555 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.399999999999999 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.209999999999994 111.308 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.400000000000006 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.010000000000005 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 55.030000000000001 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.533 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.319999999999993 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.450000000000003 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.140000000000001 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.439999999999998 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.310000000000002 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 73.340000000000003 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.509999999999998 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 74.230000000000004 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 38.030000000000001 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.319999999999993 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 50' ' ' LEU . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.310000000000002 112.36 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.319999999999993 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 64.140000000000001 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 75.109999999999999 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 75.439999999999998 111.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.520000000000003 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.150000000000006 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 73.200000000000003 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.566 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HG23 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.409999999999997 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.120000000000005 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 32' ' ' PHE . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.450000000000003 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.310000000000002 110.948 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.430000000000007 112.344 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.209999999999994 111.092 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 54.549999999999997 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.099999999999994 111.182 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.420000000000002 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.219999999999999 110.925 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.465 0.111 . . . . 54.439999999999998 112.147 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 63.100000000000001 111.075 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.340000000000003 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.150000000000006 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 71.150000000000006 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.150000000000006 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.409999999999997 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.439999999999998 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.420000000000002 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 74.430000000000007 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.502 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.409999999999997 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.462 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.030000000000001 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.430000000000007 109.588 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 53.310000000000002 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.100000000000001 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.420000000000002 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.229999999999997 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.150000000000006 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 74.209999999999994 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.504 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.140000000000001 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.409999999999997 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 74.439999999999998 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.524 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 75.329999999999998 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.520000000000003 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.230000000000004 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 75.450000000000003 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 75.420000000000002 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 75.209999999999994 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 74.329999999999998 111.117 179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.992 0.33 . . . . 72.519999999999996 112.473 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 65' ' ' ILE . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.010000000000005 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.120000000000005 111.393 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.409999999999997 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.48 ' HA ' HG22 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.329999999999998 110.352 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.230000000000004 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CD1' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.129999999999995 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.340000000000003 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.430000000000007 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 72.420000000000002 112.28 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.239999999999995 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.319999999999993 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 54.039999999999999 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.120000000000005 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 72.430000000000007 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 66' ' ' ALA . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.439999999999998 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.200000000000003 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.239999999999995 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.209999999999994 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.120000000000005 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.209999999999994 109.531 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.399999999999999 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.209999999999994 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.400000000000006 111.268 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.010000000000005 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 55.030000000000001 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.230000000000004 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.519999999999996 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.230000000000004 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.319999999999993 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.450000000000003 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.140000000000001 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.439999999999998 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.310000000000002 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 73.340000000000003 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.509999999999998 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 74.230000000000004 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 38.030000000000001 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.319999999999993 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.329999999999998 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.340000000000003 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.310000000000002 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.319999999999993 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 64.140000000000001 111.288 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 75.109999999999999 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.450000000000003 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 75.439999999999998 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.520000000000003 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.150000000000006 110.182 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' CG1' ' CE1' ' A' ' 54' ' ' TYR . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 73.200000000000003 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.129999999999995 111.787 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG22 ' CE2' ' A' ' 47' ' ' TYR . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.120000000000005 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 11' ' ' VAL . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.450000000000003 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.310000000000002 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.119999999999997 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.430000000000007 111.815 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.209999999999994 111.13 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 54.549999999999997 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.199 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.420000000000002 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.952 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.475 0.115 . . . . 54.439999999999998 112.23 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 63.100000000000001 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.340000000000003 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.150000000000006 110.359 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.494 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 71.150000000000006 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.150000000000006 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.409999999999997 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.239999999999995 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.439999999999998 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.403 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 74.430000000000007 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.511 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.409999999999997 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.030000000000001 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.430000000000007 109.607 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 53.310000000000002 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.100000000000001 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.130000000000003 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.230000000000004 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.229999999999997 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.150000000000006 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.474 ' CD1' ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 74.209999999999994 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.140000000000001 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.409999999999997 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 74.439999999999998 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.520000000000003 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.230000000000004 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.130000000000003 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 75.450000000000003 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 75.420000000000002 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 75.209999999999994 111.185 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 74.329999999999998 111.08 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.462 -0.255 . . . . 64.349999999999994 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.16 136.77 54.39 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.594 2.196 . . . . 60.030000000000001 112.315 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.7 129.37 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.219999999999999 110.912 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.65 154.08 28.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 38.030000000000001 112.511 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.72 -75.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 63.130000000000003 110.918 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -154.55 132.45 11.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.86 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.0 114.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.736 -0.745 . . . . 53.149999999999999 112.314 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 50.8 Cg_endo -71.18 -59.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.312 2.008 . . . . 72.519999999999996 112.326 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 65' ' ' ILE . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.010000000000005 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.120000000000005 111.651 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.409999999999997 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 16' ' ' ASN . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.120000000000005 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.268 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.329999999999998 110.857 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.230000000000004 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.129999999999995 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 33.7 m120 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.340000000000003 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.430000000000007 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 20' ' ' ILE . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 72.420000000000002 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.310000000000002 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.329999999999998 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.319999999999993 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 54.039999999999999 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 72.430000000000007 109.855 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.340000000000003 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.439999999999998 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.200000000000003 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.239999999999995 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.209999999999994 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.120000000000005 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.209999999999994 109.434 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.399999999999999 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.209999999999994 111.51 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.400000000000006 111.075 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.010000000000005 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 55.030000000000001 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.230000000000004 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.230000000000004 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.527 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.319999999999993 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.140000000000001 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.439999999999998 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.310000000000002 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 73.340000000000003 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.509999999999998 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 38.030000000000001 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.319999999999993 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 57' ' ' SER . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.329999999999998 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.340000000000003 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.310000000000002 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.319999999999993 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 64.140000000000001 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 75.109999999999999 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.450000000000003 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 75.439999999999998 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.520000000000003 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HD3' ' CD1' ' A' ' 118' ' ' TYR . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.150000000000006 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 73.200000000000003 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 111.774 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.409999999999997 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.120000000000005 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 111.422 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.310000000000002 110.169 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.119999999999997 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 HG22 ' HD3' ' A' ' 35' ' ' PRO . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.430000000000007 111.521 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.209999999999994 110.824 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.239999999999995 110.932 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 54.549999999999997 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.099999999999994 111.152 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.420000000000002 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.37 144.38 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.219999999999999 111.118 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.38 152.76 28.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.678 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 49.6 mt -134.02 107.0 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.439 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.22 -18.36 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.609 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.7 114.91 2.22 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.483 -0.647 . . . . 71.420000000000002 111.483 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 4.9 m-85 -106.68 127.21 28.56 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.584 0.23 . . . . 73.349999999999994 111.211 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo -82.13 -163.81 3.45 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.94 -1.275 . . . . 54.439999999999998 112.262 -0.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 63.100000000000001 111.232 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.340000000000003 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.404 ' HD2' ' CE2' ' A' ' 32' ' ' PHE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.150000000000006 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.428 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 71.150000000000006 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.632 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.150000000000006 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.409999999999997 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.239999999999995 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.439999999999998 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.420000000000002 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.329999999999998 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.489 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.409999999999997 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.46 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.030000000000001 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.430000000000007 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 53.310000000000002 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.100000000000001 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.130000000000003 112.842 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.230000000000004 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.420000000000002 110.778 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.407 HG21 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.229999999999997 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.150000000000006 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 74.209999999999994 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.140000000000001 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.409999999999997 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 74.439999999999998 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.340000000000003 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.520000000000003 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.230000000000004 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.130000000000003 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 75.450000000000003 108.375 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 75.420000000000002 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 75.209999999999994 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.457 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 74.329999999999998 111.11 179.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.49 -0.244 . . . . 64.349999999999994 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 175.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.582 2.188 . . . . 60.030000000000001 112.373 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.65 -52.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.219999999999999 110.904 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.49 -91.7 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 38.030000000000001 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -139.72 140.44 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 63.130000000000003 110.884 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.02 137.32 58.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.845 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.39 149.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 53.149999999999999 112.405 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo -77.82 -48.44 0.1 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.533 2.155 . . . . 72.519999999999996 112.42 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 65' ' ' ILE . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.010000000000005 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.120000000000005 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.13 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.120000000000005 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.010000000000005 110.38 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.329999999999998 111.228 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.129999999999995 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.340000000000003 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.430000000000007 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 20' ' ' ILE . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 72.420000000000002 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.310000000000002 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.239999999999995 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.329999999999998 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.319999999999993 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 54.039999999999999 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.120000000000005 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 72.430000000000007 109.557 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.340000000000003 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.439999999999998 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.200000000000003 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.239999999999995 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.209999999999994 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.120000000000005 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.209999999999994 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.399999999999999 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.417 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.209999999999994 111.511 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.257 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.010000000000005 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 55.030000000000001 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.519999999999996 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.319999999999993 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.450000000000003 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.140000000000001 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.439999999999998 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.310000000000002 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 73.340000000000003 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.509999999999998 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 74.230000000000004 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 38.030000000000001 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.319999999999993 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.329999999999998 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.340000000000003 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.310000000000002 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.319999999999993 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 64.140000000000001 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 75.109999999999999 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.450000000000003 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 75.439999999999998 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.520000000000003 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.150000000000006 110.047 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 73.200000000000003 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.129999999999995 111.903 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.484 HG23 ' CE2' ' A' ' 47' ' ' TYR . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.409999999999997 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.120000000000005 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.701 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.310000000000002 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.119999999999997 112.176 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.430000000000007 111.824 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.209999999999994 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.239999999999995 111.316 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 54.549999999999997 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.21 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.420000000000002 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.07 123.52 22.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.219999999999999 111.093 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.22 151.21 33.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.336 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.437 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 46.8 mt -140.18 106.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 75.140000000000001 111.381 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.59 -17.71 61.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 75.319999999999993 110.955 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.62 114.45 1.61 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.083 -0.579 . . . . 71.420000000000002 111.737 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 79' ' ' ILE . 31.1 m-85 -105.85 132.13 21.15 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.73 0.3 . . . . 73.349999999999994 111.169 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo -80.98 -163.84 3.55 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.678 -1.384 . . . . 54.439999999999998 112.401 -0.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 63.100000000000001 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.340000000000003 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.150000000000006 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.511 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 71.150000000000006 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.487 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.150000000000006 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.511 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.409999999999997 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.239999999999995 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.439999999999998 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.420000000000002 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 74.430000000000007 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.409999999999997 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.030000000000001 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.430000000000007 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 53.310000000000002 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.100000000000001 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.130000000000003 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.230000000000004 111.08 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 102' ' ' SER . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.420000000000002 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.049 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.957 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' CD1' ' HD3' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 74.209999999999994 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.140000000000001 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.409999999999997 109.949 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 74.439999999999998 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.541 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 75.329999999999998 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.520000000000003 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.230000000000004 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.130000000000003 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 75.450000000000003 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 75.420000000000002 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 75.209999999999994 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.43 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.400000000000006 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 74.329999999999998 111.049 179.892 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.48 -0.248 . . . . 64.349999999999994 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.64 168.25 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 60.030000000000001 112.305 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -149.81 -178.76 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 63.219999999999999 110.869 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.49 -173.21 46.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 38.030000000000001 112.478 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 t -145.23 84.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 63.130000000000003 110.893 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -178.81 111.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 72.209999999999994 110.692 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . -167.15 49.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.471 -0.871 . . . . 53.149999999999999 113.081 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo -69.4 -56.93 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.36 2.04 . . . . 72.519999999999996 112.041 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 65' ' ' ILE . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.010000000000005 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.120000000000005 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.409999999999997 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 16' ' ' ASN . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.98 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.230000000000004 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CD1' ' CD1' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 p-10 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.340000000000003 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.6 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.430000000000007 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.6 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 72.420000000000002 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.310000000000002 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.239999999999995 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.319999999999993 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 54.039999999999999 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.120000000000005 110.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 110.158 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.439999999999998 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CD1' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.200000000000003 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 47' ' ' TYR . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.239999999999995 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.209999999999994 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.120000000000005 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.209999999999994 109.634 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.399999999999999 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.209999999999994 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.400000000000006 111.186 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.010000000000005 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 55.030000000000001 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.519999999999996 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.450000000000003 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.140000000000001 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.439999999999998 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.310000000000002 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.509999999999998 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 74.230000000000004 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 38.030000000000001 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.319999999999993 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.329999999999998 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.340000000000003 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.310000000000002 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.319999999999993 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 64.140000000000001 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 75.109999999999999 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.450000000000003 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 75.439999999999998 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.520000000000003 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.150000000000006 110.056 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 73.200000000000003 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.129999999999995 112.122 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.409999999999997 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.120000000000005 112.349 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 30' ' ' ILE . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.450000000000003 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.310000000000002 110.358 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.119999999999997 111.776 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.430000000000007 111.633 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.209999999999994 111.169 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 111.101 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 54.549999999999997 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.099999999999994 111.249 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.420000000000002 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.76 119.57 38.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.219999999999999 110.936 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.78 95.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 73.450000000000003 110.76 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 HD12 ' CD2' ' A' ' 32' ' ' PHE . 35.9 mt -73.44 87.12 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 75.140000000000001 111.191 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -51.12 -26.56 6.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 110.702 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.82 110.34 0.63 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.872 -0.603 . . . . 71.420000000000002 111.714 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' HA ' ' C ' ' A' ' 83' ' ' PRO . 26.3 p90 -111.88 153.06 44.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.546 0.212 . . . . 73.349999999999994 110.925 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -71.52 -168.0 4.91 Favored 'Cis proline' 0 C--N 1.346 0.426 0 C-N-CA 123.164 -1.598 . . . . 54.439999999999998 113.286 0.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 85' ' ' ILE . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 63.100000000000001 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.340000000000003 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.150000000000006 110.871 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 71.150000000000006 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.150000000000006 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.409999999999997 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.239999999999995 108.238 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.439999999999998 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.420000000000002 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.329999999999998 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 74.430000000000007 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.409999999999997 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.421 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.030000000000001 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.430000000000007 109.354 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 53.310000000000002 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.130000000000003 113.003 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.230000000000004 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.420000000000002 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.436 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.229999999999997 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 74.209999999999994 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.140000000000001 109.232 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.409999999999997 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 74.439999999999998 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.49 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 75.329999999999998 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.340000000000003 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.520000000000003 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.130000000000003 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 75.450000000000003 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 75.420000000000002 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 75.209999999999994 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 74.329999999999998 111.091 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 64.349999999999994 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.18 -38.3 7.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.575 2.183 . . . . 60.030000000000001 112.336 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 mt 61.93 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 63.219999999999999 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.14 -143.46 4.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 38.030000000000001 112.55 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 m -110.05 -177.36 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 63.130000000000003 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.95 -173.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.209999999999994 110.93 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.48 72.26 0.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 53.149999999999999 112.428 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo -84.73 -50.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.789 2.326 . . . . 72.519999999999996 112.703 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.010000000000005 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 111.89 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.409999999999997 109.723 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 109.978 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.329999999999998 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.230000000000004 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.129999999999995 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.340000000000003 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.430000000000007 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 20' ' ' ILE . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 72.420000000000002 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.310000000000002 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.239999999999995 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.329999999999998 110.505 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 54.039999999999999 111.042 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.569 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 72.430000000000007 109.697 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.340000000000003 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 66' ' ' ALA . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.439999999999998 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.200000000000003 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.239999999999995 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.547 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.209999999999994 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.120000000000005 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.209999999999994 109.57 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.399999999999999 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.209999999999994 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.400000000000006 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.010000000000005 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 55.030000000000001 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.230000000000004 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.230000000000004 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.319999999999993 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.450000000000003 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.140000000000001 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.439999999999998 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.310000000000002 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 73.340000000000003 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.509999999999998 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 74.230000000000004 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 38.030000000000001 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.319999999999993 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.329999999999998 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.340000000000003 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.310000000000002 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.319999999999993 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 64.140000000000001 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.450000000000003 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 75.439999999999998 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.520000000000003 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.150000000000006 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 73.200000000000003 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.129999999999995 111.566 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' HB ' HG21 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.120000000000005 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' CB ' ' ND2' ' A' ' 73' ' ' ASN . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.310000000000002 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.119999999999997 111.596 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.430000000000007 111.707 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 110.884 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 54.549999999999997 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.099999999999994 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.420000000000002 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.46 166.0 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.819 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.51 119.84 40.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.826 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 79' ' ' ILE . 26.2 mt -109.09 84.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 75.140000000000001 111.159 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -53.41 -25.26 15.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.87 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -138.36 109.64 0.69 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.909 -0.662 . . . . 71.420000000000002 112.058 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 19.7 p90 -114.08 155.11 45.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.262 . . . . 73.349999999999994 110.931 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo -74.51 -171.25 8.94 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.496 -1.46 . . . . 54.439999999999998 112.283 0.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 85' ' ' ILE . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 63.100000000000001 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.624 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.340000000000003 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.150000000000006 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.489 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 71.150000000000006 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.150000000000006 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.409999999999997 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.239999999999995 108.837 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.439999999999998 112.302 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.441 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.420000000000002 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.146 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 74.430000000000007 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.409999999999997 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.030000000000001 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.430000000000007 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 53.310000000000002 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.130000000000003 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.230000000000004 109.13 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.420000000000002 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.229999999999997 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.150000000000006 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' PHE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 74.209999999999994 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.140000000000001 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.409999999999997 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 74.439999999999998 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.517 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 75.329999999999998 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.340000000000003 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.520000000000003 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.230000000000004 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.130000000000003 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 75.450000000000003 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 75.420000000000002 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 75.209999999999994 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.432 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 74.329999999999998 111.138 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.496 -0.241 . . . . 64.349999999999994 112.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.88 -26.99 26.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.604 2.203 . . . . 60.030000000000001 112.332 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.29 162.32 4.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 63.219999999999999 110.944 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.34 114.69 2.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 38.030000000000001 112.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -75.8 64.0 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 63.130000000000003 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.32 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.932 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.1 86.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.821 -0.704 . . . . 53.149999999999999 112.388 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo -73.58 -54.82 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.521 2.147 . . . . 72.519999999999996 112.576 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG21 ' HB ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.010000000000005 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.120000000000005 111.484 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.409999999999997 109.633 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.329999999999998 110.889 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.230000000000004 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.129999999999995 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.340000000000003 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.430000000000007 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.622 HG12 ' CG ' ' A' ' 19' ' ' GLU . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 72.420000000000002 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.310000000000002 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.239999999999995 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.329999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.319999999999993 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 54.039999999999999 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.120000000000005 110.513 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 72.430000000000007 109.624 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.340000000000003 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.439999999999998 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.200000000000003 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.209999999999994 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.120000000000005 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.209999999999994 109.596 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.399999999999999 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.568 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.209999999999994 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 111.624 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.010000000000005 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 55.030000000000001 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.230000000000004 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.519999999999996 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.230000000000004 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' C ' ' HD2' ' A' ' 45' ' ' PRO . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.319999999999993 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.450000000000003 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.140000000000001 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.439999999999998 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.310000000000002 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.509999999999998 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 74.230000000000004 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 38.030000000000001 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.319999999999993 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.329999999999998 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.310000000000002 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.319999999999993 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 64.140000000000001 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 75.109999999999999 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.450000000000003 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 75.439999999999998 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.520000000000003 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.150000000000006 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 54' ' ' TYR . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 73.200000000000003 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 ' HB ' HG21 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.120000000000005 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.450000000000003 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.310000000000002 110.587 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 111.78 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.430000000000007 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.209999999999994 111.217 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.239999999999995 111.069 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 54.549999999999997 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.4 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.420000000000002 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.65 154.92 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -100.85 116.25 32.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.450000000000003 111.023 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 11.9 mt -107.43 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 110.823 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.42 -38.36 1.23 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.039 0.447 . . . . 75.319999999999993 110.898 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 79' ' ' ILE . . . -133.02 -142.36 4.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 71.420000000000002 110.834 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 174.6 140.93 0.18 Allowed Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 117.041 0.42 . . . . 73.349999999999994 110.831 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo -74.69 -161.17 2.36 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.572 -1.428 . . . . 54.439999999999998 112.152 -0.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 63.100000000000001 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.340000000000003 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.150000000000006 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 71.150000000000006 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.150000000000006 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.409999999999997 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.239999999999995 108.895 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.439999999999998 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.420000000000002 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 74.430000000000007 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.409999999999997 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 87' ' ' LEU . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.030000000000001 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.430000000000007 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 53.310000000000002 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.100000000000001 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.130000000000003 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.230000000000004 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.420000000000002 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 46' ' ' LYS . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.229999999999997 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.150000000000006 110.099 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 46' ' ' LYS . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.409999999999997 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 74.439999999999998 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.340000000000003 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.520000000000003 108.653 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.230000000000004 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.130000000000003 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 75.450000000000003 108.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 75.420000000000002 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 75.209999999999994 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.43 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.400000000000006 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 74.329999999999998 111.13 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.554 -0.218 . . . . 64.349999999999994 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.98 63.13 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.588 2.192 . . . . 60.030000000000001 112.322 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.33 126.2 32.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 63.219999999999999 110.86 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.03 175.32 23.0 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 38.030000000000001 112.578 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 m -74.74 -168.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 63.130000000000003 110.82 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.06 44.77 2.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 72.209999999999994 111.029 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.92 156.98 52.85 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.643 -0.789 . . . . 53.149999999999999 112.181 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CB ' ' HA ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -81.91 -50.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.437 2.092 . . . . 72.519999999999996 112.511 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 10' ' ' THR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.010000000000005 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 9' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.120000000000005 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.409999999999997 109.463 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 16' ' ' ASN . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.120000000000005 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.010000000000005 110.067 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.329999999999998 111.126 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.230000000000004 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.129999999999995 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.340000000000003 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.430000000000007 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 72.420000000000002 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.239999999999995 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' CG2' ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.329999999999998 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.319999999999993 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 54.039999999999999 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.120000000000005 110.897 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 72.430000000000007 109.816 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.439999999999998 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.200000000000003 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.239999999999995 111.603 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.120000000000005 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.209999999999994 109.761 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.399999999999999 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.209999999999994 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.400000000000006 111.172 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.010000000000005 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 55.030000000000001 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.230000000000004 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.519999999999996 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.230000000000004 110.097 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.319999999999993 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.450000000000003 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.140000000000001 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.439999999999998 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.310000000000002 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 73.340000000000003 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.509999999999998 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 74.230000000000004 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 38.030000000000001 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.319999999999993 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.329999999999998 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.310000000000002 112.124 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.319999999999993 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.450000000000003 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 75.439999999999998 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.150000000000006 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 54' ' ' TYR . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 73.200000000000003 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.129999999999995 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 54' ' ' TYR . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.409999999999997 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.120000000000005 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' CG1' ' CD1' ' A' ' 32' ' ' PHE . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.406 ' CB ' ' ND2' ' A' ' 73' ' ' ASN . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.310000000000002 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' CE2' ' A' ' 82' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.119999999999997 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.430000000000007 111.567 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.209999999999994 110.858 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.406 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 22.0 m-80 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.239999999999995 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 54.549999999999997 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.099999999999994 111.114 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.29 150.06 25.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.219999999999999 110.991 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -91.68 148.23 22.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.450000000000003 110.707 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 79' ' ' ILE . 43.6 mt -137.6 121.29 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 75.140000000000001 111.413 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 -19.12 20.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 75.319999999999993 110.589 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.01 117.01 2.88 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.285 -0.726 . . . . 71.420000000000002 111.285 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.444 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 1.6 m-85 -107.98 127.14 28.21 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.559 0.218 . . . . 73.349999999999994 111.389 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo -79.6 -164.64 4.08 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.889 -1.296 . . . . 54.439999999999998 112.293 -0.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 63.100000000000001 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.340000000000003 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.150000000000006 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 71.150000000000006 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.456 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.150000000000006 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.461 ' O ' ' CE ' ' A' ' 93' ' ' LYS . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.409999999999997 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.239999999999995 108.72 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.439999999999998 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.420000000000002 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 95' ' ' GLN . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.409999999999997 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.030000000000001 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.41 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.430000000000007 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 53.310000000000002 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.100000000000001 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.130000000000003 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.230000000000004 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.420000000000002 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.229999999999997 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 74.209999999999994 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.140000000000001 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.409999999999997 109.817 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 74.439999999999998 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.546 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 75.329999999999998 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.340000000000003 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.520000000000003 108.238 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.230000000000004 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.130000000000003 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.419 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 75.450000000000003 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 75.420000000000002 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 75.209999999999994 111.334 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.400000000000006 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.4 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 74.329999999999998 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.49 -0.244 . . . . 64.349999999999994 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 139.82 53.39 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.6 2.2 . . . . 60.030000000000001 112.287 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.6 mt -111.27 35.7 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 63.219999999999999 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.94 151.17 9.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 38.030000000000001 112.525 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 m -142.81 161.37 38.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 63.130000000000003 110.933 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -143.62 120.56 11.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.69 76.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 53.149999999999999 112.59 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo -65.56 -62.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 72.519999999999996 112.131 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.010000000000005 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 111.511 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.409999999999997 109.596 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.120000000000005 112.04 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 15' ' ' LYS . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.010000000000005 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.329999999999998 109.856 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HB3' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.230000000000004 111.635 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.129999999999995 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.340000000000003 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.430000000000007 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 112.243 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.310000000000002 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.239999999999995 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.329999999999998 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 54.039999999999999 110.905 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.120000000000005 110.335 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 72.430000000000007 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.340000000000003 111.831 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' HA ' HD21 ' A' ' 87' ' ' LEU . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.439999999999998 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.200000000000003 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.239999999999995 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.209999999999994 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.120000000000005 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.209999999999994 109.63 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 71' ' ' THR . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.399999999999999 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.209999999999994 111.429 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.400000000000006 111.13 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.010000000000005 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 55.030000000000001 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.230000000000004 110.72 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.519999999999996 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.230000000000004 110.933 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.669 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.319999999999993 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.450000000000003 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.140000000000001 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.439999999999998 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.310000000000002 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 73.340000000000003 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 74.230000000000004 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 38.030000000000001 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.319999999999993 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.329999999999998 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.436 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.340000000000003 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.310000000000002 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.319999999999993 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 64.140000000000001 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 75.109999999999999 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.520000000000003 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 54' ' ' TYR . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.409999999999997 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.120000000000005 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.450000000000003 110.885 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.119999999999997 112.311 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.448 HG22 ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.430000000000007 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.209999999999994 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.406 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 9.9 m-80 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 54.549999999999997 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 111.103 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.420000000000002 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.22 130.89 35.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 111.079 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -76.31 131.58 39.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.642 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 79' ' ' ILE . 28.6 mt -119.38 107.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 111.369 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -81.24 -13.01 58.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 75.319999999999993 110.904 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.57 116.86 1.58 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.195 -0.526 . . . . 71.420000000000002 111.795 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.9 135.65 19.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.721 0.296 . . . . 73.349999999999994 111.179 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo -82.37 -163.18 3.14 Favored 'Cis proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.621 -1.408 . . . . 54.439999999999998 112.505 0.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 63.100000000000001 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.605 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.150000000000006 110.629 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.531 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 71.150000000000006 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.524 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.239999999999995 108.849 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.439999999999998 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.329999999999998 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 74.430000000000007 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.409999999999997 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.434 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.030000000000001 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.430000000000007 109.624 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 53.310000000000002 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.100000000000001 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.130000000000003 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.230000000000004 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.420000000000002 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.229999999999997 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.150000000000006 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 111' ' ' PHE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 74.209999999999994 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.140000000000001 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.409999999999997 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.656 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 74.439999999999998 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.508 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 75.329999999999998 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.340000000000003 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.520000000000003 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.130000000000003 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 75.450000000000003 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 75.420000000000002 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 74.329999999999998 111.054 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.518 -0.233 . . . . 64.349999999999994 112.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -33.25 13.54 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.577 2.185 . . . . 60.030000000000001 112.37 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.11 162.97 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 63.219999999999999 110.928 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 118.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 38.030000000000001 112.482 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.5 m -117.11 -80.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 63.130000000000003 110.934 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 177.57 44.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 72.209999999999994 110.763 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.39 132.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 53.149999999999999 112.13 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo -72.39 -58.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.192 1.928 . . . . 72.519999999999996 112.456 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 65' ' ' ILE . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.010000000000005 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.674 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.409999999999997 110.122 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.120000000000005 111.077 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' HA ' HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.010000000000005 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.329999999999998 110.261 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.230000000000004 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.527 ' CE2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.129999999999995 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.527 ' ND2' ' CE2' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.340000000000003 109.043 178.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.430000000000007 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 72.420000000000002 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.310000000000002 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.239999999999995 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.319999999999993 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 54.039999999999999 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.120000000000005 110.975 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 109.913 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.340000000000003 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.439999999999998 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.200000000000003 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.239999999999995 111.504 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.209999999999994 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.120000000000005 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.209999999999994 109.623 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.399999999999999 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.209999999999994 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.400000000000006 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.010000000000005 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 55.030000000000001 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.230000000000004 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.519999999999996 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.230000000000004 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.319999999999993 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.450000000000003 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.140000000000001 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' CD ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.439999999999998 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.310000000000002 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 73.340000000000003 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.509999999999998 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 74.230000000000004 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 38.030000000000001 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.319999999999993 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 57' ' ' SER . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.329999999999998 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 110.903 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.310000000000002 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.319999999999993 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 64.140000000000001 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 75.109999999999999 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.450000000000003 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 75.439999999999998 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.520000000000003 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.150000000000006 109.945 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 73.200000000000003 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.918 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.476 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.409999999999997 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.120000000000005 112.168 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.450000000000003 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.310000000000002 110.396 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.119999999999997 111.903 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.430000000000007 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.209999999999994 111.978 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.239999999999995 111.418 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 54.549999999999997 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.099999999999994 111.25 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.57 110.78 13.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.904 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -66.95 110.27 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.742 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.444 HD11 HG21 ' A' ' 79' ' ' ILE . 31.0 mt -88.8 85.8 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 111.32 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -20.89 29.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.287 -0.415 . . . . 75.319999999999993 110.882 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.32 111.17 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.053 -0.594 . . . . 71.420000000000002 111.787 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -113.29 153.9 45.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.708 0.289 . . . . 73.349999999999994 111.0 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.582 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo -73.73 -168.94 6.48 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 -1.489 . . . . 54.439999999999998 112.388 0.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 85' ' ' ILE . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 63.100000000000001 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.340000000000003 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.150000000000006 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.537 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 71.150000000000006 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.150000000000006 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.409999999999997 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.239999999999995 108.917 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.439999999999998 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.329999999999998 111.312 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.552 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.409999999999997 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.504 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.030000000000001 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.430000000000007 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 53.310000000000002 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.100000000000001 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.130000000000003 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.229999999999997 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.150000000000006 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 74.209999999999994 110.379 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.140000000000001 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.409999999999997 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.641 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 74.439999999999998 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.51 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 75.329999999999998 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 110' ' ' LYS . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.520000000000003 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.230000000000004 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.130000000000003 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 75.450000000000003 108.542 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 75.420000000000002 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 74.329999999999998 111.024 179.784 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.461 -0.256 . . . . 64.349999999999994 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 163.71 37.24 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.613 2.209 . . . . 60.030000000000001 112.254 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.72 -175.22 5.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.219999999999999 110.938 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.19 37.79 1.92 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 38.030000000000001 112.528 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -102.76 31.96 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 63.130000000000003 110.832 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -135.71 145.6 46.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.922 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.62 149.94 16.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 53.149999999999999 112.635 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 40.9 Cg_endo -69.75 -53.21 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.662 2.242 . . . . 72.519999999999996 112.39 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 111.365 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 109.855 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 16' ' ' ASN . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.120000000000005 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 73' ' ' ASN . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.010000000000005 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 13' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.329999999999998 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.230000000000004 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.129999999999995 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.430000000000007 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 20' ' ' ILE . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 72.420000000000002 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 30' ' ' ILE . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.310000000000002 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.329999999999998 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.319999999999993 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 54.039999999999999 110.589 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.120000000000005 110.339 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 72.430000000000007 109.913 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' HA ' HD21 ' A' ' 87' ' ' LEU . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.439999999999998 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.200000000000003 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.239999999999995 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.563 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.209999999999994 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.120000000000005 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 109.555 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' TRP . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.399999999999999 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.209999999999994 111.308 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.400000000000006 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.010000000000005 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 55.030000000000001 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.47 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.533 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.319999999999993 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.450000000000003 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.140000000000001 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.439999999999998 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.310000000000002 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 73.340000000000003 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.509999999999998 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 74.230000000000004 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 38.030000000000001 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.319999999999993 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 50' ' ' LEU . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.310000000000002 112.36 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.319999999999993 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 64.140000000000001 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 75.109999999999999 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 75.439999999999998 111.073 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.520000000000003 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.150000000000006 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 73.200000000000003 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.566 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' HG23 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.409999999999997 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.120000000000005 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 32' ' ' PHE . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.450000000000003 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.310000000000002 110.948 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.430000000000007 112.344 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.209999999999994 111.092 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' CG ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 54.549999999999997 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.099999999999994 111.182 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.420000000000002 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.28 109.31 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.219999999999999 110.925 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.98 106.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.735 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.9 88.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 111.279 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -23.61 32.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 110.905 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.91 107.19 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.972 -0.632 . . . . 71.420000000000002 111.949 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -114.15 154.05 46.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.7 0.286 . . . . 73.349999999999994 111.041 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo -76.28 -171.55 9.84 Favored 'Cis proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 -1.47 . . . . 54.439999999999998 112.147 0.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 63.100000000000001 111.075 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.340000000000003 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.150000000000006 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 71.150000000000006 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.150000000000006 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.409999999999997 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.439999999999998 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.420000000000002 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 74.430000000000007 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.502 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.409999999999997 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.462 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.030000000000001 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.430000000000007 109.588 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 53.310000000000002 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.100000000000001 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.420000000000002 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.229999999999997 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.150000000000006 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 74.209999999999994 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.504 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.140000000000001 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.409999999999997 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 74.439999999999998 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.524 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 75.329999999999998 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.520000000000003 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.230000000000004 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 75.450000000000003 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 75.420000000000002 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 75.209999999999994 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 74.329999999999998 111.117 179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.542 -0.223 . . . . 64.349999999999994 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.97 113.53 3.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.592 2.194 . . . . 60.030000000000001 112.27 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.99 160.92 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.219999999999999 110.936 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.74 51.68 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 38.030000000000001 112.527 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 m -176.08 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 63.130000000000003 110.889 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.42 110.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 72.209999999999994 110.946 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.78 49.6 76.05 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.861 -0.685 . . . . 53.149999999999999 112.698 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo -75.71 -55.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.492 2.128 . . . . 72.519999999999996 112.473 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 65' ' ' ILE . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.010000000000005 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.120000000000005 111.393 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.409999999999997 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 16' ' ' ASN . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.48 ' HA ' HG22 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.329999999999998 110.352 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.230000000000004 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CD1' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.129999999999995 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.340000000000003 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.430000000000007 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 72.420000000000002 112.28 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.239999999999995 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.319999999999993 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 54.039999999999999 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.120000000000005 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 72.430000000000007 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 66' ' ' ALA . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.439999999999998 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.200000000000003 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.239999999999995 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.209999999999994 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.120000000000005 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.209999999999994 109.531 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 36' ' ' TRP . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.399999999999999 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.209999999999994 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.400000000000006 111.268 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.010000000000005 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 55.030000000000001 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.230000000000004 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.519999999999996 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.230000000000004 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.319999999999993 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.450000000000003 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.140000000000001 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.439999999999998 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.310000000000002 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 73.340000000000003 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.509999999999998 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 74.230000000000004 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 38.030000000000001 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.319999999999993 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.329999999999998 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.340000000000003 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.310000000000002 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.319999999999993 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 64.140000000000001 111.288 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 75.109999999999999 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.450000000000003 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 75.439999999999998 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.520000000000003 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.150000000000006 110.182 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' CG1' ' CE1' ' A' ' 54' ' ' TYR . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 73.200000000000003 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.129999999999995 111.787 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG22 ' CE2' ' A' ' 47' ' ' TYR . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.120000000000005 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 11' ' ' VAL . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.450000000000003 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.310000000000002 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.119999999999997 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.430000000000007 111.815 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.209999999999994 111.13 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 54.549999999999997 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.199 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.420000000000002 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.0 163.42 17.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.952 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.11 121.04 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.450000000000003 110.8 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.2 mt -106.6 84.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.175 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -24.58 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.319999999999993 110.828 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.89 107.89 0.65 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.961 -0.638 . . . . 71.420000000000002 112.015 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -114.73 153.52 46.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.649 0.261 . . . . 73.349999999999994 110.949 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.609 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo -75.05 -171.14 8.99 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.552 -1.437 . . . . 54.439999999999998 112.23 0.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 63.100000000000001 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.340000000000003 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.150000000000006 110.359 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.494 ' CD1' ' HD3' ' A' ' 89' ' ' PRO . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 71.150000000000006 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.150000000000006 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.409999999999997 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.239999999999995 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.439999999999998 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.403 ' CA ' ' HG2' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 74.430000000000007 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.511 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.409999999999997 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.030000000000001 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.430000000000007 109.607 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 53.310000000000002 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.100000000000001 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.130000000000003 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.230000000000004 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.229999999999997 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.150000000000006 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.474 ' CD1' ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 74.209999999999994 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.140000000000001 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.409999999999997 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 74.439999999999998 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 109' ' ' ILE . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.520000000000003 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.230000000000004 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.130000000000003 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 75.450000000000003 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 75.420000000000002 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 75.209999999999994 111.185 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.426 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 74.329999999999998 111.08 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 50.8 Cg_endo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.765 0.235 . . . . 72.519999999999996 112.326 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.010000000000005 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.120000000000005 111.651 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.409999999999997 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 20' ' ' ILE . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.120000000000005 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 68' ' ' VAL . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.268 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 73' ' ' ASN . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.329999999999998 110.857 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.544 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.544 ' ND2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.230000000000004 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.129999999999995 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 78.5 m-20 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.340000000000003 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.430000000000007 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 65.129999999999995 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.845 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.310000000000002 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.329999999999998 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.319999999999993 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 53.340000000000003 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 63' ' ' VAL . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 61.200000000000003 109.855 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.340000000000003 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD23 HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.439999999999998 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.200000000000003 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.239999999999995 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.209999999999994 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.120000000000005 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.209999999999994 109.434 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.399999999999999 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.209999999999994 111.51 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.400000000000006 111.075 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.010000000000005 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 54.119999999999997 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.230000000000004 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.230000000000004 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.319999999999993 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.140000000000001 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.004 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.439999999999998 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.927 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.310000000000002 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 72.329999999999998 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.509999999999998 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.8 HD13 HG13 ' A' ' 105' ' ' VAL . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 73.439999999999998 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 32.420000000000002 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.319999999999993 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.329999999999998 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.340000000000003 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.310000000000002 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.319999999999993 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 60.450000000000003 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 55.229999999999997 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.450000000000003 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 63.329999999999998 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.520000000000003 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.150000000000006 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.906 HG11 ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 43.109999999999999 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 111.774 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.409999999999997 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.120000000000005 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 111.422 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.310000000000002 110.169 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.119999999999997 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.430000000000007 111.521 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.209999999999994 110.824 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 13' ' ' VAL . 13.8 m120 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.239999999999995 110.932 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 44.210000000000001 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' ASP . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.099999999999994 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.420000000000002 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.219999999999999 111.118 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 120.899 0.291 . . . . 54.439999999999998 112.262 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 99' ' ' TYR . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 60.210000000000001 111.232 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 29' ' ' LEU . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.340000000000003 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 30' ' ' ILE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.150000000000006 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.775 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 64.25 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.643 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.150000000000006 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.409999999999997 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.239999999999995 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.439999999999998 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.420000000000002 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.329999999999998 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.517 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 60.439999999999998 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.409999999999997 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.848 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.030000000000001 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.430000000000007 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 52.530000000000001 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.100000000000001 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.130000000000003 112.842 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.230000000000004 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.420000000000002 110.778 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.004 HG22 ' HB2' ' A' ' 46' ' ' LYS . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.229999999999997 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.150000000000006 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 50' ' ' LEU . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 54.119999999999997 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.140000000000001 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.409999999999997 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 64.349999999999994 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.775 HG23 HD21 ' A' ' 87' ' ' LEU . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 72.099999999999994 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.863 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.340000000000003 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.520000000000003 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.848 ' OD1' HG11 ' A' ' 97' ' ' VAL . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.230000000000004 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.130000000000003 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 74.019999999999996 108.375 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 73.140000000000001 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 73.219999999999999 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.863 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 73.219999999999999 111.11 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' CA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 CA-C-O 121.027 0.345 . . . . 72.519999999999996 112.42 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 51' ' ' GLY . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.010000000000005 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.120000000000005 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 67' ' ' LYS . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.13 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 21' ' ' VAL . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.120000000000005 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.844 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.010000000000005 110.38 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.024 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.329999999999998 111.228 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.566 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.566 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.129999999999995 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.340000000000003 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.430000000000007 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' HG21 ' A' ' 28' ' ' VAL . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 65.129999999999995 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.822 HG21 HG13 ' A' ' 30' ' ' ILE . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.310000000000002 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.239999999999995 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.329999999999998 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.319999999999993 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 53.340000000000003 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.120000000000005 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 61.200000000000003 109.557 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.340000000000003 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.03 HD12 HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.439999999999998 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.200000000000003 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.239999999999995 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.863 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.209999999999994 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.120000000000005 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.209999999999994 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.399999999999999 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.209999999999994 111.511 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.257 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.010000000000005 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 54.119999999999997 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.519999999999996 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.319999999999993 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.450000000000003 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.140000000000001 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.655 ' CD ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.439999999999998 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.310000000000002 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 72.329999999999998 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.509999999999998 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 105' ' ' VAL . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 73.439999999999998 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 32.420000000000002 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.319999999999993 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.329999999999998 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.340000000000003 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.310000000000002 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.319999999999993 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 60.450000000000003 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 55.229999999999997 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.450000000000003 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 63.329999999999998 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.520000000000003 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.150000000000006 110.047 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 112' ' ' ILE . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 43.109999999999999 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' ARG . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.129999999999995 111.903 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 9' ' ' VAL . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.409999999999997 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.120000000000005 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.604 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.701 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.310000000000002 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.863 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.119999999999997 112.176 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 35' ' ' PRO . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.430000000000007 111.824 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.209999999999994 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.239999999999995 111.316 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 44.210000000000001 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.024 HG12 ' HB2' ' A' ' 14' ' ' ALA . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.21 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.420000000000002 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.219999999999999 111.093 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 CA-C-O 120.972 0.322 . . . . 54.439999999999998 112.401 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 60.210000000000001 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.340000000000003 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.150000000000006 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.03 HD23 HD12 ' A' ' 29' ' ' LEU . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 64.25 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.150000000000006 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.793 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.409999999999997 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.239999999999995 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.439999999999998 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.793 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.420000000000002 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 60.439999999999998 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.409999999999997 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.888 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.030000000000001 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.430000000000007 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 52.530000000000001 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.100000000000001 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.130000000000003 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.230000000000004 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.420000000000002 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 HD23 ' A' ' 50' ' ' LEU . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.049 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.957 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.655 HD11 ' CD ' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 54.119999999999997 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 121' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.140000000000001 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.409999999999997 109.949 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 64.349999999999994 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.897 HG21 HG21 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 72.099999999999994 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.902 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.520000000000003 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.888 ' HB3' HG21 ' A' ' 97' ' ' VAL . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.230000000000004 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.130000000000003 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 74.019999999999996 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 73.140000000000001 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 73.219999999999999 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.726 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.400000000000006 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.902 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 73.219999999999999 111.049 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.006 0.336 . . . . 72.519999999999996 112.041 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.010000000000005 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.120000000000005 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.409999999999997 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 20' ' ' ILE . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.774 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.98 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.230000000000004 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 13.2 p30 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.340000000000003 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.61 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.430000000000007 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 65.129999999999995 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG11 ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.310000000000002 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 22' ' ' LEU . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.239999999999995 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.319999999999993 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 53.340000000000003 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.863 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.120000000000005 110.897 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 61.200000000000003 110.158 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.098 HD12 HD11 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.439999999999998 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.03 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.200000000000003 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.239999999999995 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.209999999999994 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.120000000000005 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.209999999999994 109.634 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.625 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.399999999999999 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.209999999999994 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.400000000000006 111.186 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.010000000000005 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 54.119999999999997 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.519999999999996 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.450000000000003 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.140000000000001 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.955 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.439999999999998 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.917 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.310000000000002 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.594 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 72.329999999999998 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.509999999999998 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.902 HD13 ' CG1' ' A' ' 105' ' ' VAL . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 73.439999999999998 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 32.420000000000002 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.319999999999993 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.329999999999998 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.340000000000003 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.310000000000002 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.319999999999993 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 60.450000000000003 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 55.229999999999997 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.450000000000003 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 63.329999999999998 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.520000000000003 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.150000000000006 110.056 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 112' ' ' ILE . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 43.109999999999999 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.129999999999995 112.122 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.409999999999997 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.120000000000005 112.349 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.450000000000003 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.310000000000002 110.358 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.119999999999997 111.776 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.408 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.430000000000007 111.633 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.827 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.209999999999994 111.169 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' ND2' HG12 ' A' ' 13' ' ' VAL . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 111.101 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 44.210000000000001 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.099999999999994 111.249 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.420000000000002 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.219999999999999 110.936 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 N-CA-C 113.286 0.456 . . . . 54.439999999999998 113.286 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 99' ' ' TYR . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 60.210000000000001 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.340000000000003 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.150000000000006 110.871 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.9 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 64.25 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.150000000000006 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.895 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.409999999999997 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.863 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.239999999999995 108.238 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.439999999999998 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.420000000000002 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.329999999999998 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.458 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 60.439999999999998 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.409999999999997 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.801 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.030000000000001 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.430000000000007 109.354 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 52.530000000000001 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.130000000000003 113.003 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.230000000000004 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.420000000000002 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 46' ' ' LYS . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.229999999999997 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 112' ' ' ILE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 54.119999999999997 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.744 HG13 HD11 ' A' ' 50' ' ' LEU . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.140000000000001 109.232 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.409999999999997 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 64.349999999999994 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 29' ' ' LEU . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 72.099999999999994 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.340000000000003 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.520000000000003 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.801 ' OD1' HG11 ' A' ' 97' ' ' VAL . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.130000000000003 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 74.019999999999996 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 73.140000000000001 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.6 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 73.219999999999999 111.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.038 0.349 . . . . 72.519999999999996 112.703 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.010000000000005 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 20' ' ' ILE . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 111.89 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.784 HG22 ' HD3' ' A' ' 67' ' ' LYS . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.409999999999997 109.723 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.729 HG11 HG23 ' A' ' 21' ' ' VAL . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 109.978 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.329999999999998 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.548 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.230000000000004 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.129999999999995 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.340000000000003 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.430000000000007 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG21 HG21 ' A' ' 10' ' ' THR . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 65.129999999999995 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG21 HG13 ' A' ' 30' ' ' ILE . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.310000000000002 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.683 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.239999999999995 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' CG ' HG22 ' A' ' 25' ' ' THR . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.329999999999998 110.505 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 53.340000000000003 111.042 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.658 ' HG2' HG23 ' A' ' 25' ' ' THR . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.569 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 61.200000000000003 109.697 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.340000000000003 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 112' ' ' ILE . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.439999999999998 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.200000000000003 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.239999999999995 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.209999999999994 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.120000000000005 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.209999999999994 109.57 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.399999999999999 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.209999999999994 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.400000000000006 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.010000000000005 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 54.119999999999997 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HA ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.230000000000004 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.230000000000004 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.862 HD23 ' HD2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.319999999999993 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.450000000000003 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.140000000000001 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.906 ' HB2' HG22 ' A' ' 105' ' ' VAL . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.439999999999998 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.310000000000002 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 72.329999999999998 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.509999999999998 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD13 ' CG1' ' A' ' 105' ' ' VAL . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 73.439999999999998 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 32.420000000000002 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.319999999999993 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.329999999999998 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.340000000000003 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.310000000000002 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.319999999999993 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 60.450000000000003 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 55.229999999999997 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.450000000000003 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 63.329999999999998 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.520000000000003 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.150000000000006 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.951 HG21 HG21 ' A' ' 112' ' ' ILE . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 43.109999999999999 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.527 HG23 ' CD ' ' A' ' 26' ' ' LYS . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.129999999999995 111.566 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.120000000000005 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.784 ' HD3' HG22 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.310000000000002 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.119999999999997 111.596 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.430000000000007 111.707 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 110.884 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 44.210000000000001 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.727 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.099999999999994 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.420000000000002 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.819 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.618 0.174 . . . . 54.439999999999998 112.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 99' ' ' TYR . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 60.210000000000001 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.340000000000003 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.150000000000006 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.812 HD21 HG23 ' A' ' 112' ' ' ILE . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 64.25 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.150000000000006 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.771 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.409999999999997 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.239999999999995 108.837 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' HE3' ' A' ' 93' ' ' LYS . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.439999999999998 112.302 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.420000000000002 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.146 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 60.439999999999998 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.409999999999997 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.87 HG21 ' HB3' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.030000000000001 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.430000000000007 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 52.530000000000001 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.130000000000003 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.546 ' H ' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.230000000000004 109.13 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.420000000000002 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.001 ' CG1' HD13 ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.229999999999997 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.150000000000006 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.673 ' HB2' HG23 ' A' ' 104' ' ' THR . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 54.119999999999997 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.140000000000001 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.409999999999997 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.349999999999994 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.951 HG21 HG21 ' A' ' 63' ' ' VAL . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 72.099999999999994 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.340000000000003 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.520000000000003 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.87 ' HB3' HG21 ' A' ' 97' ' ' VAL . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.230000000000004 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.130000000000003 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 73.140000000000001 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 73.219999999999999 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.637 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 73.219999999999999 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.932 0.305 . . . . 72.519999999999996 112.576 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.010000000000005 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 12' ' ' VAL . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.120000000000005 111.484 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' HD2' ' A' ' 67' ' ' LYS . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.409999999999997 109.633 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' THR . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.758 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.98 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.329999999999998 110.889 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.230000000000004 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.129999999999995 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.340000000000003 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.634 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.430000000000007 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' O ' HG21 ' A' ' 28' ' ' VAL . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 65.129999999999995 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 28' ' ' VAL . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.310000000000002 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.239999999999995 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.329999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.319999999999993 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 53.340000000000003 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.120000000000005 110.513 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 61.200000000000003 109.624 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 20' ' ' ILE . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.340000000000003 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.439999999999998 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.200000000000003 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.209999999999994 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.120000000000005 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.209999999999994 109.596 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.399999999999999 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.209999999999994 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 111.624 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.010000000000005 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 54.119999999999997 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.230000000000004 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.519999999999996 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.230000000000004 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 31' ' ' GLU . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.319999999999993 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.450000000000003 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.140000000000001 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.439999999999998 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.310000000000002 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 72.329999999999998 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.509999999999998 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 73.439999999999998 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.769 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 32.420000000000002 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.319999999999993 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.329999999999998 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.310000000000002 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.319999999999993 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 60.450000000000003 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 55.229999999999997 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.450000000000003 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 63.329999999999998 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.520000000000003 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.150000000000006 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 112' ' ' ILE . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 43.109999999999999 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.120000000000005 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.76 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.450000000000003 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.310000000000002 110.587 179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 111.78 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.430000000000007 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.209999999999994 111.217 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.239999999999995 111.069 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 44.210000000000001 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.98 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.4 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.420000000000002 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.918 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.757 0.232 . . . . 54.439999999999998 112.152 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 60.210000000000001 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.340000000000003 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.150000000000006 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 64.25 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.553 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.150000000000006 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.691 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.409999999999997 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.239999999999995 108.895 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.439999999999998 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.420000000000002 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 60.439999999999998 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.409999999999997 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HB3' ' A' ' 115' ' ' ASN . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.030000000000001 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.430000000000007 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 52.530000000000001 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.100000000000001 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.130000000000003 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.230000000000004 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.420000000000002 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 107' ' ' ASP . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.814 ' CG1' HD23 ' A' ' 50' ' ' LEU . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.229999999999997 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.448 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.150000000000006 110.099 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 54.119999999999997 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.409999999999997 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 64.349999999999994 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 63' ' ' VAL . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 72.099999999999994 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.806 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.340000000000003 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CG ' ' HD3' ' A' ' 110' ' ' LYS . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.520000000000003 108.653 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.912 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.230000000000004 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.130000000000003 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 74.019999999999996 108.542 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 73.140000000000001 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.649 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.400000000000006 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.806 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 73.219999999999999 111.13 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo . . . . . 0 N--CA 1.46 -0.473 0 CA-C-O 120.835 0.264 . . . . 72.519999999999996 112.511 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.010000000000005 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.791 HG22 ' CG2' ' A' ' 12' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.120000000000005 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.409999999999997 109.463 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.822 HG21 ' HB ' ' A' ' 20' ' ' ILE . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.120000000000005 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.883 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.010000000000005 110.067 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.329999999999998 111.126 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.565 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.230000000000004 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.864 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.129999999999995 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.340000000000003 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.430000000000007 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 65.129999999999995 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.787 ' HA ' HG11 ' A' ' 28' ' ' VAL . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.239999999999995 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' HG21 ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.329999999999998 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.319999999999993 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 53.340000000000003 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.814 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.120000000000005 110.897 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 61.200000000000003 109.816 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD22 HD11 ' A' ' 112' ' ' ILE . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.439999999999998 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.200000000000003 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.239999999999995 111.603 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.120000000000005 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.209999999999994 109.761 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.399999999999999 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.209999999999994 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.400000000000006 111.172 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.010000000000005 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 54.119999999999997 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.230000000000004 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.519999999999996 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.230000000000004 110.097 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.319999999999993 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.450000000000003 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.140000000000001 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.439999999999998 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.841 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.310000000000002 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 72.329999999999998 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.509999999999998 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 32.420000000000002 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.319999999999993 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.329999999999998 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HG13 ' A' ' 63' ' ' VAL . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.310000000000002 112.124 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.319999999999993 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 60.450000000000003 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 55.229999999999997 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.450000000000003 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 63.329999999999998 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.150000000000006 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 112' ' ' ILE . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 43.109999999999999 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.129999999999995 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.834 ' O ' HG23 ' A' ' 9' ' ' VAL . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.409999999999997 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.120000000000005 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.310000000000002 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.119999999999997 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.402 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.430000000000007 111.567 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.209999999999994 110.858 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.483 ' ND2' ' HB ' ' A' ' 13' ' ' VAL . 15.0 m120 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.239999999999995 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 44.210000000000001 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.881 HG12 ' HB2' ' A' ' 14' ' ' ALA . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.099999999999994 111.114 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.219999999999999 110.991 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.785 0.244 . . . . 54.439999999999998 112.293 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 60.210000000000001 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.340000000000003 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.150000000000006 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD21 HG23 ' A' ' 112' ' ' ILE . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 64.25 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.150000000000006 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.409999999999997 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.239999999999995 108.72 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.439999999999998 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.420000000000002 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 60.439999999999998 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.409999999999997 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.872 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.030000000000001 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.430000000000007 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 52.530000000000001 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.100000000000001 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.130000000000003 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.230000000000004 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.420000000000002 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.229999999999997 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 54.119999999999997 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.140000000000001 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.409999999999997 109.817 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 64.349999999999994 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.962 HD11 HD22 ' A' ' 29' ' ' LEU . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 72.099999999999994 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.932 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.340000000000003 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HG3' ' HD3' ' A' ' 110' ' ' LYS . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.520000000000003 108.238 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.872 ' OD1' HG11 ' A' ' 97' ' ' VAL . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.230000000000004 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.130000000000003 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 74.019999999999996 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 73.140000000000001 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 73.219999999999999 111.334 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.400000000000006 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 73.219999999999999 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.78 0.242 . . . . 72.519999999999996 112.131 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.010000000000005 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 12' ' ' VAL . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 111.511 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 67' ' ' LYS . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.409999999999997 109.596 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' HB ' ' A' ' 20' ' ' ILE . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.120000000000005 112.04 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.932 HG13 ' ND2' ' A' ' 73' ' ' ASN . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.010000000000005 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.329999999999998 109.856 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.625 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.230000000000004 111.635 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.885 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.129999999999995 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.340000000000003 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.430000000000007 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.685 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 65.129999999999995 112.243 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 HG13 ' A' ' 30' ' ' ILE . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.310000000000002 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.239999999999995 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.329999999999998 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 110.905 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.787 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.120000000000005 110.335 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 61.200000000000003 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.340000000000003 111.831 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.808 HD22 HD11 ' A' ' 112' ' ' ILE . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.439999999999998 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.885 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.200000000000003 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.239999999999995 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.209999999999994 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.120000000000005 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.703 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.209999999999994 109.63 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.703 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.399999999999999 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.209999999999994 111.429 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.400000000000006 111.13 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.010000000000005 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 54.119999999999997 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.230000000000004 110.72 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.519999999999996 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.230000000000004 110.933 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.698 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.319999999999993 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.450000000000003 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.140000000000001 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 105' ' ' VAL . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.439999999999998 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.310000000000002 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 72.329999999999998 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.755 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 73.439999999999998 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 32.420000000000002 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.319999999999993 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.329999999999998 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.340000000000003 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.310000000000002 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.319999999999993 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 60.450000000000003 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 55.229999999999997 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 63.329999999999998 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.520000000000003 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 112' ' ' ILE . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 43.109999999999999 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.409999999999997 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.120000000000005 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 69' ' ' ASP . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.450000000000003 110.885 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.883 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.119999999999997 112.311 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.407 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.430000000000007 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.883 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.209999999999994 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.932 ' ND2' HG13 ' A' ' 13' ' ' VAL . 7.3 m120 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.210000000000001 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 14' ' ' ALA . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 111.103 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.420000000000002 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 111.079 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 121.003 0.334 . . . . 54.439999999999998 112.505 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 60.210000000000001 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.150000000000006 110.629 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 64.25 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.769 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.787 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.239999999999995 108.849 177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.439999999999998 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.819 ' HB2' ' CE ' ' A' ' 117' ' ' LYS . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.329999999999998 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 60.439999999999998 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.409999999999997 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.839 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.030000000000001 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.430000000000007 109.624 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 52.530000000000001 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.100000000000001 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.130000000000003 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.230000000000004 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.420000000000002 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.422 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.755 ' CG1' HD23 ' A' ' 50' ' ' LEU . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.229999999999997 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.150000000000006 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 112' ' ' ILE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 54.119999999999997 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.673 HG13 HD21 ' A' ' 50' ' ' LEU . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.140000000000001 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.409999999999997 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 64.349999999999994 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 87' ' ' LEU . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 72.099999999999994 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.876 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.340000000000003 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.520000000000003 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.839 ' OD1' HG11 ' A' ' 97' ' ' VAL . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.130000000000003 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.819 ' CE ' ' HB2' ' A' ' 92' ' ' ALA . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 74.019999999999996 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 73.140000000000001 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 73.219999999999999 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.876 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 73.219999999999999 111.054 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 CA-C-O 120.669 0.195 . . . . 72.519999999999996 112.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.573 HG12 ' HA3' ' A' ' 51' ' ' GLY . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.010000000000005 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.751 HG22 ' CG2' ' A' ' 12' ' ' VAL . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.674 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 67' ' ' LYS . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.409999999999997 110.122 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.751 ' CG2' HG22 ' A' ' 10' ' ' THR . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.120000000000005 111.077 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.010000000000005 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.089 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.329999999999998 110.261 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.230000000000004 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.129999999999995 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.541 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 1.7 m-20 -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.340000000000003 109.043 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.430000000000007 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 65.129999999999995 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.879 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.310000000000002 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.239999999999995 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.319999999999993 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 53.340000000000003 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.120000000000005 110.975 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 61.200000000000003 109.913 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.879 HG11 ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.340000000000003 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.887 HD22 HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.439999999999998 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.869 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.200000000000003 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.662 ' OE2' HD22 ' A' ' 43' ' ' LEU . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.239999999999995 111.504 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.209999999999994 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.120000000000005 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.209999999999994 109.623 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.399999999999999 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.209999999999994 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.400000000000006 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.010000000000005 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 54.119999999999997 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.230000000000004 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.519999999999996 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.230000000000004 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.662 HD22 ' OE2' ' A' ' 31' ' ' GLU . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.319999999999993 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.450000000000003 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.140000000000001 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.439999999999998 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.310000000000002 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 72.329999999999998 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.509999999999998 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 HG13 ' A' ' 105' ' ' VAL . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 73.439999999999998 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 9' ' ' VAL . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 32.420000000000002 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.319999999999993 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 49' ' ' GLU . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.329999999999998 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' ILE . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 110.903 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.310000000000002 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.319999999999993 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 60.450000000000003 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 55.229999999999997 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.450000000000003 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.520000000000003 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.150000000000006 109.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.761 HG11 ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 43.109999999999999 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' ARG . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.918 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.409999999999997 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.120000000000005 112.168 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 13' ' ' VAL . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.450000000000003 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.310000000000002 110.396 179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.119999999999997 111.903 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.430000000000007 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.209999999999994 111.978 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 68' ' ' VAL . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.239999999999995 111.418 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 44.210000000000001 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.089 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.099999999999994 111.25 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.617 0.174 . . . . 54.439999999999998 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 99' ' ' TYR . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 60.210000000000001 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.340000000000003 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.150000000000006 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 29' ' ' LEU . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 64.25 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.150000000000006 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.409999999999997 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.239999999999995 108.917 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.439999999999998 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.329999999999998 111.312 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 60.439999999999998 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.409999999999997 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.967 HG11 ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.030000000000001 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.430000000000007 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.76 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 52.530000000000001 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.100000000000001 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.130000000000003 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.229999999999997 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.150000000000006 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 50' ' ' LEU . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 54.119999999999997 110.379 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 50' ' ' LEU . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.140000000000001 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.409999999999997 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 64.349999999999994 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.756 HG21 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 72.099999999999994 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.921 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.520000000000003 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.967 ' OD1' HG11 ' A' ' 97' ' ' VAL . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.230000000000004 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.130000000000003 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 74.019999999999996 108.542 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 73.140000000000001 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.761 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.921 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 73.219999999999999 111.024 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.084 0.368 . . . . 72.519999999999996 112.39 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.835 HG23 ' HA3' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.79 HG22 ' CG2' ' A' ' 12' ' ' VAL . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 111.365 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.503 HG22 ' HE2' ' A' ' 67' ' ' LYS . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 109.855 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.79 ' CG2' HG22 ' A' ' 10' ' ' THR . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.120000000000005 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.682 ' HA ' HG23 ' A' ' 68' ' ' VAL . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.010000000000005 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.329999999999998 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.230000000000004 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.129999999999995 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.430000000000007 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 65.129999999999995 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.310000000000002 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.329999999999998 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.319999999999993 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CD ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 53.340000000000003 110.589 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.619 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.120000000000005 110.339 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 61.200000000000003 109.913 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.906 HD22 HD11 ' A' ' 112' ' ' ILE . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.439999999999998 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.669 HG13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.200000000000003 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.239999999999995 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.209999999999994 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.120000000000005 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 109.555 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.399999999999999 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.209999999999994 111.308 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.400000000000006 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.010000000000005 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 54.119999999999997 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.573 ' HA ' HD13 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 40' ' ' CYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.319999999999993 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.450000000000003 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.140000000000001 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.975 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.439999999999998 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.310000000000002 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 72.329999999999998 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.509999999999998 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 73.439999999999998 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.835 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 32.420000000000002 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.319999999999993 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 63' ' ' VAL . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.310000000000002 112.36 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.319999999999993 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 60.450000000000003 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 55.229999999999997 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 111.073 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.520000000000003 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.150000000000006 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 112' ' ' ILE . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 43.109999999999999 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.441 HG11 ' OG1' ' A' ' 10' ' ' THR . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.566 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.409999999999997 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.120000000000005 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HE2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.450000000000003 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.441 ' OD1' HG22 ' A' ' 71' ' ' THR . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.310000000000002 110.948 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 69' ' ' ASP . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.430000000000007 112.344 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' ASP . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.209999999999994 111.092 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.588 ' OD1' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 44.210000000000001 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 14' ' ' ALA . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.099999999999994 111.182 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.420000000000002 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.219999999999999 110.925 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.465 0.111 . . . . 54.439999999999998 112.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 99' ' ' TYR . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 60.210000000000001 111.075 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.340000000000003 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.150000000000006 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 64.25 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.150000000000006 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.798 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.409999999999997 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.439999999999998 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.798 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.420000000000002 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 60.439999999999998 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.409999999999997 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.030000000000001 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 86' ' ' LYS . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.430000000000007 109.588 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 52.530000000000001 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.100000000000001 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.420000000000002 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.705 HG23 ' HB2' ' A' ' 107' ' ' ASP . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.229999999999997 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.150000000000006 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.705 ' HB2' HG23 ' A' ' 104' ' ' THR . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 54.119999999999997 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 121' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.140000000000001 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.409999999999997 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 64.349999999999994 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 29' ' ' LEU . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 72.099999999999994 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.886 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.520000000000003 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.881 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.230000000000004 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 74.019999999999996 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 73.140000000000001 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 73.219999999999999 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.992 0.33 . . . . 72.519999999999996 112.473 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.010000000000005 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' ILE . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.120000000000005 111.393 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.409999999999997 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.782 HG11 HG23 ' A' ' 21' ' ' VAL . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.839 ' HA ' HG23 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.329999999999998 110.352 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.230000000000004 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.644 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.129999999999995 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.340000000000003 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.430000000000007 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 10' ' ' THR . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 65.129999999999995 112.28 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 30' ' ' ILE . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.239999999999995 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.319999999999993 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 53.340000000000003 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.120000000000005 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 61.200000000000003 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 112' ' ' ILE . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.439999999999998 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.814 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.200000000000003 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.239999999999995 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.209999999999994 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.120000000000005 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.209999999999994 109.531 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.399999999999999 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.209999999999994 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.400000000000006 111.268 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.010000000000005 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 54.119999999999997 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.230000000000004 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.519999999999996 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.230000000000004 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.319999999999993 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.450000000000003 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.140000000000001 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HE2' HD11 ' A' ' 108' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.439999999999998 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.912 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.310000000000002 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.509999999999998 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.673 ' HG ' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 73.439999999999998 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 32.420000000000002 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.319999999999993 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.329999999999998 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' LEU . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.340000000000003 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.310000000000002 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.319999999999993 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 60.450000000000003 111.288 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 55.229999999999997 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.450000000000003 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 63.329999999999998 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.520000000000003 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.150000000000006 110.182 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.773 ' CG2' HG21 ' A' ' 112' ' ' ILE . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 43.109999999999999 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' ARG . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.129999999999995 111.787 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.829 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.120000000000005 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HA ' ' H ' ' A' ' 31' ' ' GLU . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.450000000000003 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.799 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.310000000000002 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.119999999999997 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.430000000000007 111.815 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.209999999999994 111.13 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 44.210000000000001 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 14' ' ' ALA . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.199 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.420000000000002 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.952 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.475 0.115 . . . . 54.439999999999998 112.23 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 60.210000000000001 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.340000000000003 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.150000000000006 110.359 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.544 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.150000000000006 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' HD13 ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.409999999999997 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.239999999999995 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.439999999999998 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.597 ' HB2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 60.439999999999998 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.409999999999997 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.811 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.030000000000001 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' THR . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.430000000000007 109.607 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.623 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 52.530000000000001 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.100000000000001 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.130000000000003 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.230000000000004 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 107' ' ' ASP . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.673 HG13 ' HG ' ' A' ' 50' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.229999999999997 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.150000000000006 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 104' ' ' THR . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.736 HD11 ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 54.119999999999997 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.140000000000001 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.409999999999997 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 64.349999999999994 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 72.099999999999994 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.683 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.520000000000003 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.811 ' OD1' HG11 ' A' ' 97' ' ' VAL . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.230000000000004 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.130000000000003 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 74.019999999999996 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 73.140000000000001 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.185 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.743 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.683 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 73.219999999999999 111.08 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.462 -0.255 . . . . 64.349999999999994 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.16 136.77 54.39 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.594 2.196 . . . . 60.030000000000001 112.315 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.7 129.37 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.219999999999999 110.912 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.65 154.08 28.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 34.240000000000002 112.511 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.72 -75.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 63.130000000000003 110.918 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -154.55 132.45 11.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.86 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.0 114.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.736 -0.745 . . . . 53.149999999999999 112.314 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 50.8 Cg_endo -71.18 -59.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.312 2.008 . . . . 72.519999999999996 112.326 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.010000000000005 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.120000000000005 111.651 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.409999999999997 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 20' ' ' ILE . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.120000000000005 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 68' ' ' VAL . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.268 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 73' ' ' ASN . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.329999999999998 110.857 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.544 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' ND2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.230000000000004 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.129999999999995 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 78.5 m-20 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.340000000000003 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.430000000000007 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 65.129999999999995 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.845 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.310000000000002 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.329999999999998 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.319999999999993 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 53.340000000000003 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.120000000000005 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 63' ' ' VAL . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 61.200000000000003 109.855 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.340000000000003 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD23 HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.439999999999998 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.200000000000003 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.239999999999995 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.209999999999994 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.120000000000005 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.209999999999994 109.434 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.399999999999999 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.209999999999994 111.51 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.400000000000006 111.075 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.010000000000005 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 54.119999999999997 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.230000000000004 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.230000000000004 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.319999999999993 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.140000000000001 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.004 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.439999999999998 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.927 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.310000000000002 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 72.329999999999998 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.509999999999998 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.8 HD13 HG13 ' A' ' 105' ' ' VAL . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 73.439999999999998 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 32.420000000000002 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.319999999999993 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.329999999999998 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.340000000000003 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.310000000000002 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.319999999999993 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 60.450000000000003 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 55.229999999999997 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.450000000000003 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 63.329999999999998 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.520000000000003 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.150000000000006 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.906 HG11 ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 43.109999999999999 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 111.774 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.409999999999997 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.120000000000005 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 111.422 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.310000000000002 110.169 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.119999999999997 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.430000000000007 111.521 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.209999999999994 110.824 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 13' ' ' VAL . 13.8 m120 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.239999999999995 110.932 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 44.210000000000001 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' ASP . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.099999999999994 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.420000000000002 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -101.37 144.38 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.219999999999999 111.118 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.38 152.76 28.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.678 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 49.6 mt -134.02 107.0 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.439 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.22 -18.36 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 54.509999999999998 110.609 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.7 114.91 2.22 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.483 -0.647 . . . . 71.420000000000002 111.483 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CE1' ' HB ' ' A' ' 79' ' ' ILE . 4.9 m-85 -106.68 127.21 28.56 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.584 0.23 . . . . 73.349999999999994 111.211 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo -82.13 -163.81 3.45 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.94 -1.275 . . . . 54.439999999999998 112.262 -0.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 99' ' ' TYR . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 60.210000000000001 111.232 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 29' ' ' LEU . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.340000000000003 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 30' ' ' ILE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.150000000000006 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.775 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 64.25 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.643 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.150000000000006 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.409999999999997 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.239999999999995 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.439999999999998 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.420000000000002 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.329999999999998 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.517 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 60.439999999999998 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.409999999999997 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.848 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.030000000000001 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.430000000000007 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 52.530000000000001 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.100000000000001 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.130000000000003 112.842 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.230000000000004 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.420000000000002 110.778 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.004 HG22 ' HB2' ' A' ' 46' ' ' LYS . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.229999999999997 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.150000000000006 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 50' ' ' LEU . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 54.119999999999997 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.140000000000001 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.409999999999997 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 64.349999999999994 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.775 HG23 HD21 ' A' ' 87' ' ' LEU . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 72.099999999999994 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.863 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.340000000000003 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.520000000000003 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.848 ' OD1' HG11 ' A' ' 97' ' ' VAL . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.230000000000004 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.130000000000003 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 74.019999999999996 108.375 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 73.140000000000001 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 73.219999999999999 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.863 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 73.219999999999999 111.11 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.49 -0.244 . . . . 64.349999999999994 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 175.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.582 2.188 . . . . 60.030000000000001 112.373 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.65 -52.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.219999999999999 110.904 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.49 -91.7 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 34.240000000000002 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -139.72 140.44 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 63.130000000000003 110.884 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.02 137.32 58.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.845 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.39 149.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 53.149999999999999 112.405 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' CA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo -77.82 -48.44 0.1 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.533 2.155 . . . . 72.519999999999996 112.42 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 51' ' ' GLY . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.010000000000005 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.120000000000005 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 67' ' ' LYS . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.13 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 21' ' ' VAL . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.120000000000005 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.844 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.010000000000005 110.38 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.024 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.329999999999998 111.228 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.566 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.129999999999995 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.340000000000003 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.430000000000007 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' HG21 ' A' ' 28' ' ' VAL . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 65.129999999999995 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.822 HG21 HG13 ' A' ' 30' ' ' ILE . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.310000000000002 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.239999999999995 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.329999999999998 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.319999999999993 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 53.340000000000003 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.120000000000005 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 61.200000000000003 109.557 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.340000000000003 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.03 HD12 HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.439999999999998 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.200000000000003 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.239999999999995 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.863 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.209999999999994 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.120000000000005 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.209999999999994 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.399999999999999 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.209999999999994 111.511 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.257 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.010000000000005 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 54.119999999999997 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.519999999999996 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.319999999999993 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.450000000000003 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.140000000000001 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.655 ' CD ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.439999999999998 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.310000000000002 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 72.329999999999998 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.509999999999998 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 105' ' ' VAL . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 73.439999999999998 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 32.420000000000002 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.319999999999993 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.329999999999998 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.340000000000003 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.310000000000002 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.319999999999993 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 60.450000000000003 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 55.229999999999997 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.450000000000003 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 63.329999999999998 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.520000000000003 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.150000000000006 110.047 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 112' ' ' ILE . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 43.109999999999999 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' ARG . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.129999999999995 111.903 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 9' ' ' VAL . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.409999999999997 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.120000000000005 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.604 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.701 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.310000000000002 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.863 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.119999999999997 112.176 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 35' ' ' PRO . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.430000000000007 111.824 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.209999999999994 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.239999999999995 111.316 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 44.210000000000001 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.024 HG12 ' HB2' ' A' ' 14' ' ' ALA . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.21 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.420000000000002 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.07 123.52 22.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.219999999999999 111.093 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.22 151.21 33.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.336 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 46.8 mt -140.18 106.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 75.140000000000001 111.381 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.59 -17.71 61.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 54.509999999999998 110.955 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.62 114.45 1.61 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.083 -0.579 . . . . 71.420000000000002 111.737 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HE2' ' HB1' ' A' ' 70' ' ' ALA . 31.1 m-85 -105.85 132.13 21.15 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.73 0.3 . . . . 73.349999999999994 111.169 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo -80.98 -163.84 3.55 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.678 -1.384 . . . . 54.439999999999998 112.401 -0.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 60.210000000000001 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.340000000000003 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.150000000000006 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.03 HD23 HD12 ' A' ' 29' ' ' LEU . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 64.25 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.150000000000006 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.793 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.409999999999997 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.239999999999995 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.439999999999998 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.793 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.420000000000002 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 60.439999999999998 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.409999999999997 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.888 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.030000000000001 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.430000000000007 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 52.530000000000001 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.100000000000001 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.130000000000003 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.230000000000004 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.420000000000002 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 HD23 ' A' ' 50' ' ' LEU . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.229999999999997 110.049 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 109.957 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.655 HD11 ' CD ' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 54.119999999999997 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 121' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.140000000000001 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.409999999999997 109.949 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 64.349999999999994 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.897 HG21 HG21 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 72.099999999999994 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.902 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.520000000000003 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.888 ' HB3' HG21 ' A' ' 97' ' ' VAL . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.230000000000004 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.130000000000003 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 74.019999999999996 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 73.140000000000001 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 73.219999999999999 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.726 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.400000000000006 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.902 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 73.219999999999999 111.049 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.48 -0.248 . . . . 64.349999999999994 112.48 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.57 ' O ' HD12 ' A' ' 3' ' ' LEU . 52.8 Cg_exo -52.64 168.25 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 60.030000000000001 112.305 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 2' ' ' PRO . 1.7 mp -149.81 -178.76 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 63.219999999999999 110.869 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.49 -173.21 46.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 34.240000000000002 112.478 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 t -145.23 84.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 63.130000000000003 110.893 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -178.81 111.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 72.209999999999994 110.692 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . -167.15 49.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.471 -0.871 . . . . 53.149999999999999 113.081 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo -69.4 -56.93 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.36 2.04 . . . . 72.519999999999996 112.041 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.010000000000005 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.120000000000005 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.409999999999997 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 20' ' ' ILE . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.774 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.98 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.545 ' ND2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.230000000000004 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.129999999999995 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 13.2 p30 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.340000000000003 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.61 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.430000000000007 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 65.129999999999995 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG11 ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.310000000000002 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 22' ' ' LEU . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.239999999999995 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.319999999999993 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 53.340000000000003 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.863 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.120000000000005 110.897 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 61.200000000000003 110.158 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.098 HD12 HD11 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.439999999999998 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.03 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.200000000000003 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.239999999999995 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.209999999999994 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.120000000000005 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.209999999999994 109.634 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.625 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.399999999999999 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.209999999999994 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.400000000000006 111.186 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.010000000000005 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 54.119999999999997 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.519999999999996 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.319999999999993 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.450000000000003 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.140000000000001 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.955 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.439999999999998 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.917 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.310000000000002 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.594 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 72.329999999999998 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.509999999999998 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.902 HD13 ' CG1' ' A' ' 105' ' ' VAL . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 73.439999999999998 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 32.420000000000002 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.319999999999993 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.329999999999998 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.340000000000003 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.310000000000002 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.319999999999993 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 60.450000000000003 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 55.229999999999997 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.450000000000003 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 63.329999999999998 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.520000000000003 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.150000000000006 110.056 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 112' ' ' ILE . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 43.109999999999999 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.129999999999995 112.122 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.409999999999997 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.120000000000005 112.349 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.450000000000003 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.310000000000002 110.358 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.119999999999997 111.776 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.408 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.430000000000007 111.633 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.827 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.209999999999994 111.169 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' ND2' HG12 ' A' ' 13' ' ' VAL . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 111.101 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 44.210000000000001 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.099999999999994 111.249 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.420000000000002 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.76 119.57 38.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.219999999999999 110.936 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.78 95.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 73.450000000000003 110.76 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 32' ' ' PHE . 35.9 mt -73.44 87.12 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 75.140000000000001 111.191 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -51.12 -26.56 6.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 54.509999999999998 110.702 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.82 110.34 0.63 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.872 -0.603 . . . . 71.420000000000002 111.714 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' HA ' ' C ' ' A' ' 83' ' ' PRO . 26.3 p90 -111.88 153.06 44.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.546 0.212 . . . . 73.349999999999994 110.925 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -71.52 -168.0 4.91 Favored 'Cis proline' 0 C--N 1.346 0.426 0 C-N-CA 123.164 -1.598 . . . . 54.439999999999998 113.286 0.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 99' ' ' TYR . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 60.210000000000001 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.340000000000003 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.150000000000006 110.871 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.9 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 64.25 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.150000000000006 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.895 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.409999999999997 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.863 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.239999999999995 108.238 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.439999999999998 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.420000000000002 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.329999999999998 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.458 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 60.439999999999998 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.409999999999997 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.801 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.030000000000001 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.430000000000007 109.354 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 52.530000000000001 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.130000000000003 113.003 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.230000000000004 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.420000000000002 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 46' ' ' LYS . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.229999999999997 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 112' ' ' ILE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 54.119999999999997 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.744 HG13 HD11 ' A' ' 50' ' ' LEU . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.140000000000001 109.232 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.409999999999997 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 64.349999999999994 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 29' ' ' LEU . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 72.099999999999994 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.340000000000003 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.520000000000003 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.801 ' OD1' HG11 ' A' ' 97' ' ' VAL . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.130000000000003 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 74.019999999999996 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 73.140000000000001 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.6 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 73.219999999999999 111.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 64.349999999999994 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.18 -38.3 7.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.575 2.183 . . . . 60.030000000000001 112.336 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 mt 61.93 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 63.219999999999999 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.14 -143.46 4.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 34.240000000000002 112.55 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 m -110.05 -177.36 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 63.130000000000003 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.95 -173.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.209999999999994 110.93 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.48 72.26 0.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 53.149999999999999 112.428 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo -84.73 -50.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.789 2.326 . . . . 72.519999999999996 112.703 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.010000000000005 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 20' ' ' ILE . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 111.89 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.784 HG22 ' HD3' ' A' ' 67' ' ' LYS . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.409999999999997 109.723 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.729 HG11 HG23 ' A' ' 21' ' ' VAL . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 109.978 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.329999999999998 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.548 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.230000000000004 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.129999999999995 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.340000000000003 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.430000000000007 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG21 HG21 ' A' ' 10' ' ' THR . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 65.129999999999995 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG21 HG13 ' A' ' 30' ' ' ILE . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.310000000000002 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.683 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.239999999999995 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' CG ' HG22 ' A' ' 25' ' ' THR . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.329999999999998 110.505 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 53.340000000000003 111.042 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.658 ' HG2' HG23 ' A' ' 25' ' ' THR . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.569 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 61.200000000000003 109.697 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.340000000000003 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 112' ' ' ILE . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.439999999999998 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.200000000000003 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.239999999999995 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.209999999999994 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.120000000000005 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.209999999999994 109.57 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.399999999999999 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.209999999999994 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.400000000000006 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.010000000000005 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 54.119999999999997 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HA ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.230000000000004 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.230000000000004 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.862 HD23 ' HD2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.319999999999993 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.450000000000003 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.140000000000001 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.906 ' HB2' HG22 ' A' ' 105' ' ' VAL . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.439999999999998 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.310000000000002 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 72.329999999999998 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.509999999999998 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD13 ' CG1' ' A' ' 105' ' ' VAL . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 73.439999999999998 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 32.420000000000002 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.319999999999993 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.329999999999998 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.340000000000003 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.310000000000002 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.319999999999993 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 60.450000000000003 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 55.229999999999997 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.450000000000003 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 63.329999999999998 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.520000000000003 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.150000000000006 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.951 HG21 HG21 ' A' ' 112' ' ' ILE . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 43.109999999999999 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.527 HG23 ' CD ' ' A' ' 26' ' ' LYS . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.129999999999995 111.566 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.120000000000005 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.784 ' HD3' HG22 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.310000000000002 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.119999999999997 111.596 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.430000000000007 111.707 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.209999999999994 110.884 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 44.210000000000001 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.727 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.099999999999994 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.420000000000002 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.46 166.0 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.819 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.51 119.84 40.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.826 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -109.09 84.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 75.140000000000001 111.159 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -53.41 -25.26 15.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 54.509999999999998 110.87 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -138.36 109.64 0.69 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.909 -0.662 . . . . 71.420000000000002 112.058 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 19.7 p90 -114.08 155.11 45.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.262 . . . . 73.349999999999994 110.931 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo -74.51 -171.25 8.94 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.496 -1.46 . . . . 54.439999999999998 112.283 0.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 99' ' ' TYR . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 60.210000000000001 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.340000000000003 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.150000000000006 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.812 HD21 HG23 ' A' ' 112' ' ' ILE . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 64.25 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.150000000000006 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.771 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.409999999999997 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.239999999999995 108.837 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' HE3' ' A' ' 93' ' ' LYS . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.439999999999998 112.302 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.420000000000002 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.329999999999998 111.146 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 60.439999999999998 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.409999999999997 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.87 HG21 ' HB3' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.030000000000001 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.430000000000007 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 52.530000000000001 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.130000000000003 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.546 ' H ' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.230000000000004 109.13 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.420000000000002 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.001 ' CG1' HD13 ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.229999999999997 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.150000000000006 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.673 ' HB2' HG23 ' A' ' 104' ' ' THR . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 54.119999999999997 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.140000000000001 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.409999999999997 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.349999999999994 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.951 HG21 HG21 ' A' ' 63' ' ' VAL . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 72.099999999999994 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.340000000000003 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.520000000000003 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.87 ' HB3' HG21 ' A' ' 97' ' ' VAL . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.230000000000004 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.130000000000003 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 73.140000000000001 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 73.219999999999999 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.637 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 73.219999999999999 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.496 -0.241 . . . . 64.349999999999994 112.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.88 -26.99 26.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.604 2.203 . . . . 60.030000000000001 112.332 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.29 162.32 4.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 63.219999999999999 110.944 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.34 114.69 2.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 34.240000000000002 112.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -75.8 64.0 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 63.130000000000003 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.32 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.932 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.1 86.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.821 -0.704 . . . . 53.149999999999999 112.388 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo -73.58 -54.82 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.521 2.147 . . . . 72.519999999999996 112.576 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.010000000000005 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 12' ' ' VAL . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.120000000000005 111.484 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' HD2' ' A' ' 67' ' ' LYS . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.409999999999997 109.633 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' THR . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.758 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.98 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.329999999999998 110.889 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.230000000000004 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.129999999999995 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.340000000000003 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.634 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.430000000000007 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' O ' HG21 ' A' ' 28' ' ' VAL . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 65.129999999999995 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 28' ' ' VAL . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.310000000000002 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.239999999999995 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.329999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.319999999999993 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 53.340000000000003 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.120000000000005 110.513 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 61.200000000000003 109.624 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 20' ' ' ILE . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.340000000000003 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.439999999999998 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.200000000000003 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.209999999999994 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.120000000000005 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.209999999999994 109.596 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.399999999999999 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.209999999999994 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.400000000000006 111.624 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.010000000000005 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 54.119999999999997 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.230000000000004 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.519999999999996 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.230000000000004 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 31' ' ' GLU . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.319999999999993 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.450000000000003 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.140000000000001 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.439999999999998 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.310000000000002 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 72.329999999999998 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.509999999999998 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 73.439999999999998 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.769 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 32.420000000000002 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.319999999999993 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.329999999999998 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.310000000000002 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.319999999999993 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 60.450000000000003 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 55.229999999999997 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.450000000000003 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 63.329999999999998 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.520000000000003 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.150000000000006 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 112' ' ' ILE . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 43.109999999999999 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.120000000000005 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.76 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.450000000000003 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.310000000000002 110.587 179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 111.78 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.430000000000007 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.209999999999994 111.217 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.239999999999995 111.069 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 44.210000000000001 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.98 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.4 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.420000000000002 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.65 154.92 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -100.85 116.25 32.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.450000000000003 111.023 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 81' ' ' GLY . 11.9 mt -107.43 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 110.823 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.42 -38.36 1.23 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.039 0.447 . . . . 54.509999999999998 110.898 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 79' ' ' ILE . . . -133.02 -142.36 4.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 71.420000000000002 110.834 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 174.6 140.93 0.18 Allowed Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 117.041 0.42 . . . . 73.349999999999994 110.831 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo -74.69 -161.17 2.36 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.572 -1.428 . . . . 54.439999999999998 112.152 -0.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 60.210000000000001 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.340000000000003 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.150000000000006 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 64.25 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.553 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.150000000000006 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.691 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.409999999999997 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.239999999999995 108.895 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.439999999999998 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.420000000000002 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 60.439999999999998 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.409999999999997 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HB3' ' A' ' 115' ' ' ASN . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.030000000000001 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.430000000000007 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 52.530000000000001 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.100000000000001 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.130000000000003 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.230000000000004 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.420000000000002 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 107' ' ' ASP . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.814 ' CG1' HD23 ' A' ' 50' ' ' LEU . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.229999999999997 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.150000000000006 110.099 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 54.119999999999997 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.409999999999997 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 64.349999999999994 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 63' ' ' VAL . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 72.099999999999994 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.806 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.340000000000003 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CG ' ' HD3' ' A' ' 110' ' ' LYS . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.520000000000003 108.653 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.912 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.230000000000004 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.130000000000003 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 74.019999999999996 108.542 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 73.140000000000001 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.649 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.400000000000006 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.806 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 73.219999999999999 111.13 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.554 -0.218 . . . . 64.349999999999994 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.98 63.13 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.588 2.192 . . . . 60.030000000000001 112.322 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.33 126.2 32.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 63.219999999999999 110.86 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.03 175.32 23.0 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 34.240000000000002 112.578 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 m -74.74 -168.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 63.130000000000003 110.82 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.06 44.77 2.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 72.209999999999994 111.029 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.92 156.98 52.85 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.643 -0.789 . . . . 53.149999999999999 112.181 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -81.91 -50.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.437 2.092 . . . . 72.519999999999996 112.511 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.010000000000005 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.791 HG22 ' CG2' ' A' ' 12' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.120000000000005 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.409999999999997 109.463 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.822 HG21 ' HB ' ' A' ' 20' ' ' ILE . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.120000000000005 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.883 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.010000000000005 110.067 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.329999999999998 111.126 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.565 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.230000000000004 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.864 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.129999999999995 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.340000000000003 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.430000000000007 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 65.129999999999995 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.787 ' HA ' HG11 ' A' ' 28' ' ' VAL . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.239999999999995 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' HG21 ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.329999999999998 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.319999999999993 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 53.340000000000003 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.814 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.120000000000005 110.897 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 61.200000000000003 109.816 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD22 HD11 ' A' ' 112' ' ' ILE . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.439999999999998 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.200000000000003 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.239999999999995 111.603 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.120000000000005 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.209999999999994 109.761 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.399999999999999 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.209999999999994 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.400000000000006 111.172 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.010000000000005 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 54.119999999999997 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.230000000000004 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.519999999999996 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.230000000000004 110.097 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.319999999999993 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.450000000000003 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.140000000000001 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.439999999999998 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.841 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.310000000000002 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 72.329999999999998 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.509999999999998 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 32.420000000000002 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.319999999999993 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.329999999999998 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HG13 ' A' ' 63' ' ' VAL . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.310000000000002 112.124 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.319999999999993 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 60.450000000000003 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 55.229999999999997 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.450000000000003 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 63.329999999999998 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.150000000000006 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 112' ' ' ILE . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 43.109999999999999 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.129999999999995 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.834 ' O ' HG23 ' A' ' 9' ' ' VAL . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.409999999999997 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.120000000000005 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.310000000000002 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.119999999999997 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.402 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.430000000000007 111.567 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.209999999999994 110.858 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.483 ' ND2' ' HB ' ' A' ' 13' ' ' VAL . 15.0 m120 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.239999999999995 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 44.210000000000001 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.881 HG12 ' HB2' ' A' ' 14' ' ' ALA . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.099999999999994 111.114 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.420000000000002 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.29 150.06 25.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.219999999999999 110.991 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -91.68 148.23 22.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.450000000000003 110.707 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.422 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.6 mt -137.6 121.29 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 75.140000000000001 111.413 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 -19.12 20.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 54.509999999999998 110.589 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.01 117.01 2.88 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.285 -0.726 . . . . 71.420000000000002 111.285 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.98 127.14 28.21 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.559 0.218 . . . . 73.349999999999994 111.389 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo -79.6 -164.64 4.08 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.889 -1.296 . . . . 54.439999999999998 112.293 -0.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 60.210000000000001 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.340000000000003 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.150000000000006 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD21 HG23 ' A' ' 112' ' ' ILE . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 64.25 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.150000000000006 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.409999999999997 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.239999999999995 108.72 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.439999999999998 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.420000000000002 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 60.439999999999998 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.409999999999997 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.872 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.030000000000001 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.430000000000007 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 52.530000000000001 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.100000000000001 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.130000000000003 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.230000000000004 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.420000000000002 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.229999999999997 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.150000000000006 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 54.119999999999997 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.140000000000001 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.409999999999997 109.817 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 64.349999999999994 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.962 HD11 HD22 ' A' ' 29' ' ' LEU . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 72.099999999999994 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.932 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.340000000000003 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HG3' ' HD3' ' A' ' 110' ' ' LYS . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.520000000000003 108.238 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.872 ' OD1' HG11 ' A' ' 97' ' ' VAL . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.230000000000004 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.130000000000003 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 74.019999999999996 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 73.140000000000001 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 73.219999999999999 111.334 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.400000000000006 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 73.219999999999999 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.49 -0.244 . . . . 64.349999999999994 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 139.82 53.39 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.6 2.2 . . . . 60.030000000000001 112.287 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.6 mt -111.27 35.7 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 63.219999999999999 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.94 151.17 9.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 34.240000000000002 112.525 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 m -142.81 161.37 38.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 63.130000000000003 110.933 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -143.62 120.56 11.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.69 76.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 53.149999999999999 112.59 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo -65.56 -62.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 72.519999999999996 112.131 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.010000000000005 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 12' ' ' VAL . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 111.511 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 67' ' ' LYS . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.409999999999997 109.596 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' HB ' ' A' ' 20' ' ' ILE . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.120000000000005 112.04 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.932 HG13 ' ND2' ' A' ' 73' ' ' ASN . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.010000000000005 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.329999999999998 109.856 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.625 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.230000000000004 111.635 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.885 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.129999999999995 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.340000000000003 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.430000000000007 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.685 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 65.129999999999995 112.243 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 HG13 ' A' ' 30' ' ' ILE . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.310000000000002 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.239999999999995 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.329999999999998 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 110.905 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.787 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.120000000000005 110.335 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 61.200000000000003 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.340000000000003 111.831 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.808 HD22 HD11 ' A' ' 112' ' ' ILE . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.439999999999998 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.885 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.200000000000003 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.239999999999995 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.209999999999994 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.120000000000005 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.703 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.209999999999994 109.63 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.703 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.399999999999999 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.209999999999994 111.429 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.400000000000006 111.13 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.010000000000005 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 54.119999999999997 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.230000000000004 110.72 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.519999999999996 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.230000000000004 110.933 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.698 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.319999999999993 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.450000000000003 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.140000000000001 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 105' ' ' VAL . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.439999999999998 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.310000000000002 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 72.329999999999998 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.755 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 73.439999999999998 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 32.420000000000002 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.319999999999993 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.329999999999998 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.340000000000003 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.310000000000002 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.319999999999993 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 60.450000000000003 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 55.229999999999997 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 63.329999999999998 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.520000000000003 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 112' ' ' ILE . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 43.109999999999999 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.409999999999997 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.120000000000005 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 69' ' ' ASP . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.450000000000003 110.885 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.883 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HE2' ' A' ' 82' ' ' PHE . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.119999999999997 112.311 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.407 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.430000000000007 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.883 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.209999999999994 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.932 ' ND2' HG13 ' A' ' 13' ' ' VAL . 7.3 m120 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.210000000000001 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 14' ' ' ALA . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 111.103 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.420000000000002 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.22 130.89 35.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 111.079 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -76.31 131.58 39.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.642 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mt -119.38 107.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 111.369 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -81.24 -13.01 58.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 54.509999999999998 110.904 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.57 116.86 1.58 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.195 -0.526 . . . . 71.420000000000002 111.795 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' HE2' ' HB1' ' A' ' 70' ' ' ALA . 59.7 m-85 -105.9 135.65 19.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.721 0.296 . . . . 73.349999999999994 111.179 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo -82.37 -163.18 3.14 Favored 'Cis proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.621 -1.408 . . . . 54.439999999999998 112.505 0.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 60.210000000000001 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.150000000000006 110.629 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 64.25 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.150000000000006 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.769 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.787 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.239999999999995 108.849 177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.439999999999998 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.819 ' HB2' ' CE ' ' A' ' 117' ' ' LYS . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.329999999999998 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 60.439999999999998 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.409999999999997 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.839 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.030000000000001 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.430000000000007 109.624 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 52.530000000000001 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.100000000000001 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.130000000000003 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.230000000000004 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.420000000000002 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.422 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.755 ' CG1' HD23 ' A' ' 50' ' ' LEU . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.229999999999997 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.150000000000006 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 112' ' ' ILE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 54.119999999999997 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.673 HG13 HD21 ' A' ' 50' ' ' LEU . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.140000000000001 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.409999999999997 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 64.349999999999994 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 87' ' ' LEU . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 72.099999999999994 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.876 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.340000000000003 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.520000000000003 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.839 ' OD1' HG11 ' A' ' 97' ' ' VAL . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.230000000000004 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.130000000000003 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.819 ' CE ' ' HB2' ' A' ' 92' ' ' ALA . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 74.019999999999996 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 73.140000000000001 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 73.219999999999999 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.400000000000006 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.876 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 73.219999999999999 111.054 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.518 -0.233 . . . . 64.349999999999994 112.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -33.25 13.54 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.577 2.185 . . . . 60.030000000000001 112.37 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.11 162.97 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 63.219999999999999 110.928 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 118.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 34.240000000000002 112.482 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.5 m -117.11 -80.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 63.130000000000003 110.934 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 177.57 44.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 72.209999999999994 110.763 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.39 132.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 53.149999999999999 112.13 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo -72.39 -58.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.192 1.928 . . . . 72.519999999999996 112.456 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.573 HG12 ' HA3' ' A' ' 51' ' ' GLY . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.010000000000005 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.751 HG22 ' CG2' ' A' ' 12' ' ' VAL . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.674 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 67' ' ' LYS . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.409999999999997 110.122 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.751 ' CG2' HG22 ' A' ' 10' ' ' THR . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.120000000000005 111.077 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.010000000000005 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.089 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.329999999999998 110.261 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.230000000000004 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.129999999999995 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.541 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 1.7 m-20 -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.340000000000003 109.043 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.430000000000007 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 65.129999999999995 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.879 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.310000000000002 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.239999999999995 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.319999999999993 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 53.340000000000003 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.120000000000005 110.975 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 61.200000000000003 109.913 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.879 HG11 ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.340000000000003 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.887 HD22 HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.439999999999998 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.869 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.200000000000003 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.662 ' OE2' HD22 ' A' ' 43' ' ' LEU . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.239999999999995 111.504 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.209999999999994 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.120000000000005 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.209999999999994 109.623 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.399999999999999 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.209999999999994 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.400000000000006 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.010000000000005 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 54.119999999999997 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.230000000000004 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.519999999999996 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.230000000000004 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.662 HD22 ' OE2' ' A' ' 31' ' ' GLU . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.319999999999993 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.450000000000003 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.140000000000001 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.439999999999998 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.310000000000002 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 72.329999999999998 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.509999999999998 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 HG13 ' A' ' 105' ' ' VAL . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 73.439999999999998 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 9' ' ' VAL . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 32.420000000000002 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.319999999999993 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 49' ' ' GLU . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.329999999999998 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' ILE . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 110.903 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.310000000000002 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.319999999999993 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 60.450000000000003 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 55.229999999999997 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.450000000000003 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.520000000000003 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.150000000000006 109.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.761 HG11 ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 43.109999999999999 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' ARG . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.918 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.409999999999997 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.120000000000005 112.168 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 13' ' ' VAL . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.450000000000003 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.310000000000002 110.396 179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.119999999999997 111.903 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.430000000000007 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.209999999999994 111.978 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 68' ' ' VAL . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.239999999999995 111.418 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 44.210000000000001 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.089 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.099999999999994 111.25 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.57 110.78 13.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.904 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -66.95 110.27 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.742 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mt -88.8 85.8 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 111.32 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -20.89 29.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.287 -0.415 . . . . 54.509999999999998 110.882 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.32 111.17 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.053 -0.594 . . . . 71.420000000000002 111.787 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -113.29 153.9 45.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.708 0.289 . . . . 73.349999999999994 111.0 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo -73.73 -168.94 6.48 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 -1.489 . . . . 54.439999999999998 112.388 0.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 99' ' ' TYR . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 60.210000000000001 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.340000000000003 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.150000000000006 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 29' ' ' LEU . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 64.25 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.150000000000006 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.409999999999997 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.239999999999995 108.917 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.439999999999998 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.329999999999998 111.312 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 60.439999999999998 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.409999999999997 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.967 HG11 ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.030000000000001 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.430000000000007 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.76 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 52.530000000000001 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.100000000000001 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.130000000000003 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.229999999999997 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.150000000000006 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 50' ' ' LEU . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 54.119999999999997 110.379 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 50' ' ' LEU . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.140000000000001 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.409999999999997 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 64.349999999999994 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.756 HG21 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 72.099999999999994 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.921 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.340000000000003 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.520000000000003 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.967 ' OD1' HG11 ' A' ' 97' ' ' VAL . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.230000000000004 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.130000000000003 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 74.019999999999996 108.542 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 73.140000000000001 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.761 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.921 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 73.219999999999999 111.024 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.461 -0.256 . . . . 64.349999999999994 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 163.71 37.24 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.613 2.209 . . . . 60.030000000000001 112.254 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 4' ' ' GLY . 4.4 pp -80.72 -175.22 5.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.219999999999999 110.938 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . . . 109.19 37.79 1.92 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 34.240000000000002 112.528 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -102.76 31.96 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 63.130000000000003 110.832 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -135.71 145.6 46.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.922 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.62 149.94 16.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 53.149999999999999 112.635 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo -69.75 -53.21 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.662 2.242 . . . . 72.519999999999996 112.39 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.835 HG23 ' HA3' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.79 HG22 ' CG2' ' A' ' 12' ' ' VAL . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 111.365 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.503 HG22 ' HE2' ' A' ' 67' ' ' LYS . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 109.855 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.79 ' CG2' HG22 ' A' ' 10' ' ' THR . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.120000000000005 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.682 ' HA ' HG23 ' A' ' 68' ' ' VAL . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.010000000000005 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.329999999999998 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.230000000000004 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.129999999999995 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.430000000000007 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 65.129999999999995 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.310000000000002 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.329999999999998 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.319999999999993 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CD ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 53.340000000000003 110.589 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.619 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.120000000000005 110.339 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 61.200000000000003 109.913 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.906 HD22 HD11 ' A' ' 112' ' ' ILE . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.439999999999998 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.669 HG13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.200000000000003 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.239999999999995 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.209999999999994 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.120000000000005 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 109.555 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.399999999999999 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.209999999999994 111.308 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.400000000000006 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.010000000000005 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 54.119999999999997 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.573 ' HA ' HD13 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 40' ' ' CYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.319999999999993 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.450000000000003 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.140000000000001 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.975 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.439999999999998 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.310000000000002 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 72.329999999999998 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.509999999999998 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 73.439999999999998 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.835 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 32.420000000000002 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.319999999999993 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 63' ' ' VAL . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.310000000000002 112.36 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.319999999999993 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 60.450000000000003 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 55.229999999999997 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 63.329999999999998 111.073 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.520000000000003 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.150000000000006 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 112' ' ' ILE . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 43.109999999999999 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.441 HG11 ' OG1' ' A' ' 10' ' ' THR . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.566 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.409999999999997 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.120000000000005 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HE2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.450000000000003 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.441 ' OD1' HG22 ' A' ' 71' ' ' THR . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.310000000000002 110.948 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 69' ' ' ASP . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.430000000000007 112.344 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' ASP . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.209999999999994 111.092 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.588 ' OD1' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 44.210000000000001 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 14' ' ' ALA . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.099999999999994 111.182 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.420000000000002 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.28 109.31 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.219999999999999 110.925 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.98 106.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.450000000000003 110.735 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.9 88.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 111.279 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -23.61 32.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 54.509999999999998 110.905 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.91 107.19 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.972 -0.632 . . . . 71.420000000000002 111.949 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -114.15 154.05 46.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.7 0.286 . . . . 73.349999999999994 111.041 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo -76.28 -171.55 9.84 Favored 'Cis proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 -1.47 . . . . 54.439999999999998 112.147 0.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 99' ' ' TYR . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 60.210000000000001 111.075 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.340000000000003 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.150000000000006 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 64.25 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.150000000000006 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.798 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.409999999999997 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.439999999999998 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.798 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.420000000000002 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 60.439999999999998 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.409999999999997 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.030000000000001 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 86' ' ' LYS . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.430000000000007 109.588 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 52.530000000000001 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.100000000000001 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.420000000000002 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.705 HG23 ' HB2' ' A' ' 107' ' ' ASP . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.229999999999997 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.150000000000006 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.705 ' HB2' HG23 ' A' ' 104' ' ' THR . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 54.119999999999997 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 121' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.140000000000001 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.409999999999997 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 64.349999999999994 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 29' ' ' LEU . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 72.099999999999994 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.886 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.520000000000003 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.881 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.230000000000004 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.130000000000003 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 74.019999999999996 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 73.140000000000001 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 73.219999999999999 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.542 -0.223 . . . . 64.349999999999994 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.97 113.53 3.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.592 2.194 . . . . 60.030000000000001 112.27 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.99 160.92 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.219999999999999 110.936 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.74 51.68 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.240000000000002 112.527 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 m -176.08 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 63.130000000000003 110.889 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.42 110.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 72.209999999999994 110.946 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.78 49.6 76.05 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.861 -0.685 . . . . 53.149999999999999 112.698 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo -75.71 -55.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.492 2.128 . . . . 72.519999999999996 112.473 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.010000000000005 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' ILE . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.120000000000005 111.393 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.409999999999997 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.782 HG11 HG23 ' A' ' 21' ' ' VAL . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.839 ' HA ' HG23 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.329999999999998 110.352 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.230000000000004 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.644 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.129999999999995 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.340000000000003 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.430000000000007 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 10' ' ' THR . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 65.129999999999995 112.28 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 30' ' ' ILE . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.239999999999995 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.319999999999993 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 53.340000000000003 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.120000000000005 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 61.200000000000003 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 112' ' ' ILE . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.439999999999998 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.814 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.200000000000003 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.239999999999995 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.209999999999994 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.120000000000005 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.209999999999994 109.531 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.399999999999999 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.209999999999994 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.400000000000006 111.268 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.010000000000005 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 54.119999999999997 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.230000000000004 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.519999999999996 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.230000000000004 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.319999999999993 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.450000000000003 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.140000000000001 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HE2' HD11 ' A' ' 108' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.439999999999998 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.912 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.310000000000002 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.509999999999998 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.673 ' HG ' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 73.439999999999998 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 32.420000000000002 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.319999999999993 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.329999999999998 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' LEU . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.340000000000003 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.310000000000002 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.319999999999993 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 60.450000000000003 111.288 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 55.229999999999997 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.450000000000003 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 63.329999999999998 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.520000000000003 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.150000000000006 110.182 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.773 ' CG2' HG21 ' A' ' 112' ' ' ILE . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 43.109999999999999 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' ARG . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.129999999999995 111.787 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.829 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.409999999999997 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.120000000000005 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HA ' ' H ' ' A' ' 31' ' ' GLU . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.450000000000003 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.799 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.310000000000002 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.119999999999997 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.430000000000007 111.815 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.209999999999994 111.13 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 44.210000000000001 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 14' ' ' ALA . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.199 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.420000000000002 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.0 163.42 17.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.952 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.11 121.04 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.450000000000003 110.8 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.2 mt -106.6 84.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.175 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -24.58 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 54.509999999999998 110.828 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.89 107.89 0.65 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.961 -0.638 . . . . 71.420000000000002 112.015 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -114.73 153.52 46.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.649 0.261 . . . . 73.349999999999994 110.949 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo -75.05 -171.14 8.99 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.552 -1.437 . . . . 54.439999999999998 112.23 0.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 60.210000000000001 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.340000000000003 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.150000000000006 110.359 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.544 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.150000000000006 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' HD13 ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.409999999999997 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.239999999999995 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.439999999999998 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.597 ' HB2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 60.439999999999998 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.409999999999997 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.811 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.030000000000001 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' THR . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.430000000000007 109.607 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.623 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 52.530000000000001 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.100000000000001 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.130000000000003 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.230000000000004 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 107' ' ' ASP . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG13 ' HG ' ' A' ' 50' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.229999999999997 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.150000000000006 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 104' ' ' THR . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.736 HD11 ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 54.119999999999997 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.140000000000001 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.409999999999997 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 64.349999999999994 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 72.099999999999994 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.683 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.340000000000003 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.520000000000003 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.811 ' OD1' HG11 ' A' ' 97' ' ' VAL . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.230000000000004 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.130000000000003 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 74.019999999999996 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 73.140000000000001 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.185 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.743 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.683 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 73.219999999999999 111.08 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 50.8 Cg_endo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.765 0.235 . . . . 72.52 112.326 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.01 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.12 111.651 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.41 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 20' ' ' ILE . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.12 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 68' ' ' VAL . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.01 110.268 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 73' ' ' ASN . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.33 110.857 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 13' ' ' VAL . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.522 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.23 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.13 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 33.7 m120 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.34 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.43 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 65.13 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.845 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.31 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.24 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.33 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.32 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 53.34 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 63' ' ' VAL . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 61.2 109.855 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.34 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD23 HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.44 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.2 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.24 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.21 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.12 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.21 109.434 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.4 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.21 111.51 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.4 111.075 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.01 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 54.12 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.23 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.23 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.32 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.45 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.14 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.004 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.44 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.927 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.31 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 72.33 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.51 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.8 HD13 HG13 ' A' ' 105' ' ' VAL . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 73.44 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 32.42 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.32 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.33 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.34 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.31 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.32 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 60.45 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 55.23 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.45 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 63.33 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.52 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.15 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.906 HG11 ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 43.11 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.13 111.774 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.41 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.12 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.422 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.31 110.169 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.12 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.43 111.521 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.21 110.824 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 20.9 m-80 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.24 110.932 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 44.21 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' ASP . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.1 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.42 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.22 111.118 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 120.899 0.291 . . . . 54.44 112.262 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 99' ' ' TYR . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 60.21 111.232 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 29' ' ' LEU . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.34 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 30' ' ' ILE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.15 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.775 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 64.25 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.643 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.15 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.41 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.24 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.44 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.42 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.33 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.517 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 60.44 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.41 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.848 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.03 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.43 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 52.53 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.1 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.13 112.842 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.23 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.42 110.778 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.004 HG22 ' HB2' ' A' ' 46' ' ' LYS . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.23 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.15 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 50' ' ' LEU . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 54.12 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.14 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.41 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 64.35 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.775 HG23 HD21 ' A' ' 87' ' ' LEU . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.863 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.34 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.52 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.848 ' OD1' HG11 ' A' ' 97' ' ' VAL . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.23 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.13 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 74.02 108.375 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 73.14 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 73.22 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.4 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.863 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 73.22 111.11 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' CA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 CA-C-O 121.027 0.345 . . . . 72.52 112.42 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 51' ' ' GLY . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.01 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.12 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 67' ' ' LYS . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.13 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 21' ' ' VAL . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.12 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.844 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.01 110.38 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.024 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.33 111.228 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.23 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.13 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.34 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.43 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' HG21 ' A' ' 28' ' ' VAL . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 65.13 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.822 HG21 HG13 ' A' ' 30' ' ' ILE . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.31 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.24 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.33 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.32 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 53.34 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.12 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 61.2 109.557 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.34 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.03 HD12 HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.44 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.2 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.24 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.863 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.21 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.12 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.21 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.4 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.21 111.511 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.4 111.257 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.01 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 54.12 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.52 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.23 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.32 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.45 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.14 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.655 ' CD ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.44 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.31 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 72.33 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.51 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 105' ' ' VAL . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 73.44 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 32.42 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.32 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.33 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.34 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.31 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.32 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 60.45 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 55.23 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.45 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 63.33 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.52 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.15 110.047 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 112' ' ' ILE . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 43.11 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' ARG . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.13 111.903 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 9' ' ' VAL . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.41 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.12 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.604 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.45 110.701 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.31 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.863 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.12 112.176 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 35' ' ' PRO . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.43 111.824 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.21 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.24 111.316 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 44.21 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.024 HG12 ' HB2' ' A' ' 14' ' ' ALA . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.1 111.21 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.42 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.22 111.093 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo . . . . . 0 N--CA 1.462 -0.351 0 CA-C-O 120.972 0.322 . . . . 54.44 112.401 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 60.21 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.34 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.15 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.03 HD23 HD12 ' A' ' 29' ' ' LEU . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 64.25 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.15 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.793 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.41 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.24 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.44 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.793 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.42 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.33 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 60.44 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.41 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.888 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.03 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.43 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 52.53 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.1 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.13 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.23 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.42 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 HD23 ' A' ' 50' ' ' LEU . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.23 110.049 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.15 109.957 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.655 HD11 ' CD ' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 54.12 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 121' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.14 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.41 109.949 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 64.35 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.897 HG21 HG21 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 72.1 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.902 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.34 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.52 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.888 ' HB3' HG21 ' A' ' 97' ' ' VAL . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.23 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.13 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 74.02 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 73.14 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 73.22 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.726 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.4 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.902 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 73.22 111.049 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.006 0.336 . . . . 72.52 112.041 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.01 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.12 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.41 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 20' ' ' ILE . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.12 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.774 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.01 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.33 110.98 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB3' HG23 ' A' ' 13' ' ' VAL . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.23 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.13 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 p-10 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.61 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.43 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 65.13 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG11 ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.31 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.24 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.32 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 53.34 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.863 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.12 110.897 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 61.2 110.158 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.34 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.098 HD12 HD11 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.44 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.03 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.2 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.24 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.21 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.12 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.21 109.634 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.625 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.4 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.21 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.4 111.186 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.01 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 54.12 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.23 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.52 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.23 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.32 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.45 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.14 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.955 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.44 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.917 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.31 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.594 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 72.33 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.51 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.902 HD13 ' CG1' ' A' ' 105' ' ' VAL . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 73.44 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 32.42 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.32 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.33 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.34 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.31 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.32 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 60.45 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 55.23 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.45 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 63.33 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.52 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.15 110.056 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 112' ' ' ILE . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 43.11 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.13 112.122 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.41 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.12 112.349 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.45 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.31 110.358 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.12 111.776 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.408 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.43 111.633 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.827 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.21 111.169 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' ND2' HG12 ' A' ' 13' ' ' VAL . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.101 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 44.21 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.1 111.249 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.42 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.22 110.936 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 N-CA-C 113.286 0.456 . . . . 54.44 113.286 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 99' ' ' TYR . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 60.21 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.34 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.15 110.871 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.9 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 64.25 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.15 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.895 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.41 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.863 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.24 108.238 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.44 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.42 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.33 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.458 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 60.44 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.41 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.801 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.03 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.43 109.354 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 52.53 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.1 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.13 113.003 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.23 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.42 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 46' ' ' LYS . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.23 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.15 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 112' ' ' ILE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 54.12 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.744 HG13 HD11 ' A' ' 50' ' ' LEU . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.14 109.232 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.41 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 64.35 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 29' ' ' LEU . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.34 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.52 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.801 ' OD1' HG11 ' A' ' 97' ' ' VAL . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.23 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.13 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 74.02 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 73.14 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.6 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.4 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 73.22 111.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 121.038 0.349 . . . . 72.52 112.703 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.01 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 20' ' ' ILE . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.12 111.89 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.784 HG22 ' HD3' ' A' ' 67' ' ' LYS . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.41 109.723 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.729 HG11 HG23 ' A' ' 21' ' ' VAL . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.12 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.01 109.978 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.33 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.522 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.23 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.13 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.34 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.43 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG21 HG21 ' A' ' 10' ' ' THR . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 65.13 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG21 HG13 ' A' ' 30' ' ' ILE . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.31 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.24 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' CG ' HG22 ' A' ' 25' ' ' THR . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.33 110.505 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 53.34 111.042 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.658 ' HG2' HG23 ' A' ' 25' ' ' THR . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.569 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 61.2 109.697 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.34 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 112' ' ' ILE . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.44 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.2 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.24 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.12 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.21 109.57 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.4 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.21 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.4 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.01 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 54.12 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HA ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.23 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.52 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.23 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.862 HD23 ' HD2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.32 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.45 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.14 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.906 ' HB2' HG22 ' A' ' 105' ' ' VAL . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.44 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.31 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.51 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD13 ' CG1' ' A' ' 105' ' ' VAL . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 73.44 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 32.42 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.32 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.33 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.34 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.31 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.32 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 60.45 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 55.23 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.45 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 63.33 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.52 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.15 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.951 HG21 HG21 ' A' ' 112' ' ' ILE . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 43.11 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.527 HG23 ' CD ' ' A' ' 26' ' ' LYS . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.13 111.566 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.41 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.12 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.784 ' HD3' HG22 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.45 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.31 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.12 111.596 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.43 111.707 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.21 110.884 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.24 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 44.21 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.727 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.1 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.42 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.819 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.618 0.174 . . . . 54.44 112.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 99' ' ' TYR . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 60.21 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.34 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.15 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.812 HD21 HG23 ' A' ' 112' ' ' ILE . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 64.25 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.15 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.771 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.41 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.24 108.837 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' HE3' ' A' ' 93' ' ' LYS . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.44 112.302 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.42 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.33 111.146 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 60.44 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.41 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.87 HG21 ' HB3' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.03 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.43 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 52.53 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.1 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.13 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.546 ' H ' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.23 109.13 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.42 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.001 ' CG1' HD13 ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.23 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.15 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.673 ' HB2' HG23 ' A' ' 104' ' ' THR . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 54.12 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.14 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.41 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.35 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.951 HG21 HG21 ' A' ' 63' ' ' VAL . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 72.1 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.34 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.52 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.87 ' HB3' HG21 ' A' ' 97' ' ' VAL . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.23 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.13 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 74.02 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 73.14 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 73.22 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.637 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.4 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 73.22 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.932 0.305 . . . . 72.52 112.576 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.01 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 12' ' ' VAL . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.12 111.484 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' HD2' ' A' ' 67' ' ' LYS . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.41 109.633 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' THR . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.12 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.758 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.98 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.33 110.889 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.23 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.13 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.34 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.634 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.43 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' O ' HG21 ' A' ' 28' ' ' VAL . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 65.13 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 28' ' ' VAL . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.31 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.24 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.33 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.32 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 53.34 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.12 110.513 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 61.2 109.624 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 20' ' ' ILE . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.34 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.44 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.2 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.24 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.21 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.12 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.21 109.596 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.4 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.21 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.4 111.624 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.01 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 54.12 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.23 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.52 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.23 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 31' ' ' GLU . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.32 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.45 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.14 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.44 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.31 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 72.33 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.51 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 73.44 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.769 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 32.42 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.32 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.33 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.34 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.31 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.32 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 60.45 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 55.23 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.45 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 63.33 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.52 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.15 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 112' ' ' ILE . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 43.11 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.41 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.12 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.76 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.45 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.31 110.587 179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.12 111.78 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.43 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.21 111.217 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.24 111.069 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 44.21 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.98 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.1 111.4 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.42 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.918 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo . . . . . 0 N--CA 1.465 -0.192 0 CA-C-O 120.757 0.232 . . . . 54.44 112.152 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 60.21 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.34 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.15 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 64.25 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.553 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.15 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.691 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.41 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.24 108.895 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.44 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.42 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.33 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 60.44 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.41 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HB3' ' A' ' 115' ' ' ASN . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.03 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.43 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 52.53 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.1 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.13 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.23 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.42 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 107' ' ' ASP . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.814 ' CG1' HD23 ' A' ' 50' ' ' LEU . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.23 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.448 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.15 110.099 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 54.12 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.14 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.41 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 64.35 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 63' ' ' VAL . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 72.1 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.806 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.34 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CG ' ' HD3' ' A' ' 110' ' ' LYS . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.52 108.653 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.912 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.23 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.13 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 74.02 108.542 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 73.14 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.649 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.4 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.806 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 73.22 111.13 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo . . . . . 0 N--CA 1.46 -0.473 0 CA-C-O 120.835 0.264 . . . . 72.52 112.511 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.01 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.791 HG22 ' CG2' ' A' ' 12' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.12 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.41 109.463 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.822 HG21 ' HB ' ' A' ' 20' ' ' ILE . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.12 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.883 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.01 110.067 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.33 111.126 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 13' ' ' VAL . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.456 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.23 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.864 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.13 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.34 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.43 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 65.13 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.787 ' HA ' HG11 ' A' ' 28' ' ' VAL . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.31 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.24 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' HG21 ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.33 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.32 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 53.34 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.814 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.12 110.897 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 61.2 109.816 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.34 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD22 HD11 ' A' ' 112' ' ' ILE . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.44 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.2 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.24 111.603 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.21 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.12 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.21 109.761 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.4 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.21 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.4 111.172 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.01 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 54.12 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.23 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.52 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.23 110.097 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.32 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.45 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.14 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.44 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.841 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.31 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 72.33 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.51 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 73.44 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 32.42 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.32 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.33 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HG13 ' A' ' 63' ' ' VAL . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.31 112.124 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.32 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 60.45 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 55.23 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.45 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 63.33 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.52 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.15 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 112' ' ' ILE . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 43.11 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.13 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.834 ' O ' HG23 ' A' ' 9' ' ' VAL . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.41 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.12 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.45 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.31 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.12 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.402 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.43 111.567 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.21 110.858 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.516 ' ND2' HG12 ' A' ' 13' ' ' VAL . 22.0 m-80 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.24 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 44.21 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.881 HG12 ' HB2' ' A' ' 14' ' ' ALA . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.1 111.114 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.42 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.22 110.991 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.785 0.244 . . . . 54.44 112.293 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 60.21 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.34 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.15 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD21 HG23 ' A' ' 112' ' ' ILE . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 64.25 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.15 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.41 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.24 108.72 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.44 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.42 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.33 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 60.44 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.41 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.872 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.03 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.43 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 52.53 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.1 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.13 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.23 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.42 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.23 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.15 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 54.12 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.14 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.41 109.817 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 64.35 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.962 HD11 HD22 ' A' ' 29' ' ' LEU . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 72.1 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.932 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.34 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HG3' ' HD3' ' A' ' 110' ' ' LYS . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.52 108.238 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.872 ' OD1' HG11 ' A' ' 97' ' ' VAL . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.23 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.13 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 74.02 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 73.14 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 73.22 111.334 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.4 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 73.22 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.78 0.242 . . . . 72.52 112.131 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.01 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 12' ' ' VAL . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.12 111.511 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 67' ' ' LYS . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.41 109.596 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' HB ' ' A' ' 20' ' ' ILE . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.12 112.04 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' OD1' ' A' ' 73' ' ' ASN . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.01 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.33 109.856 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.625 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.23 111.635 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.885 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.13 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.34 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.43 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.685 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 65.13 112.243 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 HG13 ' A' ' 30' ' ' ILE . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.31 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.24 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.33 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.32 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 53.34 110.905 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.787 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.12 110.335 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 61.2 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.34 111.831 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.808 HD22 HD11 ' A' ' 112' ' ' ILE . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.44 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.885 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.2 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.24 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.21 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.12 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.703 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.21 109.63 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.703 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.4 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.21 111.429 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.4 111.13 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.01 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 54.12 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.23 110.72 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.52 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.23 110.933 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.698 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.32 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.45 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.14 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 105' ' ' VAL . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.44 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.31 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 72.33 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.51 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.755 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 73.44 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 32.42 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.32 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.33 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.34 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.31 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.32 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 60.45 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 55.23 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.45 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 63.33 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.52 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.15 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 112' ' ' ILE . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 43.11 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.13 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.41 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.12 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 69' ' ' ASP . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.45 110.885 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.883 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.31 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.12 112.311 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.407 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.43 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.883 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.21 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.782 ' OD1' HG13 ' A' ' 13' ' ' VAL . 9.9 m-80 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.24 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.21 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 14' ' ' ALA . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.1 111.103 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.42 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.22 111.079 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 121.003 0.334 . . . . 54.44 112.505 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 60.21 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.34 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.15 110.629 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 64.25 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.15 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.769 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.41 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.787 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.24 108.849 177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.44 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.819 ' HB2' ' CE ' ' A' ' 117' ' ' LYS . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.42 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.33 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 60.44 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.41 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.839 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.03 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.43 109.624 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 52.53 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.1 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.13 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.23 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.42 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.422 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.755 ' CG1' HD23 ' A' ' 50' ' ' LEU . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.23 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.15 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 112' ' ' ILE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 54.12 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.673 HG13 HD21 ' A' ' 50' ' ' LEU . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.14 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.41 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 64.35 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 87' ' ' LEU . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 72.1 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.876 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.34 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.52 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.839 ' OD1' HG11 ' A' ' 97' ' ' VAL . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.23 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.13 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.819 ' CE ' ' HB2' ' A' ' 92' ' ' ALA . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 74.02 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 73.14 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.876 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 73.22 111.054 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 CA-C-O 120.669 0.195 . . . . 72.52 112.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.573 HG12 ' HA3' ' A' ' 51' ' ' GLY . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.01 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.751 HG22 ' CG2' ' A' ' 12' ' ' VAL . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.674 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 67' ' ' LYS . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.41 110.122 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.751 ' CG2' HG22 ' A' ' 10' ' ' THR . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.12 111.077 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.01 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.089 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.33 110.261 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.23 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.13 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.541 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.34 109.043 178.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.43 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 65.13 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.879 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.31 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.24 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.33 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.32 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 53.34 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.12 110.975 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 61.2 109.913 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.879 HG11 ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.34 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.887 HD22 HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.44 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.869 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.2 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.662 ' OE2' HD22 ' A' ' 43' ' ' LEU . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.24 111.504 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.21 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.12 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.21 109.623 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.4 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.21 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.4 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.01 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 54.12 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.23 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.52 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.23 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.662 HD22 ' OE2' ' A' ' 31' ' ' GLU . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.32 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.45 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.14 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.44 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.31 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 72.33 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.51 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 HG13 ' A' ' 105' ' ' VAL . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 73.44 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 9' ' ' VAL . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 32.42 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.32 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 49' ' ' GLU . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.33 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' ILE . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.34 110.903 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.31 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.32 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 60.45 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 55.23 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.45 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 63.33 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.52 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.15 109.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.761 HG11 ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 43.11 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' ARG . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.13 111.918 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.41 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.12 112.168 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 13' ' ' VAL . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.45 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.31 110.396 179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.12 111.903 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.43 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.21 111.978 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 68' ' ' VAL . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.24 111.418 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 44.21 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.089 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.1 111.25 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.42 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.22 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.617 0.174 . . . . 54.44 112.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 99' ' ' TYR . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 60.21 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.34 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.15 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 29' ' ' LEU . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 64.25 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.15 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.41 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.24 108.917 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.44 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.42 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.33 111.312 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 60.44 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.41 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.967 HG11 ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.03 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.43 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.76 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 52.53 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.1 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.13 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.23 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.23 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.15 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 50' ' ' LEU . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 54.12 110.379 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 50' ' ' LEU . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.14 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.41 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 64.35 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.756 HG21 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 72.1 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.921 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.34 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.52 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.967 ' OD1' HG11 ' A' ' 97' ' ' VAL . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.23 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.13 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 74.02 108.542 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 73.14 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.761 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.921 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 73.22 111.024 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.084 0.368 . . . . 72.52 112.39 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.835 HG23 ' HA3' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.01 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.79 HG22 ' CG2' ' A' ' 12' ' ' VAL . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.12 111.365 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.503 HG22 ' HE2' ' A' ' 67' ' ' LYS . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.41 109.855 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.79 ' CG2' HG22 ' A' ' 10' ' ' THR . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.12 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.682 ' HA ' HG23 ' A' ' 68' ' ' VAL . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.01 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.33 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.23 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.13 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.34 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.43 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 65.13 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.31 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.24 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.33 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.32 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CD ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 53.34 110.589 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.619 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.12 110.339 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 61.2 109.913 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.34 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.906 HD22 HD11 ' A' ' 112' ' ' ILE . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.44 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.669 HG13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.2 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.24 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.21 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.12 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.21 109.555 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.4 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.21 111.308 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.4 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.01 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 54.12 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.573 ' HA ' HD13 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.23 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.23 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 40' ' ' CYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.32 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.45 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.14 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.975 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.44 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.31 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 72.33 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.51 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 73.44 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.835 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 32.42 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.32 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.33 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 63' ' ' VAL . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.31 112.36 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.32 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 60.45 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 55.23 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.45 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 63.33 111.073 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.52 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.15 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 112' ' ' ILE . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 43.11 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.441 HG11 ' OG1' ' A' ' 10' ' ' THR . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.13 111.566 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.41 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.12 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HE2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.45 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.441 ' OD1' HG22 ' A' ' 71' ' ' THR . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.31 110.948 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.12 110.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 69' ' ' ASP . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.43 112.344 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' ASP . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.21 111.092 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.588 ' OD1' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 44.21 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 14' ' ' ALA . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.1 111.182 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.42 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.22 110.925 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.465 0.111 . . . . 54.44 112.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 99' ' ' TYR . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 60.21 111.075 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.34 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.15 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 64.25 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.15 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.798 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.41 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.44 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.798 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.42 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.33 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 60.44 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.41 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.03 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 86' ' ' LYS . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.43 109.588 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 52.53 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.1 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.13 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.23 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.42 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.705 HG23 ' HB2' ' A' ' 107' ' ' ASP . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.23 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.15 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.705 ' HB2' HG23 ' A' ' 104' ' ' THR . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 54.12 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 121' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.14 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.41 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 64.35 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 29' ' ' LEU . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 72.1 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.886 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.34 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.52 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.881 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.23 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.13 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 74.02 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 73.14 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 73.22 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.992 0.33 . . . . 72.52 112.473 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.01 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' ILE . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.12 111.393 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.41 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.782 HG11 HG23 ' A' ' 21' ' ' VAL . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.12 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.839 ' HA ' HG23 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.01 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.33 110.352 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.23 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.644 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.13 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.34 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.43 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 10' ' ' THR . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 65.13 112.28 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 30' ' ' ILE . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.31 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.24 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.33 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.32 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 53.34 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.12 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 61.2 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.34 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 112' ' ' ILE . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.44 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.814 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.2 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.24 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.21 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.12 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.21 109.531 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.4 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.21 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.4 111.268 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.01 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 54.12 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.23 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.52 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.23 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.32 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.45 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.14 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HE2' HD11 ' A' ' 108' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.44 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.912 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.31 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.51 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.673 ' HG ' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 73.44 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 32.42 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.32 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.33 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' LEU . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.34 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.31 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.32 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 60.45 111.288 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 55.23 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.45 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 63.33 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.52 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.15 110.182 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.773 ' CG2' HG21 ' A' ' 112' ' ' ILE . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 43.11 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' ARG . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.13 111.787 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.829 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.41 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.12 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HA ' ' H ' ' A' ' 31' ' ' GLU . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.45 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.799 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.31 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.12 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.43 111.815 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.21 111.13 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 44.21 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 14' ' ' ALA . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.199 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.42 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.952 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.475 0.115 . . . . 54.44 112.23 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 60.21 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.34 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.15 110.359 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.544 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.15 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' HD13 ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.41 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.24 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.44 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.42 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.597 ' HB2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.33 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 60.44 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.41 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.811 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.03 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' THR . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.43 109.607 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.623 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 52.53 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.1 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.13 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.23 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.42 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 107' ' ' ASP . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.673 HG13 ' HG ' ' A' ' 50' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.23 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.15 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 104' ' ' THR . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.736 HD11 ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 54.12 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.14 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.41 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 64.35 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 72.1 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.683 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.34 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.52 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.811 ' OD1' HG11 ' A' ' 97' ' ' VAL . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.23 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.13 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 74.02 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 73.14 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 73.22 111.185 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.743 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.683 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 73.22 111.08 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.462 -0.255 . . . . 64.35 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.16 136.77 54.39 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.594 2.196 . . . . 60.03 112.315 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.7 129.37 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.22 110.912 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.65 154.08 28.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 34.24 112.511 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.72 -75.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 63.13 110.918 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -154.55 132.45 11.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 72.21 110.86 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.0 114.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.736 -0.745 . . . . 53.15 112.314 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 50.8 Cg_endo -71.18 -59.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.312 2.008 . . . . 72.52 112.326 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG21 ' CD2' ' A' ' 47' ' ' TYR . 2.1 p -61.14 132.09 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.01 110.242 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.4 m -78.99 94.72 5.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 75.12 111.651 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.44 88.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.56 -0.533 . . . . 71.41 109.56 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 20' ' ' ILE . 12.0 t -90.09 117.68 33.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 72.12 111.6 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 68' ' ' VAL . 5.6 m -70.96 162.54 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 73.01 110.268 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 73' ' ' ASN . . . -51.87 -22.87 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 75.33 110.857 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB3' HG23 ' A' ' 13' ' ' VAL . 14.7 tptm -67.3 -39.96 86.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.938 -0.573 . . . . 73.5 111.159 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.522 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -111.93 -7.54 14.14 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.374 0.509 . . . . 75.23 112.374 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.79 -12.05 1.71 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 111.846 0.313 . . . . 73.13 111.846 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 33.7 m120 -96.46 -6.41 37.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.571 -0.9 . . . . 73.34 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -26.7 8.59 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.197 -1.365 . . . . 74.43 111.755 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.7 mm -113.18 -42.64 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.578 0.585 . . . . 65.13 112.578 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.845 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.5 t -88.45 -19.09 7.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.353 0.597 . . . . 74.31 110.621 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -105.89 18.58 21.89 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.116 -0.947 . . . . 73.24 111.083 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -88.09 131.2 34.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.526 -0.761 . . . . 73.33 110.567 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.41 7.18 17.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 73.32 111.811 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -68.63 -25.7 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 53.34 110.621 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.56 169.44 13.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 70.12 111.074 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 63' ' ' VAL . 10.1 m-20 -75.69 119.66 20.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.855 -0.424 . . . . 61.2 109.855 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.1 t -110.73 127.66 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.502 . . . . 74.34 112.023 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD23 HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -101.36 102.5 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.475 -0.784 . . . . 50.44 109.859 179.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -95.83 127.2 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.238 -0.585 . . . . 72.2 111.226 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 1.4 tt0 -114.83 89.63 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 70.24 111.755 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 70.2 m-85 -53.41 135.24 39.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.672 -0.492 . . . . 75.21 109.672 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.477 ' CE1' ' CD ' ' A' ' 67' ' ' LYS . 8.0 p90 -153.11 -167.92 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.601 0.715 . . . . 73.12 112.007 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.98 178.19 1.55 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 114.637 -1.165 . . . . 75.21 109.434 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.4 Cg_endo -90.98 -18.87 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.609 2.206 . . . . 62.4 111.22 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.63 9.76 22.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.625 -1.17 . . . . 75.21 111.51 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.36 99.1 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.941 -0.572 . . . . 74.4 111.075 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.44 -23.96 29.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.732 -0.746 . . . . 73.01 112.448 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -67.58 -51.8 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 54.12 110.76 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.9 t -57.62 -39.09 76.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 73.23 110.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -58.94 -20.33 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.91 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.78 -18.59 17.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.224 0.535 . . . . 71.23 110.437 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 mp -90.07 -14.93 32.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 75.32 111.647 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -65.81 -39.38 30.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.982 -0.554 . . . . 74.45 112.357 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.7 Cg_exo -54.91 -36.26 91.35 Favored 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 121.887 1.725 . . . . 75.14 111.197 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.004 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -81.46 -28.23 34.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.814 -1.085 . . . . 65.44 110.165 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.927 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -76.87 -29.04 55.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.304 -0.862 . . . . 74.31 111.155 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.8 mt-10 -87.18 -33.54 19.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.415 . . . . 72.33 110.512 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' O ' HD12 ' A' ' 53' ' ' LEU . 18.3 mt-10 -81.94 -39.27 23.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 61.51 110.536 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.8 HD13 HG13 ' A' ' 105' ' ' VAL . 2.2 tp -81.41 -44.59 17.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.83 0.824 . . . . 73.44 109.039 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.5 99.79 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.129 -1.396 . . . . 32.42 111.865 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -65.85 -49.16 69.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.346 0.593 . . . . 74.32 109.476 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -63.79 -35.83 81.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.699 -0.682 . . . . 72.33 109.921 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 4.4 m-85 -72.56 -28.56 62.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.418 -0.355 . . . . 74.34 110.254 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.05 13.66 28.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.341 0.497 . . . . 74.31 112.341 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.2 ttmt -155.22 11.26 0.34 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.164 0.801 . . . . 65.32 113.164 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 47.1 m -109.81 -102.66 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.115 0.416 . . . . 60.45 111.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -128.21 27.62 5.61 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.958 0.409 . . . . 55.23 110.626 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 1.1 m-85 -152.37 21.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 74.45 110.569 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -62.58 -24.7 67.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 63.33 110.618 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -107.42 16.58 23.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.574 -0.739 . . . . 63.52 109.419 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.2 ttm180 -125.78 -142.36 0.29 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.273 -0.876 . . . . 74.15 109.85 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.906 HG11 ' CB ' ' A' ' 120' ' ' ALA . 2.6 p -48.01 121.27 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-O 120.847 0.356 . . . . 43.11 110.434 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.9 t -114.0 145.98 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.182 -0.463 . . . . 71.13 111.774 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 9' ' ' VAL . 19.6 mm -89.19 110.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 74.41 109.882 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.39 164.32 12.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.543 0.687 . . . . 73.12 112.585 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 7.7 ttmt -148.42 171.38 16.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.551 -0.75 . . . . 75.0 110.612 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 p -166.82 145.2 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.422 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.803 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 t0 -85.84 100.02 11.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 53.31 110.169 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -66.12 -12.76 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.891 -0.595 . . . . 61.12 112.097 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 t -110.96 -12.26 14.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.449 -0.341 . . . . 70.43 111.521 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -109.7 -15.52 14.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.424 . . . . 75.21 110.824 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 20.9 m-80 -130.84 126.19 35.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.897 -0.592 . . . . 72.24 110.932 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.58 99.92 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 44.21 110.733 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' ASP . 30.3 m -81.1 149.73 66.94 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 64.1 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.31 -16.98 24.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.628 2.218 . . . . 75.42 112.695 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -101.37 144.38 30.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.22 111.118 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -80.38 152.76 28.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.678 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 49.6 mt -134.02 107.0 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 75.14 111.439 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.22 -18.36 36.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 54.51 110.609 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.7 114.91 2.22 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.483 -0.647 . . . . 71.42 111.483 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CE1' ' HB ' ' A' ' 79' ' ' ILE . 4.9 m-85 -106.68 127.21 28.56 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.584 0.23 . . . . 73.35 111.211 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_endo -82.13 -163.81 3.45 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.94 -1.275 . . . . 54.44 112.262 -0.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 99' ' ' TYR . 38.5 m -147.12 155.75 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 60.21 111.232 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 29' ' ' LEU . 1.8 mt -132.49 96.39 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.533 0.682 . . . . 73.34 110.996 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 30' ' ' ILE . 57.0 mttt -97.92 130.16 44.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 71.15 111.019 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.775 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -105.51 109.63 21.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 64.25 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.643 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 9.2 m-85 -95.36 93.76 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.72 0.295 . . . . 73.15 110.333 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 18.8 Cg_endo -59.93 167.98 6.43 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 122.893 2.396 . . . . 64.41 112.082 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.29 54.92 3.22 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.95 -0.759 . . . . 75.24 108.95 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.47 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.498 -1.228 . . . . 72.44 111.564 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.95 54.26 1.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.197 0.522 . . . . 74.42 110.939 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HG3' ' HB3' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -74.56 -0.68 18.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.676 -0.693 . . . . 74.33 111.123 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.12 -21.57 11.66 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.989 -0.624 . . . . 43.25 112.638 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.517 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.9 tt0 -136.26 53.03 7.08 Favored Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 121.171 0.51 . . . . 60.44 110.651 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 81.1 Cg_exo -44.09 -176.24 0.0 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.149 0 C-N-CA 123.58 2.853 . . . . 75.41 112.916 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.848 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.7 t -107.29 82.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.8 -0.444 . . . . 64.03 109.8 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -61.23 135.13 57.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.247 -0.649 . . . . 64.43 109.247 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -141.07 178.93 7.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 52.53 112.018 -177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 t -98.42 -32.99 11.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 62.1 110.418 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.24 124.05 3.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 62.13 112.842 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.82 -177.71 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.69 0.281 . . . . 75.23 110.294 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -106.01 52.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 74.42 110.778 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 107' ' ' ASP . 11.2 t -144.31 129.7 18.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 63.43 111.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.004 HG22 ' HB2' ' A' ' 46' ' ' LYS . 26.5 t -79.96 -30.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.701 -0.681 . . . . 53.23 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -35.63 79.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.218 0.532 . . . . 74.15 110.715 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 23.6 t0 -73.69 -26.23 60.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.571 -0.74 . . . . 53.32 109.661 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 50' ' ' LEU . 12.9 mt -70.34 -47.99 58.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 54.12 110.483 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.5 mt -56.04 -52.86 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 65.14 109.011 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.49 -19.6 65.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.76 -0.655 . . . . 60.41 109.782 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.9 t80 -65.17 -77.62 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.765 -0.652 . . . . 64.35 110.435 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.775 HG23 HD21 ' A' ' 87' ' ' LEU . 1.2 mp -64.32 -5.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.214 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.863 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -93.68 -20.63 19.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.094 -0.503 . . . . 65.34 111.454 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.51 -26.39 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.402 -0.962 . . . . 60.52 108.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.848 ' OD1' HG11 ' A' ' 97' ' ' VAL . 62.8 m-80 -93.78 -31.46 14.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.982 -1.463 . . . . 74.23 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.88 161.17 45.6 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.298 -0.865 . . . . 52.13 112.264 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 8.1 mttp -90.35 -33.78 15.95 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.375 -0.972 . . . . 74.02 108.375 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 62' ' ' ARG . 1.4 m-85 -67.67 -22.03 65.32 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.479 -1.237 . . . . 73.14 109.822 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 59.57 42.91 16.66 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.011 -0.54 . . . . 73.22 111.38 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -62.94 98.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.4 110.829 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.863 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 73.22 111.11 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.49 -0.244 . . . . 64.35 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 175.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.582 2.188 . . . . 60.03 112.373 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.65 -52.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.22 110.904 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.49 -91.7 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 34.24 112.505 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -139.72 140.44 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 63.13 110.884 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.02 137.32 58.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.845 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.39 149.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 53.15 112.405 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB2' ' CA ' ' A' ' 52' ' ' ALA . 73.8 Cg_endo -77.82 -48.44 0.1 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.533 2.155 . . . . 72.52 112.42 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 51' ' ' GLY . 1.2 t -68.43 158.85 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 64.01 110.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.8 m -92.95 88.67 6.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 75.12 110.881 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 67' ' ' LYS . 17.2 t -72.04 94.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.13 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.778 HG11 HG23 ' A' ' 21' ' ' VAL . 9.1 p -103.4 134.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 72.12 111.267 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.844 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.6 m -85.94 167.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.35 . . . . 73.01 110.38 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.024 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.71 -20.99 9.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 75.33 111.228 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 13' ' ' VAL . 2.7 ttmt -71.34 -26.42 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 73.5 111.485 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -125.95 -5.13 6.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.615 0.598 . . . . 75.23 112.615 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.51 -19.75 6.41 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.194 0.442 . . . . 73.13 112.194 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 42.1 m-80 -96.66 -1.76 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.788 0.804 . . . . 73.34 108.924 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.48 -25.74 9.44 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.221 -1.354 . . . . 74.43 111.295 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' HG21 ' A' ' 28' ' ' VAL . 7.9 mm -111.95 -44.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.67 0.619 . . . . 65.13 112.67 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.822 HG21 HG13 ' A' ' 30' ' ' ILE . 96.3 t -86.88 -25.39 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.426 0.631 . . . . 74.31 110.533 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -97.14 20.87 10.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.22 -0.9 . . . . 73.24 110.863 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.12 121.66 29.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.482 -0.781 . . . . 73.33 110.238 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 t70 -75.6 -1.75 25.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.578 -0.283 . . . . 73.32 111.705 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -71.45 -22.72 61.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 53.34 110.915 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.45 159.24 27.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 70.12 111.006 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 17.5 m-20 -76.55 126.65 31.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.557 -0.534 . . . . 61.2 109.557 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 21' ' ' VAL . 1.7 t -120.92 131.76 72.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.133 0.492 . . . . 74.34 112.247 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.03 HD12 HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -105.15 104.9 14.72 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.58 -0.736 . . . . 50.44 110.055 179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -95.37 128.29 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.32 -0.552 . . . . 72.2 111.907 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 18.5 pt-20 -118.65 106.6 12.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.369 0.604 . . . . 70.24 111.486 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.863 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 77.7 m-85 -68.97 138.16 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 75.21 109.406 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 13.1 p90 -156.22 -168.49 2.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.624 0.726 . . . . 73.12 112.186 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.57 177.84 1.68 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.704 -1.135 . . . . 75.21 109.54 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.4 Cg_endo -91.4 -17.7 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.648 2.232 . . . . 62.4 111.341 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.32 21.69 13.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.593 -1.185 . . . . 75.21 111.511 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -97.9 114.93 27.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.708 -0.678 . . . . 74.4 111.257 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.66 -26.86 72.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 73.01 112.128 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.9 -50.82 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 54.12 110.744 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -58.16 -36.66 73.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.645 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -53.77 -24.81 16.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.752 -0.658 . . . . 74.52 110.948 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.61 -22.15 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 71.23 111.244 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.9 mp -85.42 -25.54 26.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.834 -0.621 . . . . 75.32 110.946 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -52.29 -46.12 94.38 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 74.45 112.351 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 14.5 Cg_exo -64.4 -38.56 33.36 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.254 1.97 . . . . 75.14 111.232 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.655 ' CD ' HD11 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -74.58 -32.76 62.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.989 -1.005 . . . . 65.44 109.73 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.57 -27.7 45.78 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.881 -1.054 . . . . 74.31 111.443 -177.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 3.0 mt-10 -85.44 -32.12 22.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.896 0.379 . . . . 72.33 110.283 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' HD12 ' A' ' 53' ' ' LEU . 21.7 mm-40 -85.01 -42.15 15.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 61.51 110.469 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 105' ' ' VAL . 1.5 tm? -81.55 -40.74 22.66 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.802 0.81 . . . . 73.44 108.912 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.87 -43.34 99.07 Favored Glycine 0 CA--C 1.5 -0.855 0 CA-C-N 114.325 -1.307 . . . . 32.42 111.554 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -49.3 70.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.26 0.553 . . . . 74.32 109.737 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 49' ' ' GLU . 24.0 mt -61.35 -30.72 70.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 72.33 110.138 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.9 m-85 -82.11 -26.21 33.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.523 . . . . 74.34 110.792 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.08 15.78 23.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.23 0.456 . . . . 74.31 112.23 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.9 ttmt -146.03 -43.38 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.961 0.356 . . . . 65.32 111.961 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 m -61.09 -149.99 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.597 0.237 . . . . 60.45 111.131 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.25 18.13 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.679 0.252 . . . . 55.23 111.679 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 14.61 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 74.45 110.345 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.5 pttp -57.92 -20.74 39.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.01 -0.541 . . . . 63.33 111.054 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -110.26 -16.55 13.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.331 0.586 . . . . 63.52 109.621 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttp180 -85.03 -145.63 0.1 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.152 -0.931 . . . . 74.15 110.047 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 112' ' ' ILE . 2.8 p -49.64 130.53 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.821 0.343 . . . . 43.11 110.274 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 62' ' ' ARG . 38.7 t -119.46 150.32 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 71.13 111.903 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.766 ' O ' HG22 ' A' ' 9' ' ' VAL . 43.6 mm -95.02 107.19 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.873 -0.603 . . . . 74.41 109.795 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -105.28 165.82 10.84 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.926 0.713 . . . . 73.12 112.926 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.604 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -156.52 146.86 21.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.845 -0.616 . . . . 75.0 111.055 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.9 p -134.49 145.13 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.792 -0.64 . . . . 72.45 110.701 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -74.63 104.65 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.088 0.47 . . . . 53.31 110.222 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.863 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.58 -8.33 19.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.857 -0.611 . . . . 61.12 112.176 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 35' ' ' PRO . 1.8 t -119.9 -25.04 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.824 0.305 . . . . 70.43 111.824 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.823 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -82.33 -17.61 45.1 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.883 0.327 . . . . 75.21 111.883 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 1.8 p30 -134.97 136.67 42.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.007 0.432 . . . . 72.24 111.316 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.52 94.14 6.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.922 -0.581 . . . . 44.21 109.466 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.024 HG12 ' HB2' ' A' ' 14' ' ' ALA . 13.2 m -86.32 150.24 51.35 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 64.1 111.21 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.91 -32.53 13.65 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.236 . . . . 75.42 112.63 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.07 123.52 22.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 73.22 111.093 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.22 151.21 33.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.336 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 82' ' ' PHE . 46.8 mt -140.18 106.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 75.14 111.381 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.59 -17.71 61.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 54.51 110.955 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.62 114.45 1.61 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.083 -0.579 . . . . 71.42 111.737 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.786 ' HE2' ' HB1' ' A' ' 70' ' ' ALA . 31.1 m-85 -105.85 132.13 21.15 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.73 0.3 . . . . 73.35 111.169 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 4.4 Cg_exo -80.98 -163.84 3.55 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.678 -1.384 . . . . 54.44 112.401 -0.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 85' ' ' ILE . 2.9 m -158.07 161.99 38.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.868 -0.605 . . . . 60.21 111.124 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' THR . 4.9 mt -120.12 161.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.407 -0.815 . . . . 73.34 109.141 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -163.16 119.03 1.76 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.249 -0.432 . . . . 71.15 110.476 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.03 HD23 HD12 ' A' ' 29' ' ' LEU . 3.3 tm? -101.35 107.68 19.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.491 -0.322 . . . . 64.25 111.75 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 5.5 m-85 -96.74 90.92 0.82 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.653 -0.499 . . . . 73.15 109.653 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.793 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 Cg_endo -55.03 177.93 0.1 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 122.739 2.293 . . . . 64.41 112.116 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -95.79 54.38 1.51 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.758 -0.83 . . . . 75.24 108.758 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.91 -18.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.597 -1.183 . . . . 72.44 112.324 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.793 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -126.16 43.39 3.1 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.122 0.487 . . . . 74.42 110.642 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmm -72.7 -0.05 12.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.637 -0.71 . . . . 74.33 111.21 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.58 -21.2 29.69 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.03 -0.605 . . . . 43.25 112.288 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.506 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.6 tt0 -134.86 52.9 8.17 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-O 121.213 0.53 . . . . 60.44 109.984 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 94.3 Cg_exo -39.82 172.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.705 2.937 . . . . 75.41 113.135 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.888 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.8 t -105.06 83.48 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.706 -0.479 . . . . 64.03 109.706 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 1.4 t -65.48 136.31 56.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.721 -0.672 . . . . 64.43 109.837 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -135.53 169.06 18.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 52.53 111.46 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -112.22 17.77 19.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 62.1 111.585 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.88 167.28 33.3 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 62.13 112.585 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.9 m -159.86 -40.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 75.23 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER 72.15 24.27 3.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.011 -0.541 . . . . 74.42 111.064 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.1 p -125.47 126.82 45.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 63.43 111.855 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG13 HD23 ' A' ' 50' ' ' LEU . 94.2 t -73.37 -28.71 25.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.824 -0.626 . . . . 53.23 110.049 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.5 mt-10 -68.5 -35.92 78.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.424 0.63 . . . . 74.15 109.957 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 10.1 t70 -73.68 -25.28 60.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.308 -0.86 . . . . 53.32 109.506 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.655 HD11 ' CD ' ' A' ' 46' ' ' LYS . 12.2 mt -68.85 -48.95 62.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.609 -0.723 . . . . 54.12 110.188 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 121' ' ' ALA . 5.0 mt -55.56 -54.49 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.128 -0.693 . . . . 65.14 109.128 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -64.45 -18.48 64.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.667 -0.697 . . . . 60.41 109.949 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.1 t80 -65.49 -77.47 0.06 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.849 -0.614 . . . . 64.35 110.504 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.897 HG21 HG21 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -66.25 -5.21 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.1 -0.5 . . . . 72.1 110.394 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.902 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 65.34 111.253 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.1 -26.17 7.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.528 -0.916 . . . . 60.52 108.528 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.888 ' HB3' HG21 ' A' ' 97' ' ' VAL . 67.4 m-80 -96.94 -31.39 12.57 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.047 -1.433 . . . . 74.23 109.664 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -77.81 158.38 46.6 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.574 -0.822 . . . . 52.13 112.561 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 6.8 mmpt? -87.04 -32.32 20.06 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.515 -0.92 . . . . 74.02 108.515 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 -21.78 63.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.352 -1.294 . . . . 73.14 110.152 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.47 42.88 26.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.112 -0.495 . . . . 73.22 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.726 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -72.26 105.73 4.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 74.4 111.024 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.902 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 73.22 111.049 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.48 -0.248 . . . . 64.35 112.48 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.57 ' O ' HD12 ' A' ' 3' ' ' LEU . 52.8 Cg_exo -52.64 168.25 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 60.03 112.305 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 2' ' ' PRO . 1.7 mp -149.81 -178.76 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 63.22 110.869 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.49 -173.21 46.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 34.24 112.478 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 t -145.23 84.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 63.13 110.893 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -178.81 111.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 72.21 110.692 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . -167.15 49.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.471 -0.871 . . . . 53.15 113.081 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo -69.4 -56.93 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.36 2.04 . . . . 72.52 112.041 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.5 p -57.8 134.16 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 64.01 110.585 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -74.62 101.16 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 75.12 111.681 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 t -80.3 93.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 71.41 110.057 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 20' ' ' ILE . 10.6 t -96.25 127.67 48.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 72.12 111.139 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.774 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.5 m -77.93 162.98 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.036 -0.529 . . . . 73.01 110.49 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -51.42 -22.94 3.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 75.33 110.98 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB3' HG23 ' A' ' 13' ' ' VAL . 17.0 tptm -67.56 -38.43 84.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 73.5 111.429 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -114.82 -10.19 12.4 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.67 0.618 . . . . 75.23 112.67 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -49.62 -30.68 9.26 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.911 0.386 . . . . 73.13 111.016 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 p-10 -81.55 -0.31 41.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.119 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.61 ' CG ' HG12 ' A' ' 20' ' ' ILE . 4.5 pt-20 -119.28 -53.55 2.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.563 0.696 . . . . 74.43 110.908 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' CG ' ' A' ' 19' ' ' GLU . 4.4 mm -75.01 -45.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.731 -1.122 . . . . 65.13 112.196 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG11 ' HB ' ' A' ' 30' ' ' ILE . 47.9 t -87.06 -26.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 121.481 0.657 . . . . 74.31 110.85 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.1 tt -95.92 19.13 11.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.108 -0.951 . . . . 73.24 110.945 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -81.5 146.58 30.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.579 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.22 5.77 50.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.427 -0.351 . . . . 73.32 111.102 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.6 p -67.61 -31.96 72.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 53.34 110.689 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.863 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -164.34 171.68 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 70.12 110.897 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -75.99 118.55 18.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 61.2 110.158 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.4 t -114.81 123.3 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.066 0.46 . . . . 74.34 111.765 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.098 HD12 HD11 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -100.13 107.45 19.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.642 -0.708 . . . . 50.44 109.993 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.03 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -91.92 131.21 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.213 -0.595 . . . . 72.2 111.3 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 20.5 tt0 -122.43 90.27 3.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.994 -0.548 . . . . 70.24 111.5 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 83' ' ' PRO . 61.3 m-85 -54.19 135.23 44.24 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.54 -0.541 . . . . 75.21 109.54 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 9.3 p90 -150.43 -164.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.403 0.62 . . . . 73.12 112.076 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -148.8 169.33 9.34 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.962 -1.017 . . . . 75.21 109.634 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.625 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 73.4 Cg_endo -87.58 -17.83 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.82 2.347 . . . . 62.4 110.489 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.512 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 67.0 p-90 -110.42 13.66 22.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.295 -1.32 . . . . 75.21 111.193 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -90.52 103.95 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 74.4 111.186 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -24.27 56.43 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.547 -0.835 . . . . 73.01 112.049 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.04 -46.91 64.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.328 . . . . 54.12 110.564 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.4 t -59.1 -35.52 73.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.113 0.482 . . . . 73.23 110.459 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -58.79 -21.38 55.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.638 -0.71 . . . . 74.52 110.792 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.32 -19.91 17.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.193 0.52 . . . . 71.23 110.625 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 4.5 mp -89.2 -17.08 29.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 75.32 111.619 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.594 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -69.2 -39.2 12.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.942 -0.572 . . . . 74.45 112.485 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 22.3 Cg_exo -52.63 -34.9 65.61 Favored 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 121.755 1.637 . . . . 75.14 111.413 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.955 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.36 -26.91 26.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.847 -1.069 . . . . 65.44 110.321 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.917 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -78.62 -26.63 45.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.51 -0.768 . . . . 74.31 111.175 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.594 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 14.9 mt-10 -87.68 -36.0 17.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 72.33 110.376 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.61 -38.81 28.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.894 -0.594 . . . . 61.51 110.411 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.902 HD13 ' CG1' ' A' ' 105' ' ' VAL . 7.8 tp -82.11 -44.48 16.45 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.767 0.794 . . . . 73.44 109.229 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.3 -33.13 86.41 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.297 -1.32 . . . . 32.42 112.572 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 48' ' ' GLU . . . -73.91 -46.74 42.58 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.677 -0.86 . . . . 74.32 108.677 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -63.15 -42.36 99.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.056 -0.974 . . . . 72.33 109.04 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 1.6 m-30 -70.67 -24.1 62.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.925 -1.034 . . . . 74.34 111.031 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.16 11.39 25.57 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.751 0.648 . . . . 74.31 112.751 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.13 -45.01 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 65.32 111.746 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -59.95 -153.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.323 -0.398 . . . . 60.45 111.171 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.88 15.42 1.09 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.638 0.256 . . . . 55.23 111.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -129.68 9.23 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.904 0.383 . . . . 74.45 110.208 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -55.44 -21.28 15.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.974 -0.557 . . . . 63.33 110.865 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -117.74 20.8 13.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.541 . . . . 63.52 109.62 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -121.64 -147.06 0.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.358 -0.837 . . . . 74.15 110.056 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 112' ' ' ILE . 1.9 p -48.86 107.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.946 0.403 . . . . 43.11 110.166 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 62' ' ' ARG . 58.5 t -95.93 149.21 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.343 0.592 . . . . 71.13 112.122 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.1 mm -95.67 113.75 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 74.41 109.386 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.46 163.85 15.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.242 0.544 . . . . 73.12 112.349 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 33' ' ' TYR . 12.6 ptmt -155.44 164.25 38.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 75.0 110.696 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.4 p -149.17 150.85 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 72.45 110.842 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -87.06 101.12 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 53.31 110.358 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -65.73 -11.36 44.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 61.12 111.776 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.408 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t -113.5 -9.08 13.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.37 -0.377 . . . . 70.43 111.633 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.827 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -113.77 -16.58 12.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.355 . . . . 75.21 111.169 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' ND2' HG12 ' A' ' 13' ' ' VAL . 19.4 m-80 -133.08 126.08 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.101 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -73.88 99.19 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 44.21 110.633 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 27.2 m -75.15 149.95 85.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 64.1 111.249 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.45 -18.77 25.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.598 2.198 . . . . 75.42 112.519 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.76 119.57 38.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 73.22 110.936 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.78 95.69 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 73.45 110.76 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 32' ' ' PHE . 35.9 mt -73.44 87.12 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 75.14 111.191 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -51.12 -26.56 6.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 54.51 110.702 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.82 110.34 0.63 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.872 -0.603 . . . . 71.42 111.714 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' HA ' ' C ' ' A' ' 83' ' ' PRO . 26.3 p90 -111.88 153.06 44.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.546 0.212 . . . . 73.35 110.925 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -71.52 -168.0 4.91 Favored 'Cis proline' 0 C--N 1.346 0.426 0 C-N-CA 123.164 -1.598 . . . . 54.44 113.286 0.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 99' ' ' TYR . 90.0 m -159.92 156.52 27.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 60.21 111.3 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.6 mt -127.71 95.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.564 0.697 . . . . 73.34 110.9 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 23.7 mttt -98.93 127.09 44.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.135 -0.939 . . . . 71.15 110.871 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.9 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tm? -102.23 106.34 17.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 64.25 111.555 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 24.3 m-85 -94.99 94.7 1.32 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.761 -0.459 . . . . 73.15 109.761 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.895 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 9.7 Cg_endo -51.74 175.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.741 0 C-N-CA 123.019 2.479 . . . . 64.41 112.363 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.863 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -102.51 53.04 0.79 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.238 -1.023 . . . . 75.24 108.238 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.15 -28.73 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.097 -1.41 . . . . 72.44 111.723 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -102.21 -81.14 0.5 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.8 -0.36 . . . . 74.42 111.122 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 88' ' ' TYR . 3.2 mtmt 61.16 10.7 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.345 -0.389 . . . . 74.33 111.067 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.27 -22.46 6.48 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.079 -0.582 . . . . 43.25 111.982 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.458 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.6 tt0 -144.31 57.47 4.91 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 109.263 -0.643 . . . . 60.44 109.263 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 78.7 Cg_exo -44.77 177.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.464 2.776 . . . . 75.41 112.926 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.801 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.8 t -102.19 81.41 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 109.193 -0.669 . . . . 64.03 109.193 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 4.1 t -63.06 131.3 48.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.783 -0.644 . . . . 64.43 109.354 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -142.69 -176.26 4.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.621 0.601 . . . . 52.53 112.621 -177.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 m -104.69 -32.36 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 62.1 110.42 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 85' ' ' ILE . . . 92.93 125.34 3.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.917 -0.659 . . . . 62.13 113.003 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 75.23 110.474 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.6 ttm180 -106.17 51.53 0.75 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 74.42 111.035 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 107' ' ' ASP . 15.1 t -143.81 142.47 30.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.005 0.431 . . . . 63.43 111.413 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.955 HG22 ' HB2' ' A' ' 46' ' ' LYS . 17.6 t -91.01 -46.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 53.23 111.155 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -34.64 21.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.915 -0.584 . . . . 74.15 111.557 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 6.7 t0 -75.24 -27.95 59.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 53.32 110.345 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 112' ' ' ILE . 14.3 mt -69.19 -48.62 61.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.939 -0.573 . . . . 54.12 110.567 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.744 HG13 HD11 ' A' ' 50' ' ' LEU . 6.2 mt -57.3 -51.29 71.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.232 -0.655 . . . . 65.14 109.232 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -64.31 -23.19 67.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.621 -0.718 . . . . 60.41 109.457 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -64.03 -75.93 0.08 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.219 -0.901 . . . . 64.35 110.271 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 29' ' ' LEU . 1.7 mp -60.86 -8.9 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 72.1 110.806 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -90.98 -20.55 22.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 65.34 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.71 -25.47 7.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.555 -0.905 . . . . 60.52 108.555 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.801 ' OD1' HG11 ' A' ' 97' ' ' VAL . 45.4 m-80 -91.29 -30.44 16.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.07 -1.423 . . . . 74.23 108.835 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -83.9 159.5 36.15 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.084 -0.962 . . . . 52.13 112.588 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.432 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.6 mtpm? -84.8 -33.48 22.95 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.383 -0.969 . . . . 74.02 108.383 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.61 -23.19 66.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.416 -1.265 . . . . 73.14 110.178 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 70.0 mmtt 54.25 37.05 26.55 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.6 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -70.12 107.76 3.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.491 . . . . 74.4 110.672 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 73.22 111.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 64.35 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.18 -38.3 7.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.575 2.183 . . . . 60.03 112.336 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 mt 61.93 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 63.22 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.14 -143.46 4.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.761 -0.733 . . . . 34.24 112.55 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 m -110.05 -177.36 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 63.13 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.95 -173.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.93 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.48 72.26 0.37 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.816 -0.707 . . . . 53.15 112.428 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 71.8 Cg_endo -84.73 -50.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.789 2.326 . . . . 72.52 112.703 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -56.76 135.58 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.854 -0.612 . . . . 64.01 110.926 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 20' ' ' ILE . 89.7 m -72.78 82.99 1.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.675 -0.693 . . . . 75.12 111.89 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.784 HG22 ' HD3' ' A' ' 67' ' ' LYS . 17.6 t -72.66 81.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.723 -0.473 . . . . 71.41 109.723 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.729 HG11 HG23 ' A' ' 21' ' ' VAL . 3.3 p -89.78 131.08 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.897 -0.592 . . . . 72.12 111.579 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.5 m -81.7 161.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 73.01 109.978 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -50.14 -23.16 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 75.33 111.156 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -67.15 -35.57 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.527 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.522 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.64 -6.64 11.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.539 0.57 . . . . 75.23 112.539 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.89 -16.48 4.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.008 0.373 . . . . 73.13 112.008 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 12.4 p30 -97.59 -1.48 43.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.732 -0.84 . . . . 73.34 108.732 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -27.68 8.1 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.219 -1.355 . . . . 74.43 111.182 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG21 HG21 ' A' ' 10' ' ' THR . 5.7 mm -109.42 -45.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.354 0.502 . . . . 65.13 112.354 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG21 HG13 ' A' ' 30' ' ' ILE . 94.0 t -85.01 -21.69 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.287 0.565 . . . . 74.31 110.348 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -97.54 21.57 10.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.432 -0.804 . . . . 73.24 110.48 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' CG ' HG22 ' A' ' 25' ' ' THR . 4.4 t0 -83.87 139.73 32.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.574 -0.739 . . . . 73.33 110.505 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -99.62 23.75 9.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.472 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -101.91 -20.34 14.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 53.34 111.042 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.658 ' HG2' HG23 ' A' ' 25' ' ' THR . 6.1 pttp -160.36 161.01 33.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.569 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-20 -77.47 125.45 29.35 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.697 -0.483 . . . . 61.2 109.697 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.1 t -118.51 120.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.094 0.473 . . . . 74.34 112.129 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 112' ' ' ILE . 15.6 tp -94.75 104.79 16.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.652 -0.703 . . . . 50.44 110.207 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -97.45 126.87 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.21 -0.596 . . . . 72.2 111.295 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 34.3 tt0 -114.75 90.18 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 70.24 111.52 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.569 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 85.7 m-85 -59.89 130.25 45.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 5.4 p90 -149.49 -163.88 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.395 0.617 . . . . 73.12 111.997 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -143.8 173.8 4.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.021 -0.99 . . . . 75.21 109.57 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 79.8 Cg_endo -88.04 -19.79 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.557 2.171 . . . . 62.4 110.728 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.5 p-90 -101.17 4.13 41.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.429 -1.259 . . . . 75.21 111.003 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -79.82 88.63 5.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 74.4 111.344 -179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -19.99 31.88 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.779 -0.724 . . . . 73.01 112.694 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -87.55 -39.1 15.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.681 0.277 . . . . 54.12 111.369 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HA ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -77.74 -23.65 49.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 73.23 111.393 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -67.62 -15.98 63.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.944 0.402 . . . . 74.52 110.609 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -91.38 -13.77 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.487 0.66 . . . . 71.23 109.933 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.862 HD23 ' HD2' ' A' ' 46' ' ' LYS . 7.5 mt -86.72 -8.57 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.661 -1.154 . . . . 75.32 111.489 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -77.71 -40.39 2.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 113.312 0.856 . . . . 74.45 113.312 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 19.0 Cg_exo -58.83 -36.24 97.33 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.194 1.929 . . . . 75.14 111.287 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.906 ' HB2' HG22 ' A' ' 105' ' ' VAL . 1.5 ptpp? -79.37 -27.68 41.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.333 -1.303 . . . . 65.44 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.26 -32.69 43.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.842 -1.072 . . . . 74.31 110.723 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -90.24 -29.46 18.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.338 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.7 mm-40 -78.69 -42.31 28.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.722 -0.844 . . . . 61.51 108.722 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD13 ' CG1' ' A' ' 105' ' ' VAL . 8.2 tp -81.2 -42.35 20.93 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.318 -0.993 . . . . 73.44 108.318 177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -55.68 -44.14 86.43 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 114.087 -1.415 . . . . 32.42 111.068 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -63.85 -49.58 72.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.477 -0.862 . . . . 74.32 109.104 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 33.9 mt -58.47 -36.1 73.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.756 . . . . 72.33 110.11 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 60' ' ' LYS . 6.6 m-85 -78.97 -25.93 43.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 74.34 111.321 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -106.46 15.02 26.47 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.305 0.483 . . . . 74.31 112.305 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -139.8 -42.4 0.44 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.702 0.287 . . . . 65.32 111.547 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 p -57.36 -159.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 60.45 111.229 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.79 10.95 1.91 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.205 -0.452 . . . . 55.23 110.978 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -130.11 19.04 5.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.156 0.503 . . . . 74.45 109.75 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 3.9 pttp -59.74 -18.48 43.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.413 -0.812 . . . . 63.33 111.101 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.76 -12.78 15.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.337 0.589 . . . . 63.52 109.808 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -82.75 -143.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.255 -0.884 . . . . 74.15 110.086 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.951 HG21 HG21 ' A' ' 112' ' ' ILE . 5.5 p -49.64 137.98 5.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 43.11 110.453 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.527 HG23 ' CD ' ' A' ' 26' ' ' LYS . 87.0 t -123.06 137.23 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.057 0.456 . . . . 71.13 111.566 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' VAL . 33.3 mm -84.71 109.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 74.41 109.88 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -109.11 160.13 16.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.759 0.651 . . . . 73.12 112.759 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.784 ' HD3' HG22 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -154.22 148.3 25.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 75.0 110.608 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.8 p -141.81 152.43 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 72.45 111.2 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -88.13 108.5 19.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 53.31 110.507 179.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -70.56 -9.07 55.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 61.12 111.596 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 4.9 t -117.01 -10.04 10.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 70.43 111.707 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.79 -15.55 13.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 75.21 110.884 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' ND2' ' CB ' ' A' ' 69' ' ' ASP . 10.3 m-80 -132.7 127.92 35.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.998 -0.546 . . . . 72.24 110.866 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.44 92.42 3.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 44.21 110.934 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.727 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 19.9 m -67.06 148.85 98.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 64.1 111.214 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.44 -25.39 13.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.592 2.194 . . . . 75.42 112.348 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.46 166.0 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.819 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.51 119.84 40.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.826 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -109.09 84.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 75.14 111.159 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -53.41 -25.26 15.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 54.51 110.87 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -138.36 109.64 0.69 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.909 -0.662 . . . . 71.42 112.058 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 19.7 p90 -114.08 155.11 45.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.649 0.262 . . . . 73.35 110.931 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.9 Cg_exo -74.51 -171.25 8.94 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.496 -1.46 . . . . 54.44 112.283 0.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 99' ' ' TYR . 87.0 m -164.11 151.0 11.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.574 -0.284 . . . . 60.21 111.044 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.9 mt -120.28 99.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.354 0.597 . . . . 73.34 110.725 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -98.69 127.3 44.57 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 71.15 111.316 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.812 HD21 HG23 ' A' ' 112' ' ' ILE . 3.1 tm? -101.29 108.51 20.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.563 . . . . 64.25 111.097 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 3.5 m-85 -95.06 91.79 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.081 -0.34 . . . . 73.15 110.081 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.771 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -56.38 177.83 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.492 2.128 . . . . 64.41 111.976 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.17 54.11 1.62 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.837 -0.801 . . . . 75.24 108.837 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' HE3' ' A' ' 93' ' ' LYS . . . 168.28 -19.02 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.679 -1.146 . . . . 72.44 112.302 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -127.52 44.61 2.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.155 0.503 . . . . 74.42 110.552 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -75.21 0.18 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.637 -0.71 . . . . 74.33 111.146 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -20.96 35.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.044 -0.598 . . . . 43.25 112.043 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.8 tt0 -138.04 53.8 6.55 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-O 121.199 0.523 . . . . 60.44 110.01 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 83.5 Cg_exo -39.03 175.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.883 3.055 . . . . 75.41 113.403 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.87 HG21 ' HB3' ' A' ' 115' ' ' ASN . 40.4 t -99.8 82.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 109.48 -0.563 . . . . 64.03 109.48 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 t -60.38 128.37 36.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.752 -0.658 . . . . 64.43 109.283 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.66 176.44 8.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.267 -0.424 . . . . 52.53 112.027 -177.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -107.96 -38.99 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 62.1 110.577 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.59 -179.82 24.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.13 112.703 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.546 ' H ' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER 179.83 106.56 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.13 -0.692 . . . . 75.23 109.13 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -69.0 54.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.883 0.373 . . . . 74.42 111.067 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 107' ' ' ASP . 13.1 t -156.75 134.32 10.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.041 0.448 . . . . 63.43 111.048 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.001 ' CG1' HD13 ' A' ' 50' ' ' LEU . 61.7 t -77.21 -28.65 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 53.23 111.458 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.64 -36.72 81.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.253 0.549 . . . . 74.15 110.685 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.673 ' HB2' HG23 ' A' ' 104' ' ' THR . 88.0 m-20 -73.77 -25.43 60.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.537 -0.756 . . . . 53.32 109.707 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.7 mt -70.24 -47.9 59.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.664 -0.698 . . . . 54.12 110.555 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.9 mt -57.24 -53.39 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.998 -0.742 . . . . 65.14 108.998 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -64.78 -18.71 65.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.691 -0.686 . . . . 60.41 109.829 178.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.8 t80 -64.74 -77.39 0.06 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.35 110.429 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.951 HG21 HG21 ' A' ' 63' ' ' VAL . 1.2 mp -65.99 -5.32 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 72.1 110.295 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 121' ' ' ALA . . . -96.09 -19.38 19.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.12 -0.491 . . . . 65.34 111.489 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.93 -26.53 8.1 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.217 -1.031 . . . . 60.52 108.217 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.87 ' HB3' HG21 ' A' ' 97' ' ' VAL . 64.3 m-80 -94.58 -31.55 13.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.918 -1.492 . . . . 74.23 109.363 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.01 158.66 46.55 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.513 -0.851 . . . . 52.13 112.602 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 5.2 mtpm? -87.79 -32.74 18.93 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.566 -0.902 . . . . 74.02 108.566 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -22.39 63.42 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.39 -1.277 . . . . 73.14 109.998 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp 58.06 42.26 22.76 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.037 -0.528 . . . . 73.22 111.403 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.637 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -68.14 103.75 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 74.4 110.739 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.206 -0.902 . . . . 73.22 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.496 -0.241 . . . . 64.35 112.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.88 -26.99 26.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.604 2.203 . . . . 60.03 112.332 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.29 162.32 4.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.944 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.34 114.69 2.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 34.24 112.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -75.8 64.0 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 63.13 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.32 -175.0 2.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.932 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.1 86.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.821 -0.704 . . . . 53.15 112.388 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 55.5 Cg_endo -73.58 -54.82 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.521 2.147 . . . . 72.52 112.576 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.814 HG21 ' CD2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -54.62 166.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.95 -0.568 . . . . 64.01 110.919 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 12' ' ' VAL . 14.1 m -108.73 89.79 3.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.427 . . . . 75.12 111.484 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' HD2' ' A' ' 67' ' ' LYS . 5.4 t -67.09 92.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 71.41 109.633 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' THR . 5.5 t -98.22 114.18 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 72.12 111.52 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.758 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.0 m -74.8 166.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.092 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.98 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -53.01 -22.33 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 75.33 110.889 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.66 -36.99 85.28 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.061 -0.518 . . . . 73.5 111.204 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -114.06 -13.86 12.43 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 112.411 0.523 . . . . 75.23 112.411 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.732 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.4 -23.56 6.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 73.13 110.916 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 21.7 m-80 -84.89 -0.65 54.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 73.34 110.612 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.634 ' CG ' HG12 ' A' ' 20' ' ' ILE . 6.3 pt-20 -121.0 -53.75 2.04 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.484 0.659 . . . . 74.43 110.604 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' O ' HG21 ' A' ' 28' ' ' VAL . 1.6 mm -74.5 -45.53 45.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.848 -1.069 . . . . 65.13 112.08 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 28' ' ' VAL . 88.4 t -87.32 -22.97 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.25 0.547 . . . . 74.31 110.543 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -100.84 22.18 12.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.331 -0.85 . . . . 73.24 110.4 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.74 156.08 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.797 . . . . 73.33 110.774 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -115.51 22.84 12.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.399 -0.364 . . . . 73.32 111.385 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -95.93 -40.34 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.949 0.404 . . . . 53.34 110.903 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 13.2 mtmt -141.94 166.9 23.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 70.12 110.513 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.9 m-20 -77.95 123.37 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.624 -0.51 . . . . 61.2 109.624 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 20' ' ' ILE . 14.0 t -116.84 117.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 74.34 111.921 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -95.25 106.24 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 50.44 109.785 179.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -98.57 130.69 47.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.486 -0.486 . . . . 72.2 111.21 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 43' ' ' LEU . 6.6 tm-20 -121.56 96.42 5.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 70.24 111.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 42.3 m-85 -61.46 137.18 58.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.497 -0.557 . . . . 75.21 109.497 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 67' ' ' LYS . 11.3 p90 -153.19 -169.19 3.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.571 0.7 . . . . 73.12 112.145 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.72 174.52 4.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.738 -1.119 . . . . 75.21 109.596 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 62.4 Cg_endo -89.11 -19.21 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.908 2.405 . . . . 62.4 110.992 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 64.5 p-90 -110.81 18.94 19.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.511 -1.222 . . . . 75.21 111.401 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -93.08 131.58 37.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 74.4 111.624 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 -24.32 68.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.216 -0.993 . . . . 73.01 111.398 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.11 -47.0 39.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.713 0.292 . . . . 54.12 110.327 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.1 p -55.5 -22.37 20.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 73.23 110.653 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -94.04 -16.53 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.908 -0.587 . . . . 74.52 110.738 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -99.95 -17.55 17.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 71.23 110.619 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 31' ' ' GLU . 3.6 mp -87.81 -18.52 29.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 75.32 111.566 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.588 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -56.75 -35.57 36.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.323 0.49 . . . . 74.45 112.323 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 26.5 Cg_endo -88.36 11.56 3.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.764 2.309 . . . . 75.14 113.007 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 3.1 ptpt -125.88 -32.09 2.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.71 -1.587 . . . . 65.44 109.008 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -84.75 -28.86 25.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.06 -0.973 . . . . 74.31 111.181 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 52.1 mt-10 -85.35 -32.53 22.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 72.33 110.323 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 53' ' ' LEU . 4.2 mp0 -85.08 -40.78 16.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 61.51 110.678 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.814 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -80.59 -41.09 24.59 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.771 -0.826 . . . . 73.44 108.771 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.769 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -62.82 -44.28 97.7 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 114.256 -1.338 . . . . 32.42 111.806 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -64.98 -48.95 72.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.024 -0.588 . . . . 74.32 109.959 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 49' ' ' GLU . 26.1 mt -61.78 -29.94 70.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 72.33 109.952 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HD13 ' A' ' 112' ' ' ILE . 3.6 m-85 -80.91 -28.19 35.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.985 -0.552 . . . . 74.34 110.749 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.58 19.51 18.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.11 0.411 . . . . 74.31 112.11 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -145.51 -42.49 0.22 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.931 0.345 . . . . 65.32 111.931 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -57.69 -156.12 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.684 0.278 . . . . 60.45 111.275 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.33 23.77 0.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.68 0.276 . . . . 55.23 111.5 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -149.05 26.23 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.039 0.447 . . . . 74.45 110.032 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.5 pttp -62.44 -18.75 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.761 -0.654 . . . . 63.33 111.119 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.52 -9.74 18.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.378 0.609 . . . . 63.52 109.771 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -85.28 -142.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.104 -0.953 . . . . 74.15 110.131 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 112' ' ' ILE . 4.3 p -49.41 137.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 CA-C-O 120.863 0.363 . . . . 43.11 110.506 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.98 140.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.573 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 9' ' ' VAL . 31.4 mm -91.03 104.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 74.41 110.144 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.63 166.62 10.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 73.12 112.243 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.76 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.29 150.96 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.788 -0.642 . . . . 75.0 110.914 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.9 p -138.6 156.26 29.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.788 -0.642 . . . . 72.45 110.904 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -89.95 106.39 18.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.953 0.406 . . . . 53.31 110.587 179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -69.01 -7.69 37.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 61.12 111.78 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 t -119.84 -14.06 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.857 0.317 . . . . 70.43 111.857 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -105.15 -16.17 14.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.752 0.31 . . . . 75.21 111.217 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -136.47 93.89 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 72.24 111.069 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.35 102.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 44.21 110.493 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.98 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -90.76 149.43 40.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 64.1 111.4 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 -27.69 13.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.613 2.208 . . . . 75.42 112.293 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -58.65 154.92 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -100.85 116.25 32.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.45 111.023 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 81' ' ' GLY . 11.9 mt -107.43 93.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 75.14 110.823 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.42 -38.36 1.23 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.039 0.447 . . . . 54.51 110.898 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 79' ' ' ILE . . . -133.02 -142.36 4.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 71.42 110.834 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 174.6 140.93 0.18 Allowed Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-N 117.041 0.42 . . . . 73.35 110.831 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.0 Cg_exo -74.69 -161.17 2.36 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.572 -1.428 . . . . 54.44 112.152 -0.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 98.4 m -158.44 158.99 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 60.21 111.262 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.0 mt -137.41 97.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.4 0.619 . . . . 73.34 111.032 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -97.72 132.2 43.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.592 -0.731 . . . . 71.15 111.263 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.3 tm? -104.89 108.8 20.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 64.25 111.171 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.553 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 2.7 m-85 -97.09 92.09 1.11 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.548 -0.296 . . . . 73.15 110.209 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.691 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.3 Cg_endo -55.6 176.79 0.14 Allowed 'Trans proline' 0 CA--C 1.509 -0.731 0 C-N-CA 122.573 2.182 . . . . 64.41 111.73 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.57 53.75 1.7 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.895 -0.78 . . . . 75.24 108.895 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.49 -24.17 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.42 -1.264 . . . . 72.44 111.731 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -124.75 57.87 1.25 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.926 0.393 . . . . 74.42 111.303 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 10.64 14.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 74.33 110.908 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.81 -24.35 10.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.083 -0.579 . . . . 43.25 111.985 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.6 tt0 -139.65 55.57 7.09 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 121.256 0.55 . . . . 60.44 109.958 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 55.3 Cg_exo -41.89 -173.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 123.955 3.104 . . . . 75.41 114.081 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HB3' ' A' ' 115' ' ' ASN . 26.0 t -109.16 82.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.203 -0.908 . . . . 64.03 109.905 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 t -60.74 134.04 56.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 64.43 109.344 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.82 179.17 6.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.385 . . . . 52.53 111.957 -177.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.7 p -120.34 -9.77 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 62.1 111.438 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.01 122.67 2.67 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.694 -0.765 . . . . 62.13 112.651 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -102.3 -3.77 26.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.575 0.226 . . . . 75.23 111.527 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 3.3 mpp_? 60.91 46.59 8.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 74.42 111.166 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 107' ' ' ASP . 14.8 t -157.63 132.52 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 63.43 111.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.814 ' CG1' HD23 ' A' ' 50' ' ' LEU . 59.8 t -70.61 -29.89 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 53.23 110.944 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' HA ' HD12 ' A' ' 109' ' ' ILE . 1.4 mt-10 -60.22 -37.39 80.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.38 0.609 . . . . 74.15 110.099 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 31.5 t70 -74.43 -27.03 60.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.17 -0.923 . . . . 53.32 109.514 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.8 mt -69.01 -49.76 54.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.582 -0.735 . . . . 54.12 110.475 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mt -54.88 -55.43 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.104 -0.702 . . . . 65.14 109.104 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -64.76 -17.82 64.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.648 -0.705 . . . . 60.41 110.002 178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -65.3 -78.26 0.05 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.889 -0.596 . . . . 64.35 110.499 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 63' ' ' VAL . 1.3 mp -66.22 -4.77 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.274 -0.421 . . . . 72.1 110.457 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.806 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.28 -20.75 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.201 -0.454 . . . . 65.34 111.316 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CG ' ' HD3' ' A' ' 110' ' ' LYS . 1.8 mm-40 -116.21 -23.52 8.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 60.52 108.653 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.912 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.9 m-80 -99.18 -30.98 11.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.065 -1.425 . . . . 74.23 109.491 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.32 157.87 43.13 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.381 -0.827 . . . . 52.13 112.717 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 7.9 mmtm -87.81 -33.52 18.58 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.542 -0.91 . . . . 74.02 108.542 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.57 -21.29 64.54 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.423 -1.262 . . . . 73.14 110.175 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt 59.55 44.73 14.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.128 -0.487 . . . . 73.22 111.212 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.649 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -74.09 107.87 6.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.136 -0.484 . . . . 74.4 110.274 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.806 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.21 -0.9 . . . . 73.22 111.13 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.554 -0.218 . . . . 64.35 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.98 63.13 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.588 2.192 . . . . 60.03 112.322 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.33 126.2 32.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 63.22 110.86 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.03 175.32 23.0 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 34.24 112.578 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 m -74.74 -168.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 63.13 110.82 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.06 44.77 2.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 72.21 111.029 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.92 156.98 52.85 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.643 -0.789 . . . . 53.15 112.181 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -81.91 -50.29 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.437 2.092 . . . . 72.52 112.511 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.8 p -79.81 135.29 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 64.01 110.23 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.791 HG22 ' CG2' ' A' ' 12' ' ' VAL . 89.4 m -82.17 85.5 6.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.661 . . . . 75.12 111.5 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . 1.9 p -73.33 87.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.469 -0.787 . . . . 71.41 109.463 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.822 HG21 ' HB ' ' A' ' 20' ' ' ILE . 4.5 t -93.13 126.24 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.534 -0.757 . . . . 72.12 111.567 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.883 ' HA ' HG23 ' A' ' 68' ' ' VAL . 11.3 m -77.29 163.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 73.01 110.067 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -52.27 -21.65 3.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.838 0.352 . . . . 75.33 111.126 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 13' ' ' VAL . 1.8 tttt -68.7 -39.37 80.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.5 111.364 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.456 HD21 HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.04 -5.68 12.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.349 0.5 . . . . 75.23 112.349 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.864 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.57 -12.51 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 111.813 0.301 . . . . 73.13 111.813 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 11.0 p30 -99.34 -3.21 34.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.642 -0.873 . . . . 73.34 108.642 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.91 -30.87 7.35 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.307 -1.315 . . . . 74.43 111.096 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -111.86 -45.34 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.639 . . . . 65.13 112.314 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.787 ' HA ' HG11 ' A' ' 28' ' ' VAL . 41.8 t -82.9 -11.55 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.116 0.484 . . . . 74.31 110.933 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -108.82 9.5 26.79 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 73.24 111.458 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' HG21 ' A' ' 28' ' ' VAL . 43.1 p-10 -71.95 136.35 46.79 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.324 -0.398 . . . . 73.33 110.734 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.52 17.09 15.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.598 -0.274 . . . . 73.32 111.454 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -86.0 -33.14 21.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 53.34 110.483 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.814 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 4.4 mmtp -148.9 167.61 25.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.974 -0.557 . . . . 70.12 110.897 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -79.27 121.38 25.02 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.816 -0.438 . . . . 61.2 109.816 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 21' ' ' VAL . 16.1 t -115.17 117.52 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.107 0.48 . . . . 74.34 112.124 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD22 HD11 ' A' ' 112' ' ' ILE . 12.6 tp -91.12 106.14 18.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.573 -0.739 . . . . 50.44 109.835 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -96.89 125.21 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.102 -0.639 . . . . 72.2 111.147 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 67' ' ' LYS . 10.5 tm-20 -117.78 92.07 3.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.536 . . . . 70.24 111.603 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 37.8 m-85 -55.72 139.73 44.04 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.225 -0.443 . . . . 75.21 109.819 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 26.8 p90 -156.66 -168.17 2.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.519 0.676 . . . . 73.12 112.333 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -145.79 172.98 4.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.733 -1.121 . . . . 75.21 109.761 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 71.5 Cg_endo -88.83 -18.37 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.803 2.335 . . . . 62.4 110.807 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 69.7 p-90 -102.07 3.69 38.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.49 -1.232 . . . . 75.21 111.382 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.53 101.38 13.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.309 -0.405 . . . . 74.4 111.172 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.58 -24.35 52.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.649 -0.786 . . . . 73.01 112.116 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.08 -46.65 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 54.12 110.637 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.1 t -60.41 -39.07 86.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 73.23 110.488 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.07 -18.88 50.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.775 -0.648 . . . . 74.52 110.877 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.56 -17.76 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 71.23 110.097 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 2.3 mp -91.75 -7.06 50.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.961 -1.018 . . . . 75.32 112.033 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -75.34 -38.12 2.67 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.563 0.579 . . . . 74.45 112.563 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 23.8 Cg_exo -55.84 -36.96 96.28 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 121.997 1.798 . . . . 75.14 111.29 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -80.95 -29.18 35.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.574 -1.194 . . . . 65.44 109.596 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.841 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -75.67 -28.7 58.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.365 -0.834 . . . . 74.31 111.537 -178.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 17.6 mt-10 -90.29 -31.25 17.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 72.33 110.244 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 mm-40 -83.0 -36.89 24.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 61.51 110.336 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 2.0 tm? -84.69 -43.11 14.65 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.419 -0.956 . . . . 73.44 108.419 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.93 -38.31 95.22 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.36 -1.291 . . . . 32.42 111.388 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -70.78 -47.23 60.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.99 -0.605 . . . . 74.32 109.376 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 49' ' ' GLU . 29.6 mt -63.67 -30.1 71.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.758 -0.656 . . . . 72.33 109.877 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HG13 ' A' ' 63' ' ' VAL . 2.8 m-85 -82.9 -25.92 32.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.827 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.11 16.78 21.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.124 0.416 . . . . 74.31 112.124 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 10.8 ttmt -140.82 -40.6 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.608 0.225 . . . . 65.32 111.608 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.3 p -57.16 -160.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.921 0.391 . . . . 60.45 111.211 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.29 10.91 2.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 55.23 110.98 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.89 14.67 6.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.09 0.471 . . . . 74.45 109.939 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.89 -21.27 28.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.708 -0.678 . . . . 63.33 110.888 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.3 13.44 30.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.285 0.564 . . . . 63.52 109.731 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -113.38 -141.33 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.274 -0.875 . . . . 74.15 109.82 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 112' ' ' ILE . 4.2 p -49.15 133.51 7.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 120.813 0.34 . . . . 43.11 110.275 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.8 141.12 40.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.062 0.458 . . . . 71.13 111.73 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.834 ' O ' HG23 ' A' ' 9' ' ' VAL . 22.9 mm -86.74 113.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 74.41 109.64 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -115.21 167.68 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.516 0.674 . . . . 73.12 112.768 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -158.63 161.51 37.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.508 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.8 p -149.19 146.55 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.182 -0.463 . . . . 72.45 111.273 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.2 t0 -83.43 100.19 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.001 -0.545 . . . . 53.31 110.061 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -67.99 -10.2 51.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 61.12 111.913 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.402 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -113.52 -12.16 12.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 70.43 111.567 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.15 -15.96 13.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.352 -0.385 . . . . 75.21 110.858 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.516 ' ND2' HG12 ' A' ' 13' ' ' VAL . 22.0 m-80 -129.95 124.82 33.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.552 . . . . 72.24 110.962 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -72.99 100.51 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 44.21 110.645 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.881 HG12 ' HB2' ' A' ' 14' ' ' ALA . 23.7 m -88.49 146.58 37.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 64.1 111.114 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.13 -17.08 12.03 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.635 2.224 . . . . 75.42 112.71 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.29 150.06 25.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 73.22 110.991 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -91.68 148.23 22.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.45 110.707 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.422 HG23 ' OG1' ' A' ' 84' ' ' THR . 43.6 mt -137.6 121.29 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 75.14 111.413 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 -19.12 20.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 54.51 110.589 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.01 117.01 2.88 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.285 -0.726 . . . . 71.42 111.285 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.98 127.14 28.21 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.559 0.218 . . . . 73.35 111.389 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 6.1 Cg_exo -79.6 -164.64 4.08 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.889 -1.296 . . . . 54.44 112.293 -0.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 14.7 m -144.47 157.35 44.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.421 . . . . 60.21 111.578 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -136.06 96.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.598 0.713 . . . . 73.34 111.237 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 19.7 mttp -98.39 129.95 45.04 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.211 -0.904 . . . . 71.15 110.717 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD21 HG23 ' A' ' 112' ' ' ILE . 2.8 tm? -104.59 110.63 23.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.41 . . . . 64.25 110.929 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 1.7 m-85 -96.57 96.62 2.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.405 -0.361 . . . . 73.15 110.177 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 12.0 Cg_endo -54.93 165.25 2.79 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 123.147 2.564 . . . . 64.41 112.112 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -94.62 53.33 1.63 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.72 -0.844 . . . . 75.24 108.72 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.17 -29.63 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.265 -1.334 . . . . 72.44 111.636 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -101.57 -78.45 0.53 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.859 0.362 . . . . 74.42 111.154 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 60.14 12.27 3.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.129 -0.487 . . . . 74.33 111.359 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.02 -23.28 6.19 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.893 -0.67 . . . . 43.25 111.939 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' PRO . 3.1 tt0 -149.82 59.34 3.74 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 121.186 0.517 . . . . 60.44 109.786 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 73.9 Cg_exo -42.99 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.692 2.928 . . . . 75.41 113.173 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.872 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.1 t -104.78 82.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.318 -0.623 . . . . 64.03 109.318 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 2.5 t -62.72 133.89 55.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 64.43 109.443 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -141.48 -176.35 4.7 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.228 0.455 . . . . 52.53 112.228 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.95 -31.05 8.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.813 -0.63 . . . . 62.1 110.425 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 85' ' ' ILE . . . 103.4 120.96 4.85 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.87 -0.681 . . . . 62.13 112.927 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 m -117.95 138.47 52.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.223 -0.288 . . . . 75.23 110.223 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.58 62.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 74.42 111.183 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 107' ' ' ASP . 7.1 t -150.45 138.34 20.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.046 0.45 . . . . 63.43 111.806 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.6 t -90.82 -33.56 5.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.78 -0.645 . . . . 53.23 111.563 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.48 -34.61 77.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.424 0.63 . . . . 74.15 110.395 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 3.8 t0 -75.82 -23.63 55.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.193 -0.912 . . . . 53.32 109.785 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 112' ' ' ILE . 12.5 mt -70.68 -49.58 45.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.685 -0.689 . . . . 54.12 110.452 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 7.0 mt -57.96 -52.59 56.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.24 -0.652 . . . . 65.14 109.24 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -64.7 -19.95 66.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.405 -0.816 . . . . 60.41 109.817 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -66.0 -77.3 0.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.754 -0.657 . . . . 64.35 110.255 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.962 HD11 HD22 ' A' ' 29' ' ' LEU . 1.4 mp -62.45 -7.42 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.897 0.38 . . . . 72.1 110.886 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.932 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -91.36 -23.29 20.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.278 -0.419 . . . . 65.34 111.487 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HG3' ' HD3' ' A' ' 110' ' ' LYS . 3.3 mm-40 -112.91 -29.45 7.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.238 -1.023 . . . . 60.52 108.238 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.872 ' OD1' HG11 ' A' ' 97' ' ' VAL . 41.2 m-80 -86.87 -31.45 20.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 74.23 108.829 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -82.97 159.97 38.28 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 115.069 -0.969 . . . . 52.13 112.626 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 89' ' ' PRO . 6.2 mtpt -88.08 -34.33 17.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.401 -0.963 . . . . 74.02 108.401 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -24.07 67.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.468 -1.242 . . . . 73.14 110.079 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 11.6 mmtt 59.54 36.85 22.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.084 -0.507 . . . . 73.22 111.334 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -65.73 104.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 74.4 110.555 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 73.22 111.097 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.49 -0.244 . . . . 64.35 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.28 139.82 53.39 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.6 2.2 . . . . 60.03 112.287 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.6 mt -111.27 35.7 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 63.22 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.94 151.17 9.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 34.24 112.525 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 m -142.81 161.37 38.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 63.13 110.933 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -143.62 120.56 11.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 72.21 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.69 76.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 53.15 112.59 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 34.4 Cg_endo -65.56 -62.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 72.52 112.131 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -48.35 143.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.256 -0.429 . . . . 64.01 110.56 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 12' ' ' VAL . 55.9 m -83.58 99.32 10.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 75.12 111.511 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 67' ' ' LYS . 35.4 t -73.82 90.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 71.41 109.596 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' HB ' ' A' ' 20' ' ' ILE . 21.8 t -91.29 119.86 39.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.307 0.575 . . . . 72.12 112.04 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' OD1' ' A' ' 73' ' ' ASN . 45.1 t -56.04 160.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.254 -0.885 . . . . 73.01 109.842 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -64.25 -19.46 65.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.324 0.583 . . . . 75.33 109.856 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.625 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.1 tttt -75.95 -41.63 50.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.193 -0.912 . . . . 73.5 110.077 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HB2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -98.18 -9.33 25.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.432 -0.507 . . . . 75.23 111.635 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.885 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.96 -13.47 4.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.715 0.293 . . . . 73.13 111.434 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 14.2 p30 -97.71 -2.43 41.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.409 -0.96 . . . . 73.34 108.409 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -32.81 6.73 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.323 -1.308 . . . . 74.43 111.058 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.685 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.5 mm -105.97 -47.99 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.144 -0.48 . . . . 65.13 112.243 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 HG13 ' A' ' 30' ' ' ILE . 53.5 t -79.92 -18.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.18 0.514 . . . . 74.31 110.912 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -103.17 21.86 15.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.441 -0.8 . . . . 73.24 110.835 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -85.88 157.5 20.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.382 -0.826 . . . . 73.33 110.642 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -115.73 24.02 11.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.524 -0.307 . . . . 73.32 111.506 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.1 t -90.17 -30.4 17.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 53.34 110.905 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.787 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -155.65 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 70.12 110.335 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB2' HG13 ' A' ' 63' ' ' VAL . 9.6 m-20 -90.54 118.19 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.028 -0.36 . . . . 61.2 110.028 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 21' ' ' VAL . 4.6 t -109.05 121.3 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.086 0.469 . . . . 74.34 111.831 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.808 HD22 HD11 ' A' ' 112' ' ' ILE . 14.7 tp -99.34 100.23 11.28 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.787 -0.642 . . . . 50.44 110.194 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.885 HD12 ' CD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.039 -0.664 . . . . 72.2 111.089 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 6.2 tm-20 -124.55 92.54 3.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 70.24 111.501 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 61.2 m-85 -54.83 144.28 23.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.464 -0.569 . . . . 75.21 109.464 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 22.2 p90 -161.19 -167.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.52 0.676 . . . . 73.12 112.035 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.703 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -146.89 177.44 1.76 Allowed Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 114.756 -1.111 . . . . 75.21 109.63 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.703 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 78.7 Cg_endo -90.62 -18.56 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.681 2.254 . . . . 62.4 111.18 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -111.41 12.86 21.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.581 -1.191 . . . . 75.21 111.429 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -85.05 116.66 23.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.778 -0.646 . . . . 74.4 111.13 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.0 -15.03 62.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.528 -0.844 . . . . 73.01 112.369 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -49.81 14.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.697 0.284 . . . . 54.12 111.009 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 18.3 p -56.39 -41.52 76.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.076 0.465 . . . . 73.23 110.72 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -50.27 -25.17 3.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.681 . . . . 74.52 111.366 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -94.17 -20.49 19.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.149 0.5 . . . . 71.23 110.933 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.698 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.2 mp -89.12 -21.4 23.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.499 -0.773 . . . . 75.32 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -52.23 -40.79 76.8 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.463 -0.79 . . . . 74.45 112.684 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 72.6 Cg_endo -81.41 -29.83 1.75 Allowed 'Trans proline' 0 CA--C 1.512 -0.616 0 C-N-CA 122.043 1.829 . . . . 75.14 112.442 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 105' ' ' VAL . 7.3 ptmt -78.47 -32.96 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 65.44 109.148 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -80.2 -29.42 38.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.103 -0.953 . . . . 74.31 110.98 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.5 mt-10 -82.83 -32.57 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.53 -0.305 . . . . 72.33 110.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.8 mt-10 -87.34 -41.99 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 61.51 110.857 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.755 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.4 tm? -78.7 -40.37 33.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.734 -0.839 . . . . 73.44 108.734 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 47' ' ' TYR . . . -66.8 -44.08 90.13 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.188 -1.369 . . . . 32.42 112.036 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -61.21 -49.04 78.74 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.358 0.599 . . . . 74.32 109.72 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 49' ' ' GLU . 22.0 mt -59.01 -35.09 72.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.71 -0.677 . . . . 72.33 111.121 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 63' ' ' VAL . 2.9 m-30 -83.0 -24.88 32.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.746 -0.382 . . . . 74.34 111.047 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.26 17.26 22.41 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.286 0.476 . . . . 74.31 112.286 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.35 -43.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.913 0.338 . . . . 65.32 111.913 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.3 t -60.71 -151.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 60.45 111.052 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.45 20.38 0.55 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.709 0.29 . . . . 55.23 111.47 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -139.58 16.25 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 74.45 110.34 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 3.2 pttp -56.83 -20.73 24.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.005 -0.543 . . . . 63.33 111.439 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -101.38 -13.09 18.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.452 0.644 . . . . 63.52 109.622 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -81.89 -136.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.937 -1.029 . . . . 74.15 110.141 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 112' ' ' ILE . 3.0 t -46.22 152.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 120.854 0.359 . . . . 43.11 110.649 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.15 107.91 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 71.13 110.94 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 9' ' ' VAL . 26.4 mm -68.63 105.29 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 74.41 109.739 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . -104.7 164.5 11.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 73.12 112.238 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -161.17 151.5 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 75.0 110.99 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 69' ' ' ASP . 10.3 p -138.36 157.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.808 -0.633 . . . . 72.45 110.885 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.883 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -92.78 97.25 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 53.31 110.29 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.683 ' HB1' ' HE2' ' A' ' 82' ' ' PHE . . . -60.91 -14.21 20.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.792 -0.64 . . . . 61.12 112.311 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.407 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 3.9 t -111.29 -10.91 14.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 70.43 111.726 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.883 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -110.45 -15.06 14.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.918 0.39 . . . . 75.21 110.783 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.782 ' OD1' HG13 ' A' ' 13' ' ' VAL . 9.9 m-80 -135.07 128.76 32.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 72.24 110.907 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.61 105.07 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.21 110.86 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 14' ' ' ALA . 19.6 m -87.13 148.73 45.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 64.1 111.103 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 -22.67 15.24 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.624 2.216 . . . . 75.42 112.469 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.22 130.89 35.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 73.22 111.079 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -76.31 131.58 39.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.642 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mt -119.38 107.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 75.14 111.369 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -81.24 -13.01 58.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 54.51 110.904 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.57 116.86 1.58 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.195 -0.526 . . . . 71.42 111.795 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' HE2' ' HB1' ' A' ' 70' ' ' ALA . 59.7 m-85 -105.9 135.65 19.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.721 0.296 . . . . 73.35 111.179 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 3.1 Cg_exo -82.37 -163.18 3.14 Favored 'Cis proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.621 -1.408 . . . . 54.44 112.505 0.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 17.7 m -146.27 154.16 41.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 60.21 110.987 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 1.2 mt -134.97 95.92 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 73.34 111.655 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 98' ' ' THR . 10.9 mttp -98.2 128.58 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.133 -0.94 . . . . 71.15 110.629 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -105.41 106.76 17.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.284 -0.416 . . . . 64.25 111.526 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 9.0 m-85 -94.43 92.54 0.79 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.725 -0.472 . . . . 73.15 109.725 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.769 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 13.4 Cg_endo -56.73 177.02 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.502 2.135 . . . . 64.41 111.919 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.787 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -95.56 53.74 1.5 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.849 -0.797 . . . . 75.24 108.849 177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.66 -24.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.497 -1.229 . . . . 72.44 111.621 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.819 ' HB2' ' CE ' ' A' ' 117' ' ' LYS . . . -122.85 49.6 1.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.023 0.439 . . . . 74.42 110.963 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.32 8.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.901 -0.59 . . . . 74.33 111.093 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.53 -18.95 21.98 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.074 -0.584 . . . . 43.25 112.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.505 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 1.9 tt0 -137.33 53.21 6.39 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-O 121.234 0.54 . . . . 60.44 110.088 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 89.1 Cg_exo -42.22 176.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.567 2.844 . . . . 75.41 113.152 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.839 HG11 ' OD1' ' A' ' 115' ' ' ASN . 21.5 t -106.33 82.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.608 -0.516 . . . . 64.03 109.608 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 86' ' ' LYS . 1.5 t -63.62 134.45 55.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 64.43 109.624 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.3 OUTLIER -142.17 -176.28 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.348 0.499 . . . . 52.53 112.348 -177.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 m -112.84 -27.13 8.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.786 -0.643 . . . . 62.1 110.963 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.89 108.75 3.09 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.725 -0.75 . . . . 62.13 112.971 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 m -94.4 2.53 55.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.527 0.204 . . . . 75.23 111.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 102' ' ' SER . 6.4 ptt-85 47.65 27.24 0.99 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 74.42 112.044 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.422 ' N ' ' HE3' ' A' ' 46' ' ' LYS . 12.2 p -115.3 128.27 56.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 63.43 111.836 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.755 ' CG1' HD23 ' A' ' 50' ' ' LEU . 87.9 t -75.64 -32.74 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 53.23 110.552 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.33 -35.1 75.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.55 0.691 . . . . 74.15 109.823 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 17.0 t0 -75.67 -22.52 56.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.987 -1.006 . . . . 53.32 109.61 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 112' ' ' ILE . 11.0 mt -69.87 -50.21 44.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.804 -0.635 . . . . 54.12 110.27 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.673 HG13 HD21 ' A' ' 50' ' ' LEU . 3.3 mt -57.3 -53.42 43.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.616 . . . . 65.14 109.335 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -20.91 66.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.522 -0.763 . . . . 60.41 109.843 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -65.23 -77.98 0.06 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.63 -0.714 . . . . 64.35 110.495 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 87' ' ' LEU . 1.3 mp -62.89 -7.47 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.231 -0.44 . . . . 72.1 110.934 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.876 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.01 -20.86 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.283 -0.417 . . . . 65.34 111.396 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -116.59 -25.65 7.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.585 -0.894 . . . . 60.52 108.585 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.839 ' OD1' HG11 ' A' ' 97' ' ' VAL . 47.2 m-80 -92.69 -30.7 15.42 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.07 -1.423 . . . . 74.23 109.013 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -81.67 159.79 40.69 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.191 -0.913 . . . . 52.13 112.512 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.819 ' CE ' ' HB2' ' A' ' 92' ' ' ALA . 15.4 mmtt -86.11 -32.93 21.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.575 -0.898 . . . . 74.02 108.575 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.16 -23.55 64.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.458 -1.246 . . . . 73.14 110.275 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 61.5 mmtt 56.54 39.12 30.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.183 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -68.65 104.0 1.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.042 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.876 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.288 -0.863 . . . . 73.22 111.054 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.518 -0.233 . . . . 64.35 112.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -33.25 13.54 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.577 2.185 . . . . 60.03 112.37 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.11 162.97 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 63.22 110.928 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.46 118.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 34.24 112.482 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.5 m -117.11 -80.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 63.13 110.934 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 177.57 44.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 72.21 110.763 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.39 132.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 53.15 112.13 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB2' ' N ' ' A' ' 52' ' ' ALA . 51.1 Cg_endo -72.39 -58.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.192 1.928 . . . . 72.52 112.456 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.573 HG12 ' HA3' ' A' ' 51' ' ' GLY . 1.1 m -62.6 -176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 120.85 0.357 . . . . 64.01 111.006 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.751 HG22 ' CG2' ' A' ' 12' ' ' VAL . 26.2 m -118.16 83.76 2.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.674 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 67' ' ' LYS . 26.0 t -63.07 84.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 71.41 110.122 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.751 ' CG2' HG22 ' A' ' 10' ' ' THR . 11.9 t -97.07 128.86 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 72.12 111.077 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -83.61 170.97 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.042 -0.526 . . . . 73.01 109.844 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.089 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -56.23 -22.88 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.382 0.61 . . . . 75.33 110.261 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 13' ' ' VAL . 9.5 mttt -61.59 -35.93 79.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.127 -0.942 . . . . 73.5 111.188 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' HB2' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -126.81 -7.24 6.14 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.706 0.632 . . . . 75.23 112.706 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -53.07 -21.58 4.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.372 0.508 . . . . 73.13 112.372 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.541 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -95.38 -2.72 48.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.77 0.795 . . . . 73.34 109.043 178.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -26.9 9.31 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.269 -1.332 . . . . 74.43 111.557 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -113.01 -46.17 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.773 0.657 . . . . 65.13 112.773 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.879 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.3 t -82.86 -24.66 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.654 0.74 . . . . 74.31 110.146 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -98.13 20.49 12.29 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.908 -1.042 . . . . 73.24 110.926 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -77.27 148.11 35.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 73.33 110.344 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.54 23.19 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.728 0.299 . . . . 73.32 111.149 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -96.94 -27.65 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 53.34 110.817 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -156.75 165.4 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 70.12 110.975 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD1' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -76.77 122.87 25.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 61.2 109.913 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.879 HG11 ' HA ' ' A' ' 21' ' ' VAL . 5.5 t -115.41 133.44 61.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 74.34 112.223 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.887 HD22 HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -106.77 102.97 12.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.177 -0.92 . . . . 50.44 109.796 179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.869 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -93.21 127.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.122 -0.631 . . . . 72.2 110.994 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.662 ' OE2' HD22 ' A' ' 43' ' ' LEU . 31.6 tt0 -117.07 86.33 2.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.966 -0.561 . . . . 70.24 111.504 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 88.1 m-85 -54.54 131.69 43.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.397 -0.594 . . . . 75.21 109.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 19.7 p90 -147.16 -166.13 2.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.496 0.665 . . . . 73.12 112.098 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -147.77 170.28 7.97 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 114.902 -1.044 . . . . 75.21 109.623 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 74.2 Cg_endo -88.68 -17.58 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.051 2.5 . . . . 62.4 110.701 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 65.8 p-90 -109.69 18.44 20.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.374 -1.285 . . . . 75.21 111.349 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -96.96 158.81 15.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 74.4 110.707 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 41' ' ' LYS . . . -105.69 -33.17 3.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.75 -0.738 . . . . 73.01 111.824 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -61.76 -43.59 98.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 54.12 110.385 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 51.1 t -60.22 -46.09 90.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.202 0.525 . . . . 73.23 110.268 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 37' ' ' CYS . 12.1 mtpt -54.68 -33.71 61.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.416 -0.811 . . . . 74.52 110.812 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.39 -17.88 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 71.23 110.74 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.662 HD22 ' OE2' ' A' ' 31' ' ' GLU . 13.7 mt -88.18 -18.0 29.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.254 -0.885 . . . . 75.32 111.974 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -68.99 -39.69 14.05 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.839 -0.619 . . . . 74.45 112.594 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 24.0 Cg_exo -52.03 -35.89 63.08 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 121.944 1.763 . . . . 75.14 111.441 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.988 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -85.51 -26.16 26.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.891 -1.049 . . . . 65.44 110.253 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -75.81 -30.34 58.99 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.416 -0.811 . . . . 74.31 110.997 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 mm-40 -85.83 -32.86 21.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.317 -0.401 . . . . 72.33 110.946 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 53' ' ' LEU . 13.4 mt-10 -83.65 -39.92 19.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 61.51 110.493 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 HG13 ' A' ' 105' ' ' VAL . 4.2 tp -82.45 -43.87 16.72 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.809 0.814 . . . . 73.44 109.01 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 9' ' ' VAL . . . -61.58 -42.33 99.74 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.174 -1.375 . . . . 32.42 111.496 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -63.71 -50.08 70.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.227 -0.657 . . . . 74.32 109.227 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 49' ' ' GLU . 25.9 mt -63.48 -32.34 73.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 72.33 110.124 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 112' ' ' ILE . 4.2 m-85 -77.02 -26.99 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 74.34 110.903 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -110.79 14.55 22.19 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.498 0.555 . . . . 74.31 112.498 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -146.39 -42.35 0.2 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.837 0.31 . . . . 65.32 111.837 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.2 t -60.41 -147.12 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.6 -0.273 . . . . 60.45 111.227 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -83.13 19.67 1.4 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.863 0.32 . . . . 55.23 111.863 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.07 17.14 2.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 74.45 110.363 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.9 pttp -59.2 -21.21 59.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 63.33 111.016 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.64 11.49 22.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.145 0.498 . . . . 63.52 110.146 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.1 ttm180 -115.21 -143.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.538 -0.756 . . . . 74.15 109.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.761 HG11 ' CB ' ' A' ' 120' ' ' ALA . 1.8 p -48.82 121.87 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 43.11 110.383 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 62' ' ' ARG . 99.2 t -110.15 149.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.173 0.511 . . . . 71.13 111.918 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 50.2 mm -96.67 118.95 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.564 -0.744 . . . . 74.41 109.657 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -120.9 169.11 10.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.165 0.507 . . . . 73.12 112.168 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -156.18 160.65 40.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.159 0.504 . . . . 75.0 111.293 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 13' ' ' VAL . 12.6 p -150.95 152.32 11.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.573 -0.74 . . . . 72.45 110.867 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -85.04 111.74 20.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.871 0.367 . . . . 53.31 110.396 179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -71.62 -2.41 17.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.296 -0.411 . . . . 61.12 111.903 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -124.54 -25.73 3.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.782 0.29 . . . . 70.43 111.782 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -81.99 -17.03 48.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.978 0.362 . . . . 75.21 111.978 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 68' ' ' VAL . 5.0 p30 -135.01 140.33 45.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.946 0.403 . . . . 72.24 111.418 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -85.48 89.07 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 44.21 109.479 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.089 HG12 ' HB2' ' A' ' 14' ' ' ALA . 17.4 m -78.06 152.31 79.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.962 -0.563 . . . . 64.1 111.25 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.17 -34.53 45.46 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.653 2.235 . . . . 75.42 112.481 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.57 110.78 13.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.22 110.904 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -66.95 110.27 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.45 110.742 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mt -88.8 85.8 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.14 111.32 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -20.89 29.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.287 -0.415 . . . . 54.51 110.882 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.32 111.17 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.053 -0.594 . . . . 71.42 111.787 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -113.29 153.9 45.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.708 0.289 . . . . 73.35 111.0 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 5.4 Cg_exo -73.73 -168.94 6.48 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 -1.489 . . . . 54.44 112.388 0.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 99' ' ' TYR . 85.5 m -157.53 149.62 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.557 -0.292 . . . . 60.21 110.992 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 2.7 mt -123.14 99.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.39 0.614 . . . . 73.34 110.819 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 32' ' ' PHE . 18.5 mttt -101.89 129.38 48.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.683 -0.689 . . . . 71.15 111.31 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 29' ' ' LEU . 3.2 tm? -103.28 105.36 15.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.901 -0.591 . . . . 64.25 111.116 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 96' ' ' PRO . 18.3 m-85 -95.16 92.82 0.93 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 73.15 110.273 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.795 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 15.6 Cg_endo -57.43 177.32 0.22 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.581 2.188 . . . . 64.41 112.004 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.6 53.88 1.3 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.739 0.78 . . . . 75.24 108.917 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.72 -23.35 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 114.439 -1.255 . . . . 72.44 111.739 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.59 41.31 3.46 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.031 0.443 . . . . 74.42 110.877 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -3.01 7.91 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.934 -0.575 . . . . 74.33 111.312 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 96' ' ' PRO . . . -96.4 -22.05 20.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.952 -0.642 . . . . 43.25 112.073 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 1.3 pp0? -130.24 47.45 2.89 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 120.845 0.355 . . . . 60.44 110.504 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 88' ' ' TYR . 98.8 Cg_exo -46.38 -179.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.084 2.522 . . . . 75.41 112.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.967 HG11 ' OD1' ' A' ' 115' ' ' ASN . 47.4 t -108.6 83.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 109.809 -0.441 . . . . 64.03 109.809 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 t -62.73 137.85 58.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.716 -0.674 . . . . 64.43 109.201 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.76 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -138.74 178.5 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.88 0.371 . . . . 52.53 111.964 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -125.87 21.54 7.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 62.1 111.286 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.18 166.19 32.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.661 -0.78 . . . . 62.13 112.822 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.5 m -153.43 -41.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.743 0.306 . . . . 75.23 111.054 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 75.47 26.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.807 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 107' ' ' ASP . 36.4 p -132.54 137.43 47.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 63.43 112.263 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.988 HG22 ' HB2' ' A' ' 46' ' ' LYS . 95.8 t -83.07 -28.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 53.23 110.208 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -33.98 71.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.793 -0.64 . . . . 74.15 110.648 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 4.4 m-20 -75.36 -25.56 57.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.66 -0.7 . . . . 53.32 109.718 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 50' ' ' LEU . 12.3 mt -70.28 -49.07 53.5 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.817 -0.629 . . . . 54.12 110.379 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 50' ' ' LEU . 5.8 mt -56.53 -52.33 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.152 -0.684 . . . . 65.14 109.152 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.87 -19.98 66.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.668 -0.696 . . . . 60.41 109.633 178.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 1.6 t80 -65.25 -78.4 0.05 Allowed 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.659 -0.701 . . . . 64.35 110.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.756 HG21 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -61.25 -8.41 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.955 0.407 . . . . 72.1 110.488 178.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.921 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -89.7 -22.06 22.41 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.054 -0.521 . . . . 65.34 111.496 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -115.64 -35.97 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.985 -1.117 . . . . 60.52 107.985 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.967 ' OD1' HG11 ' A' ' 97' ' ' VAL . 9.8 m-80 -82.38 -33.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.119 -1.855 . . . . 74.23 109.711 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -80.43 159.17 42.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.386 -0.825 . . . . 52.13 112.632 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 2.3 mmmp? -87.28 -32.17 19.84 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.542 -0.91 . . . . 74.02 108.542 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.61 -22.18 63.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.315 -1.311 . . . . 73.14 110.146 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt 58.92 44.15 16.98 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.096 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.761 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -70.01 105.06 2.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.925 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.921 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.247 -0.883 . . . . 73.22 111.024 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.461 -0.256 . . . . 64.35 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 163.71 37.24 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.613 2.209 . . . . 60.03 112.254 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 4' ' ' GLY . 4.4 pp -80.72 -175.22 5.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.22 110.938 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.458 ' N ' HD12 ' A' ' 3' ' ' LEU . . . 109.19 37.79 1.92 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 34.24 112.528 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -102.76 31.96 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 63.13 110.832 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -135.71 145.6 46.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 72.21 110.922 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.62 149.94 16.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 53.15 112.635 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 48' ' ' GLU . 40.9 Cg_endo -69.75 -53.21 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.662 2.242 . . . . 72.52 112.39 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.835 HG23 ' HA3' ' A' ' 51' ' ' GLY . 0.9 OUTLIER -48.67 141.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 64.01 111.343 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.79 HG22 ' CG2' ' A' ' 12' ' ' VAL . 91.1 m -74.12 84.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 75.12 111.365 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.503 HG22 ' HE2' ' A' ' 67' ' ' LYS . 37.0 t -70.36 89.2 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 71.41 109.855 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.79 ' CG2' HG22 ' A' ' 10' ' ' THR . 15.4 t -97.64 117.33 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 72.12 110.989 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.682 ' HA ' HG23 ' A' ' 68' ' ' VAL . 7.6 p -71.86 165.29 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 121.19 0.519 . . . . 73.01 110.547 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -54.75 -21.11 9.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.506 -0.77 . . . . 75.33 111.325 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -71.6 -28.53 63.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 73.5 111.502 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -122.53 -7.89 8.59 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.298 0.481 . . . . 75.23 112.298 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.27 -16.23 2.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.449 0.537 . . . . 73.13 112.449 -179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 3.5 p-10 -97.71 -3.28 39.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 73.34 108.879 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 -23.88 9.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.23 -1.35 . . . . 74.43 111.57 -178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 12' ' ' VAL . 2.9 mm -117.82 -45.57 3.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.481 0.549 . . . . 65.13 112.481 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 28' ' ' VAL . 79.4 t -82.52 -25.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.35 0.595 . . . . 74.31 110.536 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -94.2 7.57 44.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.168 -0.924 . . . . 73.24 111.573 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.38 150.86 4.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.054 -0.521 . . . . 73.33 111.132 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -114.97 19.38 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.572 -0.285 . . . . 73.32 111.479 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CD ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -107.57 -27.85 10.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 53.34 110.589 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.619 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.9 163.09 33.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 70.12 110.339 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.0 m-20 -84.44 125.79 32.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.913 -0.403 . . . . 61.2 109.913 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 21' ' ' VAL . 2.0 t -116.53 130.63 71.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 74.34 112.007 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.906 HD22 HD11 ' A' ' 112' ' ' ILE . 13.5 tp -103.19 103.14 13.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.48 -0.782 . . . . 50.44 109.919 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.669 HG13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -93.08 125.52 45.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.145 -0.622 . . . . 72.2 110.964 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . 22.4 tt0 -114.83 86.43 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 70.24 111.299 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 76.9 m-85 -55.88 130.06 42.09 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.542 -0.54 . . . . 75.21 109.542 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.2 p90 -147.77 -165.31 2.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 73.12 111.678 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -138.44 177.32 2.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.094 -0.957 . . . . 75.21 109.555 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 94.9 Cg_endo -91.06 -18.5 1.05 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.477 2.118 . . . . 62.4 111.293 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.0 8.92 20.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.546 -1.206 . . . . 75.21 111.308 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 0.5 OUTLIER -68.09 96.24 0.61 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.851 -0.613 . . . . 74.4 111.303 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.16 -17.31 58.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.543 -0.837 . . . . 73.01 112.282 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -89.14 -48.81 7.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 54.12 110.969 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.573 ' HA ' HD13 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -64.43 -26.82 68.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 73.23 110.851 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.83 -20.99 60.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.495 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -89.76 -16.41 30.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.864 -0.607 . . . . 71.23 110.627 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 40' ' ' CYS . 4.4 mp -86.72 -13.62 44.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.208 -0.905 . . . . 75.32 112.112 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -72.47 -37.24 4.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 113.069 0.766 . . . . 74.45 113.069 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 21.2 Cg_exo -54.29 -34.39 79.74 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 121.94 1.76 . . . . 75.14 111.364 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.975 ' HB2' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.42 -26.52 22.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.595 -1.184 . . . . 65.44 109.927 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.81 -25.6 53.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.393 -0.821 . . . . 74.31 111.012 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 8.1 mt-10 -87.42 -32.37 19.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.826 0.346 . . . . 72.33 110.688 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.5 mt-10 -86.48 -38.58 17.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.101 0.477 . . . . 61.51 110.387 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD23 ' CG1' ' A' ' 105' ' ' VAL . 1.7 tm? -81.31 -41.5 22.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.321 -0.992 . . . . 73.44 108.321 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.835 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.06 -46.34 93.62 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.252 -1.34 . . . . 32.42 111.54 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -60.68 -49.71 76.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.094 -0.553 . . . . 74.32 109.972 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 49' ' ' GLU . 23.9 mt -61.99 -30.9 71.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 72.33 110.328 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 63' ' ' VAL . 3.3 m-85 -79.51 -27.63 41.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.706 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -109.06 15.69 23.13 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.36 0.504 . . . . 74.31 112.36 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -149.77 -43.69 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 111.946 0.35 . . . . 65.32 111.946 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.2 t -61.8 -146.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.663 -0.244 . . . . 60.45 111.117 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.48 17.92 1.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.762 0.282 . . . . 55.23 111.762 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.28 11.03 3.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 74.45 110.485 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 1.2 pttt -56.33 -21.97 27.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.484 . . . . 63.33 111.073 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.57 -17.92 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.579 . . . . 63.52 109.836 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -85.07 -145.87 0.1 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.254 -0.884 . . . . 74.15 110.069 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 112' ' ' ILE . 3.7 p -51.75 137.13 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.84 0.352 . . . . 43.11 110.376 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.441 HG11 ' OG1' ' A' ' 10' ' ' THR . 42.8 t -121.93 138.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 71.13 111.566 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.6 mm -86.62 106.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 74.41 109.972 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -105.35 170.71 7.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.453 0.644 . . . . 73.12 112.633 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HE2' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -159.7 157.78 30.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.836 -0.62 . . . . 75.0 111.233 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 p -150.04 157.15 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.771 . . . . 72.45 110.342 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.441 ' OD1' HG22 ' A' ' 71' ' ' THR . 1.6 t0 -89.7 120.96 31.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 53.31 110.948 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -87.6 28.01 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.12 110.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 69' ' ' ASP . 7.7 t -160.93 -21.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 70.43 112.344 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' ASP . . . -97.82 -15.76 20.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.786 0.326 . . . . 75.21 111.092 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.588 ' OD1' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -113.98 -157.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.778 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.64 83.18 1.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.022 0.439 . . . . 44.21 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 14' ' ' ALA . 11.8 m -83.17 145.97 50.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 64.1 111.182 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 -21.7 9.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 75.42 112.556 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.28 109.31 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.306 -0.406 . . . . 73.22 110.925 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.98 106.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.45 110.735 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.9 88.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 75.14 111.279 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -23.61 32.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 54.51 110.905 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.91 107.19 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.972 -0.632 . . . . 71.42 111.949 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -114.15 154.05 46.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.7 0.286 . . . . 73.35 111.041 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 4.3 Cg_exo -76.28 -171.55 9.84 Favored 'Cis proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 -1.47 . . . . 54.44 112.147 0.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 99' ' ' TYR . 95.6 m -163.08 142.95 8.97 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.94 -0.304 . . . . 60.21 111.075 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.9 mt -112.88 100.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.171 0.51 . . . . 73.34 110.792 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HD3' ' CE1' ' A' ' 32' ' ' PHE . 3.9 mtpp -100.2 127.02 46.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.881 -0.6 . . . . 71.15 111.164 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.844 HD21 HG23 ' A' ' 112' ' ' ILE . 3.3 tm? -97.86 108.23 20.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.584 . . . . 64.25 111.361 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.3 m-85 -96.2 90.89 0.76 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 110.021 -0.362 . . . . 73.15 110.021 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.798 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.9 Cg_endo -55.55 179.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.72 0 C-N-CA 122.678 2.252 . . . . 64.41 111.903 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -96.77 53.82 1.26 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.06 -22.46 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.546 -1.206 . . . . 72.44 111.93 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.798 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -122.07 42.64 3.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.901 0.381 . . . . 74.42 111.22 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -0.25 12.08 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.12 -0.491 . . . . 74.33 111.161 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.35 -23.34 27.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.064 -0.589 . . . . 43.25 112.104 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.494 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 3.5 tt0 -135.12 52.95 8.02 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 121.217 0.532 . . . . 60.44 110.209 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 71.0 Cg_exo -40.82 175.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.672 2.914 . . . . 75.41 113.308 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 115' ' ' ASN . 36.7 t -101.48 82.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 109.639 -0.504 . . . . 64.03 109.639 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 86' ' ' LYS . 8.9 t -59.78 126.79 28.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.636 -0.711 . . . . 64.43 109.588 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -135.75 178.73 6.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.032 -0.531 . . . . 52.53 111.886 -177.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.6 m -109.18 -46.03 3.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.035 -0.529 . . . . 62.1 110.587 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.77 178.74 27.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.896 -0.669 . . . . 62.13 112.435 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.53 111.64 0.08 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.611 -0.514 . . . . 75.23 109.611 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 53.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.422 -0.353 . . . . 74.42 110.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.705 HG23 ' HB2' ' A' ' 107' ' ' ASP . 12.7 t -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.965 0.412 . . . . 63.43 111.384 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' HB2' ' A' ' 46' ' ' LYS . 21.8 t -78.72 -29.88 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.898 -0.592 . . . . 53.23 111.584 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.08 -37.35 76.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 74.15 110.631 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.705 ' HB2' HG23 ' A' ' 104' ' ' THR . 80.4 m-20 -74.04 -26.2 60.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 112' ' ' ILE . 13.8 mt -70.11 -48.15 58.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.619 -0.719 . . . . 54.12 110.603 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 121' ' ' ALA . 6.3 mt -56.84 -53.7 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.945 -0.761 . . . . 65.14 108.945 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -64.45 -18.73 65.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.764 -0.653 . . . . 60.41 109.868 178.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.7 t80 -65.11 -77.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.811 -0.631 . . . . 64.35 110.602 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 29' ' ' LEU . 1.2 mp -66.87 -4.6 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.087 -0.506 . . . . 72.1 110.346 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.886 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -94.65 -19.54 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.14 -0.482 . . . . 65.34 111.243 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.06 -29.87 6.86 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.115 -1.068 . . . . 60.52 108.115 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.881 ' HB3' HG21 ' A' ' 97' ' ' VAL . 65.0 m-80 -90.31 -31.53 16.9 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.88 -1.509 . . . . 74.23 109.579 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -78.97 159.97 46.1 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.63 -0.795 . . . . 52.13 112.604 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 89' ' ' PRO . 4.4 mmpt? -87.88 -33.02 18.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.43 -0.952 . . . . 74.02 108.43 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -69.31 -22.37 63.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.413 -1.267 . . . . 73.14 110.233 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 57.63 41.91 24.79 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.158 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.41 105.9 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.797 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.886 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.255 -0.879 . . . . 73.22 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.542 -0.223 . . . . 64.35 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.97 113.53 3.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.592 2.194 . . . . 60.03 112.27 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.99 160.92 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.22 110.936 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.74 51.68 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.24 112.527 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 m -176.08 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 63.13 110.889 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.42 110.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.946 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.78 49.6 76.05 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.861 -0.685 . . . . 53.15 112.698 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 57.1 Cg_endo -75.71 -55.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.492 2.128 . . . . 72.52 112.473 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.912 HG21 ' CD2' ' A' ' 47' ' ' TYR . 1.3 p -52.89 130.77 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.869 -0.605 . . . . 64.01 110.985 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' ILE . 99.4 m -61.61 82.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 75.12 111.393 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 67' ' ' LYS . 1.7 p -70.89 93.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 71.41 109.795 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.782 HG11 HG23 ' A' ' 21' ' ' VAL . 7.7 p -105.03 136.94 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 72.12 111.301 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.839 ' HA ' HG23 ' A' ' 68' ' ' VAL . 2.7 m -86.99 177.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.298 -0.41 . . . . 73.01 109.918 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 75' ' ' VAL . . . -62.48 -17.59 59.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 75.33 110.352 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -67.26 -40.11 86.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.609 -0.723 . . . . 73.5 111.504 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -117.3 -7.13 11.24 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.459 0.54 . . . . 75.23 112.459 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.644 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -54.09 -17.89 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.321 0.489 . . . . 73.13 112.321 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 22' ' ' LEU . 13.5 p30 -97.3 -1.37 44.79 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.797 -0.816 . . . . 73.34 108.797 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -25.25 8.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.302 -1.317 . . . . 74.43 111.447 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 10' ' ' THR . 4.3 mm -110.16 -44.87 6.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.28 0.474 . . . . 65.13 112.28 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 30' ' ' ILE . 52.8 t -87.66 -21.0 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.452 0.644 . . . . 74.31 110.311 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -98.33 18.93 15.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.25 -0.887 . . . . 73.24 110.459 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -84.73 143.7 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 73.33 110.373 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -100.75 21.94 12.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.49 -0.323 . . . . 73.32 111.261 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -92.87 -22.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.484 -0.325 . . . . 53.34 110.888 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.34 164.28 24.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 70.12 110.687 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 20.4 m-20 -76.47 117.65 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.917 -0.401 . . . . 61.2 109.917 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG11 ' HA ' ' A' ' 21' ' ' VAL . 3.0 t -111.07 128.44 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 74.34 111.714 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 112' ' ' ILE . 13.0 tp -104.47 106.01 16.34 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.457 -0.792 . . . . 50.44 110.486 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.814 HG13 HG21 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -91.8 126.52 44.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 119.982 -0.687 . . . . 72.2 110.852 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.2 tt0 -108.74 85.96 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 70.24 111.551 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 83' ' ' PRO . 69.5 m-85 -56.68 130.6 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.21 109.291 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . 4.8 p90 -155.25 -164.96 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.472 0.653 . . . . 73.12 112.008 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -144.0 170.16 8.93 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.888 -1.051 . . . . 75.21 109.531 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 69.2 Cg_endo -89.0 -17.22 2.06 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.703 2.269 . . . . 62.4 110.746 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 68.9 p-90 -106.1 6.42 31.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.449 -1.25 . . . . 75.21 111.549 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -85.72 117.43 24.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 74.4 111.268 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.04 -13.58 67.0 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.597 -0.811 . . . . 73.01 112.356 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -79.38 -44.8 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.703 0.287 . . . . 54.12 110.962 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -61.39 -41.53 97.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.956 0.407 . . . . 73.23 110.476 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -51.02 -26.36 6.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 74.52 111.095 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 45' ' ' PRO . . . -87.27 -21.53 25.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 71.23 110.921 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -83.0 -33.44 26.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.508 -0.769 . . . . 75.32 110.962 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -41.0 -46.04 6.56 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.251 -0.886 . . . . 74.45 112.45 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 11.8 Cg_exo -66.23 -35.68 31.44 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.199 1.932 . . . . 75.14 111.556 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HE2' HD11 ' A' ' 108' ' ' LEU . 3.3 ptmt -76.46 -31.79 58.02 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.234 -0.894 . . . . 65.44 109.781 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.912 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -82.27 -25.69 33.81 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 74.31 111.407 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 8' ' ' PRO . 2.3 mt-10 -80.73 -34.36 34.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.138 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -90.33 -40.13 12.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.026 -0.533 . . . . 61.51 111.265 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.673 ' HG ' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -77.48 -38.02 50.03 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.966 0.889 . . . . 73.44 108.675 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.49 -45.01 31.17 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 114.332 -1.304 . . . . 32.42 112.514 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . . . -59.28 -49.08 79.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.235 0.541 . . . . 74.32 110.134 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -59.81 -44.68 93.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 72.33 110.094 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' LEU . 3.5 m-85 -70.44 -23.11 62.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.533 -0.758 . . . . 74.34 111.517 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . . . -108.5 11.6 26.72 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.403 0.52 . . . . 74.31 112.403 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -143.41 -43.5 0.29 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.855 0.317 . . . . 65.32 111.855 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -59.2 -150.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 60.45 111.288 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -81.58 19.5 1.02 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.783 0.29 . . . . 55.23 111.783 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -139.72 16.84 2.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.883 0.373 . . . . 74.45 110.4 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.0 pttp -58.69 -20.02 44.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 63.33 111.025 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -107.01 -15.74 14.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 63.52 110.081 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.56 -145.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.488 -0.778 . . . . 74.15 110.182 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.773 ' CG2' HG21 ' A' ' 112' ' ' ILE . 2.1 p -48.99 115.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.922 0.391 . . . . 43.11 110.465 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' ARG . 61.3 t -104.6 145.06 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 71.13 111.787 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.829 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.9 mm -90.63 111.44 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 74.41 110.005 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -108.65 165.28 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.115 0.483 . . . . 73.12 112.275 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HA ' ' H ' ' A' ' 31' ' ' GLU . 2.0 ptmt -159.26 154.67 25.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.144 -0.48 . . . . 75.0 111.383 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.7 p -147.01 155.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 72.45 110.94 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.799 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -91.39 105.05 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.919 0.39 . . . . 53.31 110.451 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -9.0 38.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.064 -0.517 . . . . 61.12 111.826 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HD3' ' A' ' 35' ' ' PRO . 6.8 t -118.0 -11.4 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.532 -0.304 . . . . 70.43 111.815 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -108.37 -15.45 14.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.21 111.13 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.452 ' ND2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -130.33 131.21 45.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.949 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.87 91.58 4.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 44.21 110.497 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 14' ' ' ALA . 25.8 m -73.07 150.07 89.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.199 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 -26.24 17.24 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 75.42 112.423 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.0 163.42 17.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.952 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.11 121.04 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.45 110.8 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.2 mt -106.6 84.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.14 111.175 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -24.58 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 54.51 110.828 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.89 107.89 0.65 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.961 -0.638 . . . . 71.42 112.015 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -114.73 153.52 46.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.649 0.261 . . . . 73.35 110.949 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' PHE . 2.8 Cg_exo -75.05 -171.14 8.99 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.552 -1.437 . . . . 54.44 112.23 0.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' TYR . 1.1 m -169.16 141.22 2.54 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.997 -0.281 . . . . 60.21 111.241 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 99' ' ' TYR . 4.7 mp -108.0 97.72 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.223 0.535 . . . . 73.34 111.548 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 98' ' ' THR . 6.4 mtmt -89.96 124.8 35.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 71.15 110.359 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 112' ' ' ILE . 3.2 tm? -102.16 110.37 22.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.424 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.544 ' CD2' ' HG3' ' A' ' 96' ' ' PRO . 5.2 m-85 -96.08 91.44 0.84 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 73.15 110.265 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' HD13 ' A' ' 87' ' ' LEU . 12.3 Cg_endo -57.26 169.25 2.23 Favored 'Trans proline' 0 CA--C 1.509 -0.734 0 C-N-CA 122.266 1.977 . . . . 64.41 111.504 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.83 55.19 2.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.648 -0.871 . . . . 75.24 108.648 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.12 -25.44 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.374 -1.284 . . . . 72.44 111.615 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' HB3' ' CG ' ' A' ' 89' ' ' PRO . . . -128.82 49.01 2.26 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.82 0.343 . . . . 74.42 111.235 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.597 ' HB2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.04 7.59 8.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.305 -0.407 . . . . 74.33 111.301 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.73 -25.59 22.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.999 -0.62 . . . . 43.25 111.611 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' PRO . 1.5 tt0 -139.53 55.48 7.1 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 121.176 0.512 . . . . 60.44 110.067 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 88' ' ' TYR . 42.1 Cg_exo -39.93 -179.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 124.027 3.151 . . . . 75.41 113.834 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.811 HG11 ' OD1' ' A' ' 115' ' ' ASN . 23.6 t -100.49 82.62 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 115.853 -0.612 . . . . 64.03 109.765 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' THR . 12.6 t -63.34 111.08 2.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 64.43 109.607 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.623 ' O ' HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -111.31 179.21 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 52.53 112.058 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.72 -42.49 3.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 62.1 111.171 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.16 171.82 21.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.561 -0.828 . . . . 62.13 112.678 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.8 m -158.32 -35.77 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 75.23 111.229 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' HD22 ' A' ' 43' ' ' LEU . 3.1 ttt-85 70.45 40.77 1.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.313 -0.403 . . . . 74.42 111.194 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.832 HG23 ' HB2' ' A' ' 107' ' ' ASP . 3.9 t -157.98 144.58 17.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 63.43 111.081 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG13 ' HG ' ' A' ' 50' ' ' LEU . 49.0 t -76.65 -46.3 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 53.23 110.447 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -40.53 7.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.693 -0.685 . . . . 74.15 111.523 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 104' ' ' THR . 44.5 m-20 -70.87 -34.64 71.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.997 -0.547 . . . . 53.32 110.073 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.736 HD11 ' HE2' ' A' ' 46' ' ' LYS . 20.3 mt -62.97 -49.31 75.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.675 -0.693 . . . . 54.12 110.703 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' ALA . 11.3 mt -53.69 -54.42 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.349 -0.612 . . . . 65.14 109.349 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 3.5 tppt? -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.605 -0.725 . . . . 60.41 109.947 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.2 t80 -66.05 -78.7 0.05 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.658 -0.701 . . . . 64.35 110.797 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -64.36 -5.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.194 -0.457 . . . . 72.1 110.257 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.683 ' CB ' ' HB2' ' A' ' 121' ' ' ALA . . . -92.15 -21.75 20.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 65.34 111.247 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 110' ' ' LYS . 3.0 mt-10 -116.53 -23.33 8.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.771 -0.826 . . . . 60.52 108.771 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.811 ' OD1' HG11 ' A' ' 97' ' ' VAL . 57.7 m-80 -95.54 -30.41 13.84 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.203 -1.362 . . . . 74.23 109.029 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 112' ' ' ILE . . . -79.59 162.83 47.68 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.198 -0.91 . . . . 52.13 112.605 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 89' ' ' PRO . 9.1 mmpt? -89.47 -32.49 17.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.381 -0.97 . . . . 74.02 108.381 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.81 -22.99 63.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.34 -1.3 . . . . 73.14 110.077 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 63.6 mmtt 55.79 40.92 30.71 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.083 -0.508 . . . . 73.22 111.185 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.743 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -69.09 104.66 2.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.937 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.683 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.21 -0.9 . . . . 73.22 111.08 179.895 . . . . . . . . 1 1 . 1 stop_ save_